 
# GREAT version 3.0.0	Species assembly: hg19	Association rule: Basal+extension: 5000 bp upstream, 1000 bp downstream, 1000000 bp max extension, curated regulatory domains included
# Ontology summary statistics are provided in the footer.
#
# Ontology	ID	Desc	BinomRank	BinomP	BinomBonfP	BinomFdrQ	RegionFoldEnrich	ExpRegions	ObsRegions	GenomeFrac	SetCov	HyperRank	HyperP	HyperBonfP	HyperFdrQ	GeneFoldEnrich	ExpGenes	ObsGenes	TotalGenes	GeneSetCov	TermCov	Regions	Genes
GO Molecular Function	GO:0050681	androgen receptor binding	1	5.045049e-3	1.000000e+0	1.000000e+0	1.982141e+2	5.045049e-3	1	5.045049e-3	1.000000e+0	1	4.208307e-3	1.000000e+0	1.000000e+0	2.373816e+2	4.212627e-3	1	38	5.000000e-1	2.631579e-2	unnamed	FHL2
GO Molecular Function	GO:0035258	steroid hormone receptor binding	2	8.410677e-3	1.000000e+0	1.000000e+0	1.188965e+2	8.410677e-3	1	8.410677e-3	1.000000e+0	2	7.193027e-3	1.000000e+0	1.000000e+0	1.387769e+2	7.205809e-3	1	65	5.000000e-1	1.538462e-2	unnamed	FHL2
GO Molecular Function	GO:0035257	nuclear hormone receptor binding	3	1.202945e-2	1.000000e+0	1.000000e+0	8.312935e+1	1.202945e-2	1	1.202945e-2	1.000000e+0	3	1.425002e-2	1.000000e+0	1.000000e+0	6.992636e+1	1.430076e-2	1	129	5.000000e-1	7.751938e-3	unnamed	FHL2
GO Molecular Function	GO:0051427	hormone receptor binding	4	1.383834e-2	1.000000e+0	1.000000e+0	7.226301e+1	1.383834e-2	1	1.383834e-2	1.000000e+0	4	1.634023e-2	1.000000e+0	1.000000e+0	6.094932e+1	1.640707e-2	1	148	5.000000e-1	6.756757e-3	unnamed	FHL2
GO Molecular Function	GO:0003713	transcription coactivator activity	5	3.228011e-2	1.000000e+0	1.000000e+0	3.097883e+1	3.228011e-2	1	3.228011e-2	1.000000e+0	5	3.025460e-2	1.000000e+0	1.000000e+0	3.280182e+1	3.048611e-2	1	275	5.000000e-1	3.636364e-3	unnamed	FHL2
GO Molecular Function	GO:0008134	transcription factor binding	6	5.376409e-2	1.000000e+0	1.000000e+0	1.859977e+1	5.376409e-2	1	5.376409e-2	1.000000e+0	6	5.023817e-2	1.000000e+0	1.000000e+0	1.965251e+1	5.088410e-2	1	459	5.000000e-1	2.178649e-3	unnamed	FHL2
GO Molecular Function	GO:0003712	transcription cofactor activity	7	6.062995e-2	1.000000e+0	1.000000e+0	1.649350e+1	6.062995e-2	1	6.062995e-2	1.000000e+0	7	5.293728e-2	1.000000e+0	1.000000e+0	1.863740e+1	5.365556e-2	1	484	5.000000e-1	2.066116e-3	unnamed	FHL2
GO Molecular Function	GO:0000989	transcription factor binding transcription factor activity	8	6.375977e-2	1.000000e+0	1.000000e+0	1.568387e+1	6.375977e-2	1	6.375977e-2	1.000000e+0	8	5.627884e-2	1.000000e+0	1.000000e+0	1.751553e+1	5.709218e-2	1	515	5.000000e-1	1.941748e-3	unnamed	FHL2
GO Molecular Function	GO:0000988	protein binding transcription factor activity	9	6.471391e-2	1.000000e+0	1.000000e+0	1.545263e+1	6.471391e-2	1	6.471391e-2	1.000000e+0	9	5.681724e-2	1.000000e+0	1.000000e+0	1.734712e+1	5.764647e-2	1	520	5.000000e-1	1.923077e-3	unnamed	FHL2
GO Molecular Function	GO:0042802	identical protein binding	10	9.800114e-2	1.000000e+0	1.000000e+0	1.020396e+1	9.800114e-2	1	9.800114e-2	1.000000e+0	10	1.043301e-1	1.000000e+0	1.000000e+0	9.328335e+0	1.072003e-1	1	967	5.000000e-1	1.034126e-3	unnamed	FHL2
GO Molecular Function	GO:0008270	zinc ion binding	11	1.136710e-1	1.000000e+0	1.000000e+0	8.797322e+0	1.136710e-1	1	1.136710e-1	1.000000e+0	11	1.276779e-1	1.000000e+0	1.000000e+0	7.573887e+0	1.320326e-1	1	1191	5.000000e-1	8.396306e-4	unnamed	FHL2
GO Molecular Function	GO:0005102	receptor binding	12	1.214505e-1	1.000000e+0	1.000000e+0	8.233804e+0	1.214505e-1	1	1.214505e-1	1.000000e+0	12	1.292303e-1	1.000000e+0	1.000000e+0	7.479685e+0	1.336955e-1	1	1206	5.000000e-1	8.291874e-4	unnamed	FHL2
GO Molecular Function	GO:0046914	transition metal ion binding	13	1.321251e-1	1.000000e+0	1.000000e+0	7.568583e+0	1.321251e-1	1	1.321251e-1	1.000000e+0	13	1.516365e-1	1.000000e+0	1.000000e+0	6.334621e+0	1.578626e-1	1	1424	5.000000e-1	7.022472e-4	unnamed	FHL2
GO Molecular Function	GO:0046872	metal ion binding	14	3.527991e-1	1.000000e+0	1.000000e+0	2.834474e+0	3.527991e-1	1	3.527991e-1	1.000000e+0	14	3.911753e-1	1.000000e+0	1.000000e+0	2.275605e+0	4.394435e-1	1	3964	5.000000e-1	2.522704e-4	unnamed	FHL2
GO Molecular Function	GO:0043169	cation binding	15	3.606111e-1	1.000000e+0	1.000000e+0	2.773071e+0	3.606111e-1	1	3.606111e-1	1.000000e+0	15	3.968711e-1	1.000000e+0	1.000000e+0	2.238337e+0	4.467602e-1	1	4030	5.000000e-1	2.481390e-4	unnamed	FHL2
GO Molecular Function	GO:0043167	ion binding	16	5.095070e-1	1.000000e+0	1.000000e+0	1.962682e+0	5.095070e-1	1	5.095070e-1	1.000000e+0	16	5.570694e-1	1.000000e+0	1.000000e+0	1.494945e+0	6.689208e-1	1	6034	5.000000e-1	1.657275e-4	unnamed	FHL2
GO Molecular Function	GO:0005515	protein binding	17	6.181781e-1	1.000000e+0	1.000000e+0	1.617657e+0	6.181781e-1	1	6.181781e-1	1.000000e+0	17	6.900633e-1	1.000000e+0	1.000000e+0	1.127985e+0	8.865362e-1	1	7997	5.000000e-1	1.250469e-4	unnamed	FHL2
GO Molecular Function	GO:0005488	binding	18	8.171102e-1	1.000000e+0	1.000000e+0	1.223825e+0	8.171102e-1	1	8.171102e-1	1.000000e+0	18	8.942547e-1	1.000000e+0	1.000000e+0	7.409644e-1	1.349593e+0	1	12174	5.000000e-1	8.214227e-5	unnamed	FHL2
GO Biological Process	GO:0055014	atrial cardiac muscle cell development	1	2.622819e-4	1.000000e+0	1.000000e+0	3.812692e+3	2.622819e-4	1	2.622819e-4	1.000000e+0	1	3.325574e-4	1.000000e+0	1.000000e+0	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	FHL2
GO Biological Process	GO:0060347	heart trabecula formation	2	1.286807e-3	1.000000e+0	1.000000e+0	7.771173e+2	1.286807e-3	1	1.286807e-3	1.000000e+0	3	1.662234e-3	1.000000e+0	1.000000e+0	6.013667e+2	1.662879e-3	1	15	5.000000e-1	6.666667e-2	unnamed	FHL2
GO Biological Process	GO:0061384	heart trabecula morphogenesis	3	2.280001e-3	1.000000e+0	1.000000e+0	4.385964e+2	2.280001e-3	1	2.280001e-3	1.000000e+0	5	2.437470e-3	1.000000e+0	1.000000e+0	4.100227e+2	2.438889e-3	1	22	5.000000e-1	4.545455e-2	unnamed	FHL2
GO Biological Process	GO:0060343	trabecula formation	4	2.593162e-3	1.000000e+0	1.000000e+0	3.856296e+2	2.593162e-3	1	2.593162e-3	1.000000e+0	6	2.658910e-3	1.000000e+0	1.000000e+0	3.758542e+2	2.660606e-3	1	24	5.000000e-1	4.166667e-2	unnamed	FHL2
GO Biological Process	GO:0055015	ventricular cardiac muscle cell development	5	2.636237e-3	1.000000e+0	1.000000e+0	3.793285e+2	2.636237e-3	1	2.636237e-3	1.000000e+0	2	1.551461e-3	1.000000e+0	1.000000e+0	6.443214e+2	1.552020e-3	1	14	5.000000e-1	7.142857e-2	unnamed	FHL2
GO Biological Process	GO:0061383	trabecula morphogenesis	6	3.740043e-3	1.000000e+0	1.000000e+0	2.673766e+2	3.740043e-3	1	3.740043e-3	1.000000e+0	7	3.765745e-3	1.000000e+0	1.000000e+0	2.653088e+2	3.769192e-3	1	34	5.000000e-1	2.941176e-2	unnamed	FHL2
GO Biological Process	GO:0055012	ventricular cardiac muscle cell differentiation	7	4.177245e-3	1.000000e+0	1.000000e+0	2.393922e+2	4.177245e-3	1	4.177245e-3	1.000000e+0	4	2.216004e-3	1.000000e+0	1.000000e+0	4.510250e+2	2.217172e-3	1	20	5.000000e-1	5.000000e-2	unnamed	FHL2
GO Biological Process	GO:0030521	androgen receptor signaling pathway	8	5.874865e-3	1.000000e+0	1.000000e+0	1.702167e+2	5.874865e-3	1	5.874865e-3	1.000000e+0	8	4.761371e-3	1.000000e+0	1.000000e+0	2.097791e+2	4.766920e-3	1	43	5.000000e-1	2.325581e-2	unnamed	FHL2
GO Biological Process	GO:0055013	cardiac muscle cell development	9	7.146840e-3	1.000000e+0	1.000000e+0	1.399220e+2	7.146840e-3	1	7.146840e-3	1.000000e+0	9	4.982553e-3	1.000000e+0	1.000000e+0	2.004556e+2	4.988637e-3	1	45	5.000000e-1	2.222222e-2	unnamed	FHL2
GO Biological Process	GO:0055006	cardiac cell development	10	7.639017e-3	1.000000e+0	1.000000e+0	1.309069e+2	7.639017e-3	1	7.639017e-3	1.000000e+0	10	5.203711e-3	1.000000e+0	1.000000e+0	1.919255e+2	5.210354e-3	1	47	5.000000e-1	2.127660e-2	unnamed	FHL2
GO Biological Process	GO:0030518	intracellular steroid hormone receptor signaling pathway	11	9.046228e-3	1.000000e+0	1.000000e+0	1.105433e+2	9.046228e-3	1	9.046228e-3	1.000000e+0	11	7.966112e-3	1.000000e+0	1.000000e+0	1.252847e+2	7.981819e-3	1	72	5.000000e-1	1.388889e-2	unnamed	FHL2
GO Biological Process	GO:0001649	osteoblast differentiation	12	1.156142e-2	1.000000e+0	1.000000e+0	8.649460e+1	1.156142e-2	1	1.156142e-2	1.000000e+0	12	8.407740e-3	1.000000e+0	1.000000e+0	1.186908e+2	8.425254e-3	1	76	5.000000e-1	1.315789e-2	unnamed	FHL2
GO Biological Process	GO:0055002	striated muscle cell development	13	1.257462e-2	1.000000e+0	1.000000e+0	7.952528e+1	1.257462e-2	1	1.257462e-2	1.000000e+0	14	1.050413e-2	1.000000e+0	1.000000e+0	9.495263e+1	1.053157e-2	1	95	5.000000e-1	1.052632e-2	unnamed	FHL2
GO Biological Process	GO:0055007	cardiac muscle cell differentiation	14	1.329217e-2	1.000000e+0	1.000000e+0	7.523225e+1	1.329217e-2	1	1.329217e-2	1.000000e+0	13	8.738896e-3	1.000000e+0	1.000000e+0	1.141835e+2	8.757829e-3	1	79	5.000000e-1	1.265823e-2	unnamed	FHL2
GO Biological Process	GO:0055001	muscle cell development	15	1.423284e-2	1.000000e+0	1.000000e+0	7.026002e+1	1.423284e-2	1	1.423284e-2	1.000000e+0	18	1.171681e-2	1.000000e+0	1.000000e+0	8.509906e+1	1.175101e-2	1	106	5.000000e-1	9.433962e-3	unnamed	FHL2
GO Biological Process	GO:0035051	cardiocyte differentiation	16	1.721953e-2	1.000000e+0	1.000000e+0	5.807360e+1	1.721953e-2	1	1.721953e-2	1.000000e+0	15	1.083493e-2	1.000000e+0	1.000000e+0	9.204592e+1	1.086414e-2	1	98	5.000000e-1	1.020408e-2	unnamed	FHL2
GO Biological Process	GO:0003206	cardiac chamber morphogenesis	17	1.806229e-2	1.000000e+0	1.000000e+0	5.536396e+1	1.806229e-2	1	1.806229e-2	1.000000e+0	17	1.116569e-2	1.000000e+0	1.000000e+0	8.931188e+1	1.119672e-2	1	101	5.000000e-1	9.900990e-3	unnamed	FHL2
GO Biological Process	GO:0003205	cardiac chamber development	18	2.129569e-2	1.000000e+0	1.000000e+0	4.695785e+1	2.129569e-2	1	2.129569e-2	1.000000e+0	19	1.314903e-2	1.000000e+0	1.000000e+0	7.580252e+1	1.319217e-2	1	119	5.000000e-1	8.403361e-3	unnamed	FHL2
GO Biological Process	GO:0048738	cardiac muscle tissue development	19	2.162079e-2	1.000000e+0	1.000000e+0	4.625178e+1	2.162079e-2	1	2.162079e-2	1.000000e+0	20	1.447015e-2	1.000000e+0	1.000000e+0	6.885878e+1	1.452248e-2	1	131	5.000000e-1	7.633588e-3	unnamed	FHL2
GO Biological Process	GO:0051146	striated muscle cell differentiation	20	2.241822e-2	1.000000e+0	1.000000e+0	4.460658e+1	2.241822e-2	1	2.241822e-2	1.000000e+0	21	1.765921e-2	1.000000e+0	1.000000e+0	5.637812e+1	1.773738e-2	1	160	5.000000e-1	6.250000e-3	unnamed	FHL2
GO Biological Process	GO:0030522	intracellular receptor signaling pathway	21	2.289937e-2	1.000000e+0	1.000000e+0	4.366933e+1	2.289937e-2	1	2.289937e-2	1.000000e+0	22	1.974579e-2	1.000000e+0	1.000000e+0	5.039385e+1	1.984369e-2	1	179	5.000000e-1	5.586592e-3	unnamed	FHL2
GO Biological Process	GO:0001503	ossification	22	2.567877e-2	1.000000e+0	1.000000e+0	3.894267e+1	2.567877e-2	1	2.567877e-2	1.000000e+0	24	2.172051e-2	1.000000e+0	1.000000e+0	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	FHL2
GO Biological Process	GO:0003007	heart morphogenesis	23	3.155445e-2	1.000000e+0	1.000000e+0	3.169125e+1	3.155445e-2	1	3.155445e-2	1.000000e+0	23	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	FHL2
GO Biological Process	GO:0042692	muscle cell differentiation	24	3.407161e-2	1.000000e+0	1.000000e+0	2.934995e+1	3.407161e-2	1	3.407161e-2	1.000000e+0	25	2.500727e-2	1.000000e+0	1.000000e+0	3.973789e+1	2.516490e-2	1	227	5.000000e-1	4.405286e-3	unnamed	FHL2
GO Biological Process	GO:0014706	striated muscle tissue development	25	3.543065e-2	1.000000e+0	1.000000e+0	2.822415e+1	3.543065e-2	1	3.543065e-2	1.000000e+0	26	2.653920e-2	1.000000e+0	1.000000e+0	3.742946e+1	2.671692e-2	1	241	5.000000e-1	4.149378e-3	unnamed	FHL2
GO Biological Process	GO:0060537	muscle tissue development	26	3.787799e-2	1.000000e+0	1.000000e+0	2.640055e+1	3.787799e-2	1	3.787799e-2	1.000000e+0	27	2.785133e-2	1.000000e+0	1.000000e+0	3.565415e+1	2.804723e-2	1	253	5.000000e-1	3.952569e-3	unnamed	FHL2
GO Biological Process	GO:0061061	muscle structure development	27	5.824539e-2	1.000000e+0	1.000000e+0	1.716874e+1	5.824539e-2	1	5.824539e-2	1.000000e+0	30	4.601990e-2	1.000000e+0	1.000000e+0	2.147738e+1	4.656061e-2	1	420	5.000000e-1	2.380952e-3	unnamed	FHL2
GO Biological Process	GO:0007507	heart development	28	6.055164e-2	1.000000e+0	1.000000e+0	1.651483e+1	6.055164e-2	1	6.055164e-2	1.000000e+0	29	4.417824e-2	1.000000e+0	1.000000e+0	2.238337e+1	4.467602e-2	1	403	5.000000e-1	2.481390e-3	unnamed	FHL2
GO Biological Process	GO:0043066	negative regulation of apoptotic process	29	7.076490e-2	1.000000e+0	1.000000e+0	1.413130e+1	7.076490e-2	1	7.076490e-2	1.000000e+0	36	7.150984e-2	1.000000e+0	1.000000e+0	1.372983e+1	7.283410e-2	1	657	5.000000e-1	1.522070e-3	unnamed	FHL2
GO Biological Process	GO:0044255	cellular lipid metabolic process	30	7.113785e-2	1.000000e+0	1.000000e+0	1.405721e+1	7.113785e-2	1	7.113785e-2	1.000000e+0	43	8.894639e-2	1.000000e+0	1.000000e+0	1.098721e+1	9.101491e-2	1	821	5.000000e-1	1.218027e-3	unnamed	FHL2
GO Biological Process	GO:0043069	negative regulation of programmed cell death	31	7.183207e-2	1.000000e+0	1.000000e+0	1.392136e+1	7.183207e-2	1	7.183207e-2	1.000000e+0	37	7.225746e-2	1.000000e+0	1.000000e+0	1.358509e+1	7.361011e-2	1	664	5.000000e-1	1.506024e-3	unnamed	FHL2
GO Biological Process	GO:0048598	embryonic morphogenesis	32	7.360031e-2	1.000000e+0	1.000000e+0	1.358690e+1	7.360031e-2	1	7.360031e-2	1.000000e+0	33	5.552481e-2	1.000000e+0	1.000000e+0	1.775689e+1	5.631617e-2	1	508	5.000000e-1	1.968504e-3	unnamed	C2orf49
GO Biological Process	GO:0009725	response to hormone stimulus	33	7.546651e-2	1.000000e+0	1.000000e+0	1.325091e+1	7.546651e-2	1	7.546651e-2	1.000000e+0	39	7.673686e-2	1.000000e+0	1.000000e+0	1.277691e+1	7.826617e-2	1	706	5.000000e-1	1.416431e-3	unnamed	FHL2
GO Biological Process	GO:0060548	negative regulation of cell death	34	7.699389e-2	1.000000e+0	1.000000e+0	1.298804e+1	7.699389e-2	1	7.699389e-2	1.000000e+0	38	7.535154e-2	1.000000e+0	1.000000e+0	1.301659e+1	7.682501e-2	1	693	5.000000e-1	1.443001e-3	unnamed	FHL2
GO Biological Process	GO:0000122	negative regulation of transcription from RNA polymerase II promoter	35	7.804643e-2	1.000000e+0	1.000000e+0	1.281289e+1	7.804643e-2	1	7.804643e-2	1.000000e+0	35	6.240758e-2	1.000000e+0	1.000000e+0	1.577010e+1	6.341112e-2	1	572	5.000000e-1	1.748252e-3	unnamed	FHL2
GO Biological Process	GO:0006629	lipid metabolic process	36	9.193917e-2	1.000000e+0	1.000000e+0	1.087676e+1	9.193917e-2	1	9.193917e-2	1.000000e+0	54	1.144784e-1	1.000000e+0	1.000000e+0	8.477914e+0	1.179536e-1	1	1064	5.000000e-1	9.398496e-4	unnamed	FHL2
GO Biological Process	GO:0048646	anatomical structure formation involved in morphogenesis	37	1.047361e-1	1.000000e+0	1.000000e+0	9.547802e+0	1.047361e-1	1	1.047361e-1	1.000000e+0	42	8.375400e-2	1.000000e+0	1.000000e+0	1.168459e+1	8.558284e-2	1	772	5.000000e-1	1.295337e-3	unnamed	FHL2
GO Biological Process	GO:0072358	cardiovascular system development	38	1.056924e-1	1.000000e+0	1.000000e+0	9.461416e+0	1.056924e-1	1	1.056924e-1	1.000000e+0	40	7.854686e-2	1.000000e+0	1.000000e+0	1.247649e+1	8.015077e-2	1	723	5.000000e-1	1.383126e-3	unnamed	FHL2
GO Biological Process	GO:0045892	negative regulation of transcription, DNA-dependent	39	1.104440e-1	1.000000e+0	1.000000e+0	9.054358e+0	1.104440e-1	1	1.104440e-1	1.000000e+0	44	9.517887e-2	1.000000e+0	1.000000e+0	1.025057e+1	9.755557e-2	1	880	5.000000e-1	1.136364e-3	unnamed	FHL2
GO Biological Process	GO:0009887	organ morphogenesis	40	1.105874e-1	1.000000e+0	1.000000e+0	9.042623e+0	1.105874e-1	1	1.105874e-1	1.000000e+0	41	8.322334e-2	1.000000e+0	1.000000e+0	1.176076e+1	8.502855e-2	1	767	5.000000e-1	1.303781e-3	unnamed	FHL2
GO Biological Process	GO:0051253	negative regulation of RNA metabolic process	41	1.131743e-1	1.000000e+0	1.000000e+0	8.835931e+0	1.131743e-1	1	1.131743e-1	1.000000e+0	46	9.918168e-2	1.000000e+0	1.000000e+0	9.826253e+0	1.017682e-1	1	918	5.000000e-1	1.089325e-3	unnamed	FHL2
GO Biological Process	GO:2000113	negative regulation of cellular macromolecule biosynthetic process	42	1.195916e-1	1.000000e+0	1.000000e+0	8.361790e+0	1.195916e-1	1	1.195916e-1	1.000000e+0	50	1.065321e-1	1.000000e+0	1.000000e+0	9.130061e+0	1.095283e-1	1	988	5.000000e-1	1.012146e-3	unnamed	FHL2
GO Biological Process	GO:0010629	negative regulation of gene expression	43	1.196382e-1	1.000000e+0	1.000000e+0	8.358535e+0	1.196382e-1	1	1.196382e-1	1.000000e+0	48	1.056935e-1	1.000000e+0	1.000000e+0	9.204592e+0	1.086414e-1	1	980	5.000000e-1	1.020408e-3	unnamed	FHL2
GO Biological Process	GO:0042981	regulation of apoptotic process	44	1.200175e-1	1.000000e+0	1.000000e+0	8.332116e+0	1.200175e-1	1	1.200175e-1	1.000000e+0	60	1.243613e-1	1.000000e+0	1.000000e+0	7.783003e+0	1.284851e-1	1	1159	5.000000e-1	8.628128e-4	unnamed	FHL2
GO Biological Process	GO:0043067	regulation of programmed cell death	45	1.213630e-1	1.000000e+0	1.000000e+0	8.239741e+0	1.213630e-1	1	1.213630e-1	1.000000e+0	62	1.256058e-1	1.000000e+0	1.000000e+0	7.703245e+0	1.298154e-1	1	1171	5.000000e-1	8.539710e-4	unnamed	FHL2
GO Biological Process	GO:0010558	negative regulation of macromolecule biosynthetic process	46	1.230904e-1	1.000000e+0	1.000000e+0	8.124112e+0	1.230904e-1	1	1.230904e-1	1.000000e+0	53	1.108233e-1	1.000000e+0	1.000000e+0	8.766278e+0	1.140735e-1	1	1029	5.000000e-1	9.718173e-4	unnamed	FHL2
GO Biological Process	GO:0045934	negative regulation of nucleobase-containing compound metabolic process	47	1.236988e-1	1.000000e+0	1.000000e+0	8.084155e+0	1.236988e-1	1	1.236988e-1	1.000000e+0	51	1.087313e-1	1.000000e+0	1.000000e+0	8.940040e+0	1.118563e-1	1	1009	5.000000e-1	9.910803e-4	unnamed	FHL2
GO Biological Process	GO:0051172	negative regulation of nitrogen compound metabolic process	48	1.247094e-1	1.000000e+0	1.000000e+0	8.018640e+0	1.247094e-1	1	1.247094e-1	1.000000e+0	52	1.101959e-1	1.000000e+0	1.000000e+0	8.817693e+0	1.134083e-1	1	1023	5.000000e-1	9.775171e-4	unnamed	FHL2
GO Biological Process	GO:0009790	embryo development	49	1.260409e-1	1.000000e+0	1.000000e+0	7.933935e+0	1.260409e-1	1	1.260409e-1	1.000000e+0	47	1.021254e-1	1.000000e+0	1.000000e+0	9.535412e+0	1.048722e-1	1	946	5.000000e-1	1.057082e-3	unnamed	C2orf49
GO Biological Process	GO:0010941	regulation of cell death	50	1.261875e-1	1.000000e+0	1.000000e+0	7.924714e+0	1.261875e-1	1	1.261875e-1	1.000000e+0	63	1.296441e-1	1.000000e+0	1.000000e+0	7.454959e+0	1.341389e-1	1	1210	5.000000e-1	8.264463e-4	unnamed	FHL2
GO Biological Process	GO:0009719	response to endogenous stimulus	51	1.264308e-1	1.000000e+0	1.000000e+0	7.909468e+0	1.264308e-1	1	1.264308e-1	1.000000e+0	59	1.223892e-1	1.000000e+0	1.000000e+0	7.912719e+0	1.263788e-1	1	1140	5.000000e-1	8.771930e-4	unnamed	FHL2
GO Biological Process	GO:0031327	negative regulation of cellular biosynthetic process	52	1.294140e-1	1.000000e+0	1.000000e+0	7.727141e+0	1.294140e-1	1	1.294140e-1	1.000000e+0	56	1.157298e-1	1.000000e+0	1.000000e+0	8.383364e+0	1.192839e-1	1	1076	5.000000e-1	9.293680e-4	unnamed	FHL2
GO Biological Process	GO:0009890	negative regulation of biosynthetic process	53	1.306849e-1	1.000000e+0	1.000000e+0	7.651996e+0	1.306849e-1	1	1.306849e-1	1.000000e+0	57	1.172929e-1	1.000000e+0	1.000000e+0	8.268103e+0	1.209467e-1	1	1091	5.000000e-1	9.165903e-4	unnamed	FHL2
GO Biological Process	GO:0045893	positive regulation of transcription, DNA-dependent	54	1.366972e-1	1.000000e+0	1.000000e+0	7.315436e+0	1.366972e-1	1	1.366972e-1	1.000000e+0	55	1.155213e-1	1.000000e+0	1.000000e+0	8.398976e+0	1.190621e-1	1	1074	5.000000e-1	9.310987e-4	unnamed	FHL2
GO Biological Process	GO:0051254	positive regulation of RNA metabolic process	55	1.403288e-1	1.000000e+0	1.000000e+0	7.126123e+0	1.403288e-1	1	1.403288e-1	1.000000e+0	58	1.219737e-1	1.000000e+0	1.000000e+0	7.940581e+0	1.259354e-1	1	1136	5.000000e-1	8.802817e-4	unnamed	FHL2
GO Biological Process	GO:0010628	positive regulation of gene expression	56	1.480202e-1	1.000000e+0	1.000000e+0	6.755834e+0	1.480202e-1	1	1.480202e-1	1.000000e+0	61	1.249837e-1	1.000000e+0	1.000000e+0	7.742918e+0	1.291503e-1	1	1165	5.000000e-1	8.583691e-4	unnamed	FHL2
GO Biological Process	GO:0010557	positive regulation of macromolecule biosynthetic process	57	1.506028e-1	1.000000e+0	1.000000e+0	6.639981e+0	1.506028e-1	1	1.506028e-1	1.000000e+0	64	1.356324e-1	1.000000e+0	1.000000e+0	7.113959e+0	1.405687e-1	1	1268	5.000000e-1	7.886435e-4	unnamed	FHL2
GO Biological Process	GO:0045935	positive regulation of nucleobase-containing compound metabolic process	58	1.543505e-1	1.000000e+0	1.000000e+0	6.478762e+0	1.543505e-1	1	1.543505e-1	1.000000e+0	65	1.361477e-1	1.000000e+0	1.000000e+0	7.086017e+0	1.411230e-1	1	1273	5.000000e-1	7.855460e-4	unnamed	FHL2
GO Biological Process	GO:0051173	positive regulation of nitrogen compound metabolic process	59	1.569956e-1	1.000000e+0	1.000000e+0	6.369604e+0	1.569956e-1	1	1.569956e-1	1.000000e+0	66	1.389275e-1	1.000000e+0	1.000000e+0	6.938846e+0	1.441162e-1	1	1300	5.000000e-1	7.692308e-4	unnamed	FHL2
GO Biological Process	GO:0031328	positive regulation of cellular biosynthetic process	60	1.595607e-1	1.000000e+0	1.000000e+0	6.267208e+0	1.595607e-1	1	1.595607e-1	1.000000e+0	69	1.447813e-1	1.000000e+0	1.000000e+0	6.647384e+0	1.504351e-1	1	1357	5.000000e-1	7.369197e-4	unnamed	FHL2
GO Biological Process	GO:0009891	positive regulation of biosynthetic process	61	1.621017e-1	1.000000e+0	1.000000e+0	6.168967e+0	1.621017e-1	1	1.621017e-1	1.000000e+0	71	1.471377e-1	1.000000e+0	1.000000e+0	6.536594e+0	1.529849e-1	1	1380	5.000000e-1	7.246377e-4	unnamed	FHL2
GO Biological Process	GO:0010605	negative regulation of macromolecule metabolic process	62	1.635114e-1	1.000000e+0	1.000000e+0	6.115780e+0	1.635114e-1	1	1.635114e-1	1.000000e+0	73	1.573451e-1	1.000000e+0	1.000000e+0	6.094932e+0	1.640707e-1	1	1480	5.000000e-1	6.756757e-4	unnamed	FHL2
GO Biological Process	GO:0006357	regulation of transcription from RNA polymerase II promoter	63	1.636782e-1	1.000000e+0	1.000000e+0	6.109548e+0	1.636782e-1	1	1.636782e-1	1.000000e+0	70	1.461136e-1	1.000000e+0	1.000000e+0	6.584307e+0	1.518763e-1	1	1370	5.000000e-1	7.299270e-4	unnamed	FHL2
GO Biological Process	GO:0031324	negative regulation of cellular metabolic process	64	1.637788e-1	1.000000e+0	1.000000e+0	6.105797e+0	1.637788e-1	1	1.637788e-1	1.000000e+0	72	1.567344e-1	1.000000e+0	1.000000e+0	6.119742e+0	1.634056e-1	1	1474	5.000000e-1	6.784261e-4	unnamed	FHL2
GO Biological Process	GO:0009888	tissue development	65	1.692045e-1	1.000000e+0	1.000000e+0	5.910010e+0	1.692045e-1	1	1.692045e-1	1.000000e+0	68	1.422163e-1	1.000000e+0	1.000000e+0	6.772147e+0	1.476637e-1	1	1332	5.000000e-1	7.507508e-4	unnamed	FHL2
GO Biological Process	GO:0009892	negative regulation of metabolic process	66	1.743568e-1	1.000000e+0	1.000000e+0	5.735367e+0	1.743568e-1	1	1.743568e-1	1.000000e+0	74	1.686034e-1	1.000000e+0	1.000000e+0	5.669705e+0	1.763760e-1	1	1591	5.000000e-1	6.285355e-4	unnamed	FHL2
GO Biological Process	GO:0048468	cell development	67	1.837839e-1	1.000000e+0	1.000000e+0	5.441172e+0	1.837839e-1	1	1.837839e-1	1.000000e+0	67	1.403671e-1	1.000000e+0	1.000000e+0	6.864916e+0	1.456682e-1	1	1314	5.000000e-1	7.610350e-4	unnamed	FHL2
GO Biological Process	GO:0044281	small molecule metabolic process	68	2.001784e-1	1.000000e+0	1.000000e+0	4.995545e+0	2.001784e-1	1	2.001784e-1	1.000000e+0	81	2.509628e-1	1.000000e+0	1.000000e+0	3.716728e+0	2.690538e-1	1	2427	5.000000e-1	4.120313e-4	unnamed	FHL2
GO Biological Process	GO:0010033	response to organic substance	69	2.019131e-1	1.000000e+0	1.000000e+0	4.952626e+0	2.019131e-1	1	2.019131e-1	1.000000e+0	77	2.147469e-1	1.000000e+0	1.000000e+0	4.391675e+0	2.277036e-1	1	2054	5.000000e-1	4.868549e-4	unnamed	FHL2
GO Biological Process	GO:0010604	positive regulation of macromolecule metabolic process	70	2.215598e-1	1.000000e+0	1.000000e+0	4.513455e+0	2.215598e-1	1	2.215598e-1	1.000000e+0	75	2.091373e-1	1.000000e+0	1.000000e+0	4.517026e+0	2.213846e-1	1	1997	5.000000e-1	5.007511e-4	unnamed	FHL2
GO Biological Process	GO:0031325	positive regulation of cellular metabolic process	71	2.230682e-1	1.000000e+0	1.000000e+0	4.482934e+0	2.230682e-1	1	2.230682e-1	1.000000e+0	76	2.132726e-1	1.000000e+0	1.000000e+0	4.423982e+0	2.260407e-1	1	2039	5.000000e-1	4.904365e-4	unnamed	FHL2
GO Biological Process	GO:0006351	transcription, DNA-dependent	72	2.234119e-1	1.000000e+0	1.000000e+0	4.476036e+0	2.234119e-1	1	2.234119e-1	1.000000e+0	80	2.497150e-1	1.000000e+0	1.000000e+0	3.736744e+0	2.676127e-1	1	2414	5.000000e-1	4.142502e-4	unnamed	FHL2
GO Biological Process	GO:0032774	RNA biosynthetic process	73	2.268650e-1	1.000000e+0	1.000000e+0	4.407908e+0	2.268650e-1	1	2.268650e-1	1.000000e+0	82	2.585235e-1	1.000000e+0	1.000000e+0	3.599561e+0	2.778117e-1	1	2506	5.000000e-1	3.990423e-4	unnamed	FHL2
GO Biological Process	GO:0009893	positive regulation of metabolic process	74	2.357828e-1	1.000000e+0	1.000000e+0	4.241191e+0	2.357828e-1	1	2.357828e-1	1.000000e+0	78	2.244425e-1	1.000000e+0	1.000000e+0	4.189735e+0	2.386786e-1	1	2153	5.000000e-1	4.644682e-4	unnamed	FHL2
GO Biological Process	GO:0034654	nucleobase-containing compound biosynthetic process	75	2.447967e-1	1.000000e+0	1.000000e+0	4.085022e+0	2.447967e-1	1	2.447967e-1	1.000000e+0	84	2.799409e-1	1.000000e+0	1.000000e+0	3.301794e+0	3.028657e-1	1	2732	5.000000e-1	3.660322e-4	unnamed	FHL2
GO Biological Process	GO:0009653	anatomical structure morphogenesis	76	2.467616e-1	1.000000e+0	1.000000e+0	4.052494e+0	2.467616e-1	1	2.467616e-1	1.000000e+0	16	1.106283e-2	1.000000e+0	1.000000e+0	9.505269e+0	2.104096e-1	2	1898	1.000000e+0	1.053741e-3	unnamed	C2orf49,FHL2
GO Biological Process	GO:0018130	heterocycle biosynthetic process	77	2.497654e-1	1.000000e+0	1.000000e+0	4.003758e+0	2.497654e-1	1	2.497654e-1	1.000000e+0	86	2.868855e-1	1.000000e+0	1.000000e+0	3.214718e+0	3.110692e-1	1	2806	5.000000e-1	3.563792e-4	unnamed	FHL2
GO Biological Process	GO:0019438	aromatic compound biosynthetic process	78	2.512206e-1	1.000000e+0	1.000000e+0	3.980565e+0	2.512206e-1	1	2.512206e-1	1.000000e+0	87	2.869791e-1	1.000000e+0	1.000000e+0	3.213573e+0	3.111801e-1	1	2807	5.000000e-1	3.562522e-4	unnamed	FHL2
GO Biological Process	GO:0044710	single-organism metabolic process	79	2.517961e-1	1.000000e+0	1.000000e+0	3.971468e+0	2.517961e-1	1	2.517961e-1	1.000000e+0	91	3.105584e-1	1.000000e+0	1.000000e+0	2.946913e+0	3.393382e-1	1	3061	5.000000e-1	3.266906e-4	unnamed	FHL2
GO Biological Process	GO:0044271	cellular nitrogen compound biosynthetic process	80	2.531794e-1	1.000000e+0	1.000000e+0	3.949768e+0	2.531794e-1	1	2.531794e-1	1.000000e+0	88	2.917453e-1	1.000000e+0	1.000000e+0	3.156228e+0	3.168339e-1	1	2858	5.000000e-1	3.498950e-4	unnamed	FHL2
GO Biological Process	GO:1901362	organic cyclic compound biosynthetic process	81	2.593182e-1	1.000000e+0	1.000000e+0	3.856266e+0	2.593182e-1	1	2.593182e-1	1.000000e+0	89	2.978897e-1	1.000000e+0	1.000000e+0	3.084986e+0	3.241505e-1	1	2924	5.000000e-1	3.419973e-4	unnamed	FHL2
GO Biological Process	GO:0016070	RNA metabolic process	82	2.686590e-1	1.000000e+0	1.000000e+0	3.722190e+0	2.686590e-1	1	2.686590e-1	1.000000e+0	92	3.211950e-1	1.000000e+0	1.000000e+0	2.839314e+0	3.521978e-1	1	3177	5.000000e-1	3.147624e-4	unnamed	FHL2
GO Biological Process	GO:0048513	organ development	83	2.824258e-1	1.000000e+0	1.000000e+0	3.540753e+0	2.824258e-1	1	2.824258e-1	1.000000e+0	79	2.446169e-1	1.000000e+0	1.000000e+0	3.820627e+0	2.617372e-1	1	2361	5.000000e-1	4.235493e-4	unnamed	FHL2
GO Biological Process	GO:0010467	gene expression	84	2.836887e-1	1.000000e+0	1.000000e+0	3.524990e+0	2.836887e-1	1	2.836887e-1	1.000000e+0	102	3.441967e-1	1.000000e+0	1.000000e+0	2.629117e+0	3.803559e-1	1	3431	5.000000e-1	2.914602e-4	unnamed	FHL2
GO Biological Process	GO:0034645	cellular macromolecule biosynthetic process	85	2.892943e-1	1.000000e+0	1.000000e+0	3.456687e+0	2.892943e-1	1	2.892943e-1	1.000000e+0	97	3.331981e-1	1.000000e+0	1.000000e+0	2.726050e+0	3.668311e-1	1	3309	5.000000e-1	3.022061e-4	unnamed	FHL2
GO Biological Process	GO:0042221	response to chemical stimulus	86	2.954524e-1	1.000000e+0	1.000000e+0	3.384640e+0	2.954524e-1	1	2.954524e-1	1.000000e+0	95	3.326549e-1	1.000000e+0	1.000000e+0	2.731002e+0	3.661660e-1	1	3303	5.000000e-1	3.027551e-4	unnamed	FHL2
GO Biological Process	GO:0009059	macromolecule biosynthetic process	87	2.955002e-1	1.000000e+0	1.000000e+0	3.384092e+0	2.955002e-1	1	2.955002e-1	1.000000e+0	100	3.377168e-1	1.000000e+0	1.000000e+0	2.685472e+0	3.723740e-1	1	3359	5.000000e-1	2.977077e-4	unnamed	FHL2
GO Biological Process	GO:0006355	regulation of transcription, DNA-dependent	88	3.043461e-1	1.000000e+0	1.000000e+0	3.285733e+0	3.043461e-1	1	3.043461e-1	1.000000e+0	93	3.260273e-1	1.000000e+0	1.000000e+0	2.792724e+0	3.580733e-1	1	3230	5.000000e-1	3.095975e-4	unnamed	FHL2
GO Biological Process	GO:2001141	regulation of RNA biosynthetic process	89	3.046463e-1	1.000000e+0	1.000000e+0	3.282495e+0	3.046463e-1	1	3.046463e-1	1.000000e+0	94	3.275736e-1	1.000000e+0	1.000000e+0	2.778103e+0	3.599579e-1	1	3247	5.000000e-1	3.079766e-4	unnamed	FHL2
GO Biological Process	GO:0090304	nucleic acid metabolic process	90	3.065231e-1	1.000000e+0	1.000000e+0	3.262397e+0	3.065231e-1	1	3.065231e-1	1.000000e+0	109	3.768188e-1	1.000000e+0	1.000000e+0	2.374441e+0	4.211518e-1	1	3799	5.000000e-1	2.632272e-4	unnamed	FHL2
GO Biological Process	GO:0051252	regulation of RNA metabolic process	91	3.113245e-1	1.000000e+0	1.000000e+0	3.212082e+0	3.113245e-1	1	3.113245e-1	1.000000e+0	98	3.336507e-1	1.000000e+0	1.000000e+0	2.721937e+0	3.673854e-1	1	3314	5.000000e-1	3.017502e-4	unnamed	FHL2
GO Biological Process	GO:0048523	negative regulation of cellular process	92	3.146568e-1	1.000000e+0	1.000000e+0	3.178065e+0	3.146568e-1	1	3.146568e-1	1.000000e+0	90	3.089005e-1	1.000000e+0	1.000000e+0	2.964344e+0	3.373427e-1	1	3043	5.000000e-1	3.286231e-4	unnamed	FHL2
GO Biological Process	GO:0030154	cell differentiation	93	3.160741e-1	1.000000e+0	1.000000e+0	3.163815e+0	3.160741e-1	1	3.160741e-1	1.000000e+0	83	2.690819e-1	1.000000e+0	1.000000e+0	3.446886e+0	2.901170e-1	1	2617	5.000000e-1	3.821169e-4	unnamed	FHL2
GO Biological Process	GO:0048869	cellular developmental process	94	3.225257e-1	1.000000e+0	1.000000e+0	3.100528e+0	3.225257e-1	1	3.225257e-1	1.000000e+0	85	2.802231e-1	1.000000e+0	1.000000e+0	3.298172e+0	3.031983e-1	1	2735	5.000000e-1	3.656307e-4	unnamed	FHL2
GO Biological Process	GO:2000112	regulation of cellular macromolecule biosynthetic process	95	3.236874e-1	1.000000e+0	1.000000e+0	3.089400e+0	3.236874e-1	1	3.236874e-1	1.000000e+0	103	3.508235e-1	1.000000e+0	1.000000e+0	2.573609e+0	3.885594e-1	1	3505	5.000000e-1	2.853067e-4	unnamed	FHL2
GO Biological Process	GO:0010556	regulation of macromolecule biosynthetic process	96	3.285042e-1	1.000000e+0	1.000000e+0	3.044101e+0	3.285042e-1	1	3.285042e-1	1.000000e+0	104	3.578608e-1	1.000000e+0	1.000000e+0	2.516881e+0	3.973172e-1	1	3584	5.000000e-1	2.790179e-4	unnamed	FHL2
GO Biological Process	GO:0048519	negative regulation of biological process	97	3.368683e-1	1.000000e+0	1.000000e+0	2.968519e+0	3.368683e-1	1	3.368683e-1	1.000000e+0	99	3.341936e-1	1.000000e+0	1.000000e+0	2.717018e+0	3.680506e-1	1	3320	5.000000e-1	3.012048e-4	unnamed	FHL2
GO Biological Process	GO:0048522	positive regulation of cellular process	98	3.411192e-1	1.000000e+0	1.000000e+0	2.931526e+0	3.411192e-1	1	3.411192e-1	1.000000e+0	96	3.331076e-1	1.000000e+0	1.000000e+0	2.726874e+0	3.667202e-1	1	3308	5.000000e-1	3.022975e-4	unnamed	FHL2
GO Biological Process	GO:0031326	regulation of cellular biosynthetic process	99	3.434354e-1	1.000000e+0	1.000000e+0	2.911756e+0	3.434354e-1	1	3.434354e-1	1.000000e+0	106	3.710294e-1	1.000000e+0	1.000000e+0	2.416421e+0	4.138352e-1	1	3733	5.000000e-1	2.678811e-4	unnamed	FHL2
GO Biological Process	GO:0010468	regulation of gene expression	100	3.434880e-1	1.000000e+0	1.000000e+0	2.911310e+0	3.434880e-1	1	3.434880e-1	1.000000e+0	107	3.723475e-1	1.000000e+0	1.000000e+0	2.406750e+0	4.154980e-1	1	3748	5.000000e-1	2.668090e-4	unnamed	FHL2
GO Biological Process	GO:0009889	regulation of biosynthetic process	101	3.455319e-1	1.000000e+0	1.000000e+0	2.894089e+0	3.455319e-1	1	3.455319e-1	1.000000e+0	108	3.736643e-1	1.000000e+0	1.000000e+0	2.397157e+0	4.171609e-1	1	3763	5.000000e-1	2.657454e-4	unnamed	FHL2
GO Biological Process	GO:0044249	cellular biosynthetic process	102	3.470471e-1	1.000000e+0	1.000000e+0	2.881453e+0	3.470471e-1	1	3.470471e-1	1.000000e+0	113	4.041671e-1	1.000000e+0	1.000000e+0	2.192102e+0	4.561831e-1	1	4115	5.000000e-1	2.430134e-4	unnamed	FHL2
GO Biological Process	GO:0006139	nucleobase-containing compound metabolic process	103	3.530780e-1	1.000000e+0	1.000000e+0	2.832235e+0	3.530780e-1	1	3.530780e-1	1.000000e+0	117	4.351591e-1	1.000000e+0	1.000000e+0	2.012606e+0	4.968682e-1	1	4482	5.000000e-1	2.231147e-4	unnamed	FHL2
GO Biological Process	GO:1901576	organic substance biosynthetic process	104	3.536536e-1	1.000000e+0	1.000000e+0	2.827626e+0	3.536536e-1	1	3.536536e-1	1.000000e+0	114	4.118439e-1	1.000000e+0	1.000000e+0	2.145184e+0	4.661604e-1	1	4205	5.000000e-1	2.378121e-4	unnamed	FHL2
GO Biological Process	GO:0009058	biosynthetic process	105	3.586722e-1	1.000000e+0	1.000000e+0	2.788061e+0	3.586722e-1	1	3.586722e-1	1.000000e+0	115	4.178650e-1	1.000000e+0	1.000000e+0	2.109565e+0	4.740314e-1	1	4276	5.000000e-1	2.338634e-4	unnamed	FHL2
GO Biological Process	GO:0019219	regulation of nucleobase-containing compound metabolic process	106	3.657269e-1	1.000000e+0	1.000000e+0	2.734281e+0	3.657269e-1	1	3.657269e-1	1.000000e+0	111	3.879706e-1	1.000000e+0	1.000000e+0	2.297046e+0	4.353417e-1	1	3927	5.000000e-1	2.546473e-4	unnamed	FHL2
GO Biological Process	GO:0046483	heterocycle metabolic process	107	3.657512e-1	1.000000e+0	1.000000e+0	2.734099e+0	3.657512e-1	1	3.657512e-1	1.000000e+0	119	4.495636e-1	1.000000e+0	1.000000e+0	1.937393e+0	5.161576e-1	1	4656	5.000000e-1	2.147766e-4	unnamed	FHL2
GO Biological Process	GO:0006725	cellular aromatic compound metabolic process	108	3.683046e-1	1.000000e+0	1.000000e+0	2.715144e+0	3.683046e-1	1	3.683046e-1	1.000000e+0	120	4.506323e-1	1.000000e+0	1.000000e+0	1.931998e+0	5.175988e-1	1	4669	5.000000e-1	2.141786e-4	unnamed	FHL2
GO Biological Process	GO:0051171	regulation of nitrogen compound metabolic process	109	3.708892e-1	1.000000e+0	1.000000e+0	2.696223e+0	3.708892e-1	1	3.708892e-1	1.000000e+0	112	3.955790e-1	1.000000e+0	1.000000e+0	2.246700e+0	4.450973e-1	1	4015	5.000000e-1	2.490660e-4	unnamed	FHL2
GO Biological Process	GO:0048518	positive regulation of biological process	110	3.729968e-1	1.000000e+0	1.000000e+0	2.680988e+0	3.729968e-1	1	3.729968e-1	1.000000e+0	105	3.689175e-1	1.000000e+0	1.000000e+0	2.432057e+0	4.111745e-1	1	3709	5.000000e-1	2.696145e-4	unnamed	FHL2
GO Biological Process	GO:0044767	single-organism developmental process	111	3.730678e-1	1.000000e+0	1.000000e+0	2.680478e+0	3.730678e-1	1	3.730678e-1	1.000000e+0	28	3.361263e-2	1.000000e+0	1.000000e+0	5.453748e+0	3.667202e-1	2	3308	1.000000e+0	6.045949e-4	unnamed	C2orf49,FHL2
GO Biological Process	GO:0034641	cellular nitrogen compound metabolic process	112	3.768107e-1	1.000000e+0	1.000000e+0	2.653853e+0	3.768107e-1	1	3.768107e-1	1.000000e+0	122	4.663767e-1	1.000000e+0	1.000000e+0	1.855306e+0	5.389945e-1	1	4862	5.000000e-1	2.056767e-4	unnamed	FHL2
GO Biological Process	GO:1901360	organic cyclic compound metabolic process	113	3.827617e-1	1.000000e+0	1.000000e+0	2.612592e+0	3.827617e-1	1	3.827617e-1	1.000000e+0	124	4.683993e-1	1.000000e+0	1.000000e+0	1.845815e+0	5.417660e-1	1	4887	5.000000e-1	2.046245e-4	unnamed	FHL2
GO Biological Process	GO:0048731	system development	114	3.900631e-1	1.000000e+0	1.000000e+0	2.563688e+0	3.900631e-1	1	3.900631e-1	1.000000e+0	101	3.405107e-1	1.000000e+0	1.000000e+0	2.660914e+0	3.758107e-1	1	3390	5.000000e-1	2.949853e-4	unnamed	FHL2
GO Biological Process	GO:0007165	signal transduction	115	3.912589e-1	1.000000e+0	1.000000e+0	2.555852e+0	3.912589e-1	1	3.912589e-1	1.000000e+0	116	4.201465e-1	1.000000e+0	1.000000e+0	2.096328e+0	4.770246e-1	1	4303	5.000000e-1	2.323960e-4	unnamed	FHL2
GO Biological Process	GO:0060255	regulation of macromolecule metabolic process	116	4.100897e-1	1.000000e+0	1.000000e+0	2.438491e+0	4.100897e-1	1	4.100897e-1	1.000000e+0	118	4.477526e-1	1.000000e+0	1.000000e+0	1.946590e+0	5.137188e-1	1	4634	5.000000e-1	2.157963e-4	unnamed	FHL2
GO Biological Process	GO:0006807	nitrogen compound metabolic process	117	4.138051e-1	1.000000e+0	1.000000e+0	2.416597e+0	4.138051e-1	1	4.138051e-1	1.000000e+0	127	4.994558e-1	1.000000e+0	1.000000e+0	1.709399e+0	5.850008e-1	1	5277	5.000000e-1	1.895016e-4	unnamed	FHL2
GO Biological Process	GO:0048856	anatomical structure development	118	4.234725e-1	1.000000e+0	1.000000e+0	2.361429e+0	4.234725e-1	1	4.234725e-1	1.000000e+0	31	4.643481e-2	1.000000e+0	1.000000e+0	4.640175e+0	4.310182e-1	2	3888	1.000000e+0	5.144033e-4	unnamed	C2orf49,FHL2
GO Biological Process	GO:0007275	multicellular organismal development	119	4.357034e-1	1.000000e+0	1.000000e+0	2.295139e+0	4.357034e-1	1	4.357034e-1	1.000000e+0	32	4.848760e-2	1.000000e+0	1.000000e+0	4.540901e+0	4.404412e-1	2	3973	1.000000e+0	5.033979e-4	unnamed	C2orf49,FHL2
GO Biological Process	GO:0080090	regulation of primary metabolic process	120	4.363900e-1	1.000000e+0	1.000000e+0	2.291528e+0	4.363900e-1	1	4.363900e-1	1.000000e+0	125	4.714664e-1	1.000000e+0	1.000000e+0	1.831574e+0	5.459786e-1	1	4925	5.000000e-1	2.030457e-4	unnamed	FHL2
GO Biological Process	GO:0044700	single organism signaling	121	4.371810e-1	1.000000e+0	1.000000e+0	2.287382e+0	4.371810e-1	1	4.371810e-1	1.000000e+0	121	4.576762e-1	1.000000e+0	1.000000e+0	1.897056e+0	5.271326e-1	1	4755	5.000000e-1	2.103049e-4	unnamed	FHL2
GO Biological Process	GO:0031323	regulation of cellular metabolic process	122	4.406599e-1	1.000000e+0	1.000000e+0	2.269324e+0	4.406599e-1	1	4.406599e-1	1.000000e+0	126	4.760505e-1	1.000000e+0	1.000000e+0	1.810618e+0	5.522975e-1	1	4982	5.000000e-1	2.007226e-4	unnamed	FHL2
GO Biological Process	GO:0007154	cell communication	123	4.446638e-1	1.000000e+0	1.000000e+0	2.248890e+0	4.446638e-1	1	4.446638e-1	1.000000e+0	123	4.676716e-1	1.000000e+0	1.000000e+0	1.849221e+0	5.407683e-1	1	4878	5.000000e-1	2.050021e-4	unnamed	FHL2
GO Biological Process	GO:0051716	cellular response to stimulus	124	4.562761e-1	1.000000e+0	1.000000e+0	2.191655e+0	4.562761e-1	1	4.562761e-1	1.000000e+0	128	5.039946e-1	1.000000e+0	1.000000e+0	1.690815e+0	5.914306e-1	1	5335	5.000000e-1	1.874414e-4	unnamed	FHL2
GO Biological Process	GO:0032502	developmental process	125	4.657420e-1	1.000000e+0	1.000000e+0	2.147111e+0	4.657420e-1	1	4.657420e-1	1.000000e+0	34	6.023099e-2	1.000000e+0	1.000000e+0	4.074300e+0	4.908819e-1	2	4428	1.000000e+0	4.516712e-4	unnamed	C2orf49,FHL2
GO Biological Process	GO:0019222	regulation of metabolic process	126	4.728179e-1	1.000000e+0	1.000000e+0	2.114979e+0	4.728179e-1	1	4.728179e-1	1.000000e+0	129	5.177180e-1	1.000000e+0	1.000000e+0	1.636520e+0	6.110526e-1	1	5512	5.000000e-1	1.814224e-4	unnamed	FHL2
GO Biological Process	GO:0044260	cellular macromolecule metabolic process	127	4.901841e-1	1.000000e+0	1.000000e+0	2.040050e+0	4.901841e-1	1	4.901841e-1	1.000000e+0	130	5.672657e-1	1.000000e+0	1.000000e+0	1.461283e+0	6.843301e-1	1	6173	5.000000e-1	1.619958e-4	unnamed	FHL2
GO Biological Process	GO:0043170	macromolecule metabolic process	128	5.266956e-1	1.000000e+0	1.000000e+0	1.898630e+0	5.266956e-1	1	5.266956e-1	1.000000e+0	131	6.104699e-1	1.000000e+0	1.000000e+0	1.330261e+0	7.517322e-1	1	6781	5.000000e-1	1.474709e-4	unnamed	FHL2
GO Biological Process	GO:0044707	single-multicellular organism process	129	5.372858e-1	1.000000e+0	1.000000e+0	1.861207e+0	5.372858e-1	1	5.372858e-1	1.000000e+0	45	9.848405e-2	1.000000e+0	1.000000e+0	3.186330e+0	6.276814e-1	2	5662	1.000000e+0	3.532321e-4	unnamed	C2orf49,FHL2
GO Biological Process	GO:0050896	response to stimulus	130	5.533212e-1	1.000000e+0	1.000000e+0	1.807268e+0	5.533212e-1	1	5.533212e-1	1.000000e+0	132	6.177696e-1	1.000000e+0	1.000000e+0	1.309787e+0	7.634832e-1	1	6887	5.000000e-1	1.452011e-4	unnamed	FHL2
GO Biological Process	GO:0032501	multicellular organismal process	131	5.539872e-1	1.000000e+0	1.000000e+0	1.805096e+0	5.539872e-1	1	5.539872e-1	1.000000e+0	49	1.064675e-1	1.000000e+0	1.000000e+0	3.064549e+0	6.526246e-1	2	5887	1.000000e+0	3.397316e-4	unnamed	C2orf49,FHL2
GO Biological Process	GO:0044237	cellular metabolic process	132	6.001923e-1	1.000000e+0	1.000000e+0	1.666133e+0	6.001923e-1	1	6.001923e-1	1.000000e+0	133	7.045181e-1	1.000000e+0	1.000000e+0	1.095519e+0	9.128097e-1	1	8234	5.000000e-1	1.214477e-4	unnamed	FHL2
GO Biological Process	GO:0044238	primary metabolic process	133	6.053666e-1	1.000000e+0	1.000000e+0	1.651892e+0	6.053666e-1	1	6.053666e-1	1.000000e+0	134	7.093792e-1	1.000000e+0	1.000000e+0	1.084847e+0	9.217893e-1	1	8315	5.000000e-1	1.202646e-4	unnamed	FHL2
GO Biological Process	GO:0071704	organic substance metabolic process	134	6.199145e-1	1.000000e+0	1.000000e+0	1.613126e+0	6.199145e-1	1	6.199145e-1	1.000000e+0	135	7.239536e-1	1.000000e+0	1.000000e+0	1.053551e+0	9.491713e-1	1	8562	5.000000e-1	1.167951e-4	unnamed	FHL2
GO Biological Process	GO:0008152	metabolic process	135	6.507895e-1	1.000000e+0	1.000000e+0	1.536595e+0	6.507895e-1	1	6.507895e-1	1.000000e+0	137	7.596471e-1	1.000000e+0	1.000000e+0	9.809156e-1	1.019456e+0	1	9196	5.000000e-1	1.087429e-4	unnamed	FHL2
GO Biological Process	GO:0050794	regulation of cellular process	136	6.759845e-1	1.000000e+0	1.000000e+0	1.479324e+0	6.759845e-1	1	6.759845e-1	1.000000e+0	136	7.406997e-1	1.000000e+0	1.000000e+0	1.018805e+0	9.815420e-1	1	8854	5.000000e-1	1.129433e-4	unnamed	FHL2
GO Biological Process	GO:0050789	regulation of biological process	137	6.921477e-1	1.000000e+0	1.000000e+0	1.444778e+0	6.921477e-1	1	6.921477e-1	1.000000e+0	138	7.668214e-1	1.000000e+0	1.000000e+0	9.669311e-1	1.034200e+0	1	9329	5.000000e-1	1.071926e-4	unnamed	FHL2
GO Biological Process	GO:0065007	biological regulation	138	7.151977e-1	1.000000e+0	1.000000e+0	1.398215e+0	7.151977e-1	1	7.151977e-1	1.000000e+0	139	7.940293e-1	1.000000e+0	1.000000e+0	9.155080e-1	1.092290e+0	1	9853	5.000000e-1	1.014919e-4	unnamed	FHL2
GO Biological Process	GO:0044763	single-organism cellular process	139	7.497126e-1	1.000000e+0	1.000000e+0	1.333844e+0	7.497126e-1	1	7.497126e-1	1.000000e+0	140	8.068544e-1	1.000000e+0	1.000000e+0	8.920589e-1	1.121002e+0	1	10112	5.000000e-1	9.889241e-5	unnamed	FHL2
GO Biological Process	GO:0044699	single-organism process	140	7.935590e-1	1.000000e+0	1.000000e+0	1.260146e+0	7.935590e-1	1	7.935590e-1	1.000000e+0	110	3.800402e-1	1.000000e+0	1.000000e+0	1.622100e+0	1.232969e+0	2	11122	1.000000e+0	1.798238e-4	unnamed	C2orf49,FHL2
GO Biological Process	GO:0009987	cellular process	141	8.656787e-1	1.000000e+0	1.000000e+0	1.155163e+0	8.656787e-1	1	8.656787e-1	1.000000e+0	141	9.369062e-1	1.000000e+0	1.000000e+0	6.677400e-1	1.497589e+0	1	13509	5.000000e-1	7.402472e-5	unnamed	FHL2
GO Cellular Component	GO:0072669	tRNA-splicing ligase complex	1	3.693282e-4	4.672002e-1	4.672002e-1	2.707619e+3	3.693282e-4	1	3.693282e-4	1.000000e+0	1	5.542315e-4	7.011028e-1	7.011028e-1	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	C2orf49
GO Cellular Component	GO:0031430	M band	2	2.234691e-3	1.000000e+0	1.000000e+0	4.474891e+2	2.234691e-3	1	2.234691e-3	1.000000e+0	2	1.994515e-3	1.000000e+0	1.000000e+0	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	FHL2
GO Cellular Component	GO:0031672	A band	3	3.141021e-3	1.000000e+0	1.000000e+0	3.183678e+2	3.141021e-3	1	3.141021e-3	1.000000e+0	3	3.101718e-3	1.000000e+0	1.000000e+0	3.221607e+2	3.104041e-3	1	28	5.000000e-1	3.571429e-2	unnamed	FHL2
GO Cellular Component	GO:0005925	focal adhesion	4	1.246052e-2	1.000000e+0	1.000000e+0	8.025350e+1	1.246052e-2	1	1.246052e-2	1.000000e+0	6	1.447015e-2	1.000000e+0	1.000000e+0	6.885878e+1	1.452248e-2	1	131	5.000000e-1	7.633588e-3	unnamed	FHL2
GO Cellular Component	GO:0005924	cell-substrate adherens junction	5	1.273928e-2	1.000000e+0	1.000000e+0	7.849738e+1	1.273928e-2	1	1.273928e-2	1.000000e+0	7	1.491033e-2	1.000000e+0	1.000000e+0	6.681852e+1	1.496591e-2	1	135	5.000000e-1	7.407407e-3	unnamed	FHL2
GO Cellular Component	GO:0030018	Z disc	6	1.367842e-2	1.000000e+0	1.000000e+0	7.310788e+1	1.367842e-2	1	1.367842e-2	1.000000e+0	4	1.083493e-2	1.000000e+0	1.000000e+0	9.204592e+1	1.086414e-2	1	98	5.000000e-1	1.020408e-2	unnamed	FHL2
GO Cellular Component	GO:0031674	I band	7	1.446111e-2	1.000000e+0	1.000000e+0	6.915100e+1	1.446111e-2	1	1.446111e-2	1.000000e+0	5	1.248814e-2	1.000000e+0	1.000000e+0	7.982743e+1	1.252702e-2	1	113	5.000000e-1	8.849558e-3	unnamed	FHL2
GO Cellular Component	GO:0030055	cell-substrate junction	8	1.449286e-2	1.000000e+0	1.000000e+0	6.899951e+1	1.449286e-2	1	1.449286e-2	1.000000e+0	8	1.568040e-2	1.000000e+0	1.000000e+0	6.352465e+1	1.574192e-2	1	142	5.000000e-1	7.042254e-3	unnamed	FHL2
GO Cellular Component	GO:0030017	sarcomere	9	1.887048e-2	1.000000e+0	1.000000e+0	5.299283e+1	1.887048e-2	1	1.887048e-2	1.000000e+0	9	1.809867e-2	1.000000e+0	1.000000e+0	5.500305e+1	1.818081e-2	1	164	5.000000e-1	6.097561e-3	unnamed	FHL2
GO Cellular Component	GO:0044449	contractile fiber part	10	2.023967e-2	1.000000e+0	1.000000e+0	4.940792e+1	2.023967e-2	1	2.023967e-2	1.000000e+0	10	1.974579e-2	1.000000e+0	1.000000e+0	5.039385e+1	1.984369e-2	1	179	5.000000e-1	5.586592e-3	unnamed	FHL2
GO Cellular Component	GO:0030016	myofibril	11	2.078730e-2	1.000000e+0	1.000000e+0	4.810630e+1	2.078730e-2	1	2.078730e-2	1.000000e+0	11	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	FHL2
GO Cellular Component	GO:0043292	contractile fiber	12	2.185705e-2	1.000000e+0	1.000000e+0	4.575183e+1	2.185705e-2	1	2.185705e-2	1.000000e+0	12	2.193980e-2	1.000000e+0	1.000000e+0	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	FHL2
GO Cellular Component	GO:0005912	adherens junction	13	2.413175e-2	1.000000e+0	1.000000e+0	4.143918e+1	2.413175e-2	1	2.413175e-2	1.000000e+0	13	2.204943e-2	1.000000e+0	1.000000e+0	4.510250e+1	2.217172e-2	1	200	5.000000e-1	5.000000e-3	unnamed	FHL2
GO Cellular Component	GO:0070161	anchoring junction	14	2.592477e-2	1.000000e+0	1.000000e+0	3.857314e+1	2.592477e-2	1	2.592477e-2	1.000000e+0	14	2.391230e-2	1.000000e+0	1.000000e+0	4.156912e+1	2.405632e-2	1	217	5.000000e-1	4.608295e-3	unnamed	FHL2
GO Cellular Component	GO:0015629	actin cytoskeleton	15	3.742279e-2	1.000000e+0	1.000000e+0	2.672168e+1	3.742279e-2	1	3.742279e-2	1.000000e+0	15	4.385306e-2	1.000000e+0	1.000000e+0	2.255125e+1	4.434344e-2	1	400	5.000000e-1	2.500000e-3	unnamed	FHL2
GO Cellular Component	GO:0030054	cell junction	16	1.083533e-1	1.000000e+0	1.000000e+0	9.229066e+0	1.083533e-1	1	1.083533e-1	1.000000e+0	16	8.587513e-2	1.000000e+0	1.000000e+0	1.138952e+1	8.780001e-2	1	792	5.000000e-1	1.262626e-3	unnamed	FHL2
GO Cellular Component	GO:0005654	nucleoplasm	17	1.212700e-1	1.000000e+0	1.000000e+0	8.246060e+0	1.212700e-1	1	1.212700e-1	1.000000e+0	17	1.512280e-1	1.000000e+0	1.000000e+0	6.352465e+0	1.574192e-1	1	1420	5.000000e-1	7.042254e-4	unnamed	FHL2
GO Cellular Component	GO:0005856	cytoskeleton	18	1.730861e-1	1.000000e+0	1.000000e+0	5.777472e+0	1.730861e-1	1	1.730861e-1	1.000000e+0	18	1.976595e-1	1.000000e+0	1.000000e+0	4.795587e+0	2.085250e-1	1	1881	5.000000e-1	5.316321e-4	unnamed	FHL2
GO Cellular Component	GO:0031981	nuclear lumen	19	1.748307e-1	1.000000e+0	1.000000e+0	5.719819e+0	1.748307e-1	1	1.748307e-1	1.000000e+0	19	2.174952e-1	1.000000e+0	1.000000e+0	4.332613e+0	2.308076e-1	1	2082	5.000000e-1	4.803074e-4	unnamed	FHL2
GO Cellular Component	GO:0044428	nuclear part	20	2.070089e-1	1.000000e+0	1.000000e+0	4.830709e+0	2.070089e-1	1	2.070089e-1	1.000000e+0	20	2.552742e-1	1.000000e+0	1.000000e+0	3.649070e+0	2.740425e-1	1	2472	5.000000e-1	4.045307e-4	unnamed	FHL2
GO Cellular Component	GO:0070013	intracellular organelle lumen	21	2.178720e-1	1.000000e+0	1.000000e+0	4.589852e+0	2.178720e-1	1	2.178720e-1	1.000000e+0	21	2.759844e-1	1.000000e+0	1.000000e+0	3.353346e+0	2.982096e-1	1	2690	5.000000e-1	3.717472e-4	unnamed	FHL2
GO Cellular Component	GO:0043233	organelle lumen	22	2.231770e-1	1.000000e+0	1.000000e+0	4.480748e+0	2.231770e-1	1	2.231770e-1	1.000000e+0	22	2.816332e-1	1.000000e+0	1.000000e+0	3.280182e+0	3.048611e-1	1	2750	5.000000e-1	3.636364e-4	unnamed	FHL2
GO Cellular Component	GO:0031974	membrane-enclosed lumen	23	2.255118e-1	1.000000e+0	1.000000e+0	4.434357e+0	2.255118e-1	1	2.255118e-1	1.000000e+0	23	2.863237e-1	1.000000e+0	1.000000e+0	3.221607e+0	3.104041e-1	1	2800	5.000000e-1	3.571429e-4	unnamed	FHL2
GO Cellular Component	GO:0043232	intracellular non-membrane-bounded organelle	24	2.709879e-1	1.000000e+0	1.000000e+0	3.690202e+0	2.709879e-1	1	2.709879e-1	1.000000e+0	24	3.348266e-1	1.000000e+0	1.000000e+0	2.711301e+0	3.688266e-1	1	3327	5.000000e-1	3.005711e-4	unnamed	FHL2
GO Cellular Component	GO:0043234	protein complex	25	3.027166e-1	1.000000e+0	1.000000e+0	3.303419e+0	3.027166e-1	1	3.027166e-1	1.000000e+0	25	3.630030e-1	1.000000e+0	1.000000e+0	2.476798e+0	4.037470e-1	1	3642	5.000000e-1	2.745744e-4	unnamed	C2orf49
GO Cellular Component	GO:0032991	macromolecular complex	26	3.347910e-1	1.000000e+0	1.000000e+0	2.986938e+0	3.347910e-1	1	3.347910e-1	1.000000e+0	26	4.132884e-1	1.000000e+0	1.000000e+0	2.136547e+0	4.680450e-1	1	4222	5.000000e-1	2.368546e-4	unnamed	C2orf49
GO Cellular Component	GO:0044446	intracellular organelle part	27	4.732075e-1	1.000000e+0	1.000000e+0	2.113238e+0	4.732075e-1	1	4.732075e-1	1.000000e+0	30	5.897910e-1	1.000000e+0	1.000000e+0	1.390765e+0	7.190289e-1	1	6486	5.000000e-1	1.541782e-4	unnamed	FHL2
GO Cellular Component	GO:0005634	nucleus	28	4.766312e-1	1.000000e+0	1.000000e+0	2.098058e+0	4.766312e-1	1	4.766312e-1	1.000000e+0	29	5.600157e-1	1.000000e+0	1.000000e+0	1.485100e+0	6.733551e-1	1	6074	5.000000e-1	1.646362e-4	unnamed	FHL2
GO Cellular Component	GO:0044422	organelle part	29	4.814989e-1	1.000000e+0	1.000000e+0	2.076848e+0	4.814989e-1	1	4.814989e-1	1.000000e+0	31	5.977049e-1	1.000000e+0	1.000000e+0	1.367157e+0	7.314450e-1	1	6598	5.000000e-1	1.515611e-4	unnamed	FHL2
GO Cellular Component	GO:0044444	cytoplasmic part	30	5.199381e-1	1.000000e+0	1.000000e+0	1.923306e+0	5.199381e-1	1	5.199381e-1	1.000000e+0	32	6.277110e-1	1.000000e+0	1.000000e+0	1.282596e+0	7.796685e-1	1	7033	5.000000e-1	1.421868e-4	unnamed	FHL2
GO Cellular Component	GO:0005737	cytoplasm	31	6.734732e-1	1.000000e+0	1.000000e+0	1.484840e+0	6.734732e-1	1	6.734732e-1	1.000000e+0	35	7.735178e-1	1.000000e+0	1.000000e+0	9.540455e-1	1.048168e+0	1	9455	5.000000e-1	1.057641e-4	unnamed	FHL2
GO Cellular Component	GO:0043231	intracellular membrane-bounded organelle	32	6.973299e-1	1.000000e+0	1.000000e+0	1.434041e+0	6.973299e-1	1	6.973299e-1	1.000000e+0	36	8.019514e-1	1.000000e+0	1.000000e+0	9.009688e-1	1.109916e+0	1	10012	5.000000e-1	9.988014e-5	unnamed	FHL2
GO Cellular Component	GO:0043227	membrane-bounded organelle	33	6.992039e-1	1.000000e+0	1.000000e+0	1.430198e+0	6.992039e-1	1	6.992039e-1	1.000000e+0	37	8.036253e-1	1.000000e+0	1.000000e+0	8.979196e-1	1.113685e+0	1	10046	5.000000e-1	9.954211e-5	unnamed	FHL2
GO Cellular Component	GO:0043229	intracellular organelle	34	7.399473e-1	1.000000e+0	1.000000e+0	1.351448e+0	7.399473e-1	1	7.399473e-1	1.000000e+0	38	8.473502e-1	1.000000e+0	1.000000e+0	8.206423e-1	1.218558e+0	1	10992	5.000000e-1	9.097525e-5	unnamed	FHL2
GO Cellular Component	GO:0043226	organelle	35	7.415866e-1	1.000000e+0	1.000000e+0	1.348460e+0	7.415866e-1	1	7.415866e-1	1.000000e+0	39	8.487331e-1	1.000000e+0	1.000000e+0	8.182602e-1	1.222105e+0	1	11024	5.000000e-1	9.071118e-5	unnamed	FHL2
GO Cellular Component	GO:0044424	intracellular part	36	8.017695e-1	1.000000e+0	1.000000e+0	1.247241e+0	8.017695e-1	1	8.017695e-1	1.000000e+0	27	4.860618e-1	1.000000e+0	1.000000e+0	1.434330e+0	1.394379e+0	2	12578	1.000000e+0	1.590078e-4	unnamed	C2orf49,FHL2
GO Cellular Component	GO:0005622	intracellular	37	8.064789e-1	1.000000e+0	1.000000e+0	1.239958e+0	8.064789e-1	1	8.064789e-1	1.000000e+0	28	4.992900e-1	1.000000e+0	1.000000e+0	1.415202e+0	1.413225e+0	2	12748	1.000000e+0	1.568874e-4	unnamed	C2orf49,FHL2
GO Cellular Component	GO:0044464	cell part	38	8.908971e-1	1.000000e+0	1.000000e+0	1.122464e+0	8.908971e-1	1	8.908971e-1	1.000000e+0	33	6.728810e-1	1.000000e+0	1.000000e+0	1.219069e+0	1.640596e+0	2	14799	1.000000e+0	1.351443e-4	unnamed	C2orf49,FHL2
GO Cellular Component	GO:0005623	cell	39	8.910977e-1	1.000000e+0	1.000000e+0	1.122211e+0	8.910977e-1	1	8.910977e-1	1.000000e+0	34	6.729719e-1	1.000000e+0	1.000000e+0	1.218986e+0	1.640707e+0	2	14800	1.000000e+0	1.351351e-4	unnamed	C2orf49,FHL2
Mouse Phenotype	MP:0000066	osteoporosis	1	6.883529e-3	1.000000e+0	1.000000e+0	1.452743e+2	6.883529e-3	1	6.883529e-3	1.000000e+0	1	5.314281e-3	1.000000e+0	1.000000e+0	1.879271e+2	5.321213e-3	1	48	5.000000e-1	2.083333e-2	unnamed	FHL2
Mouse Phenotype	MP:0004016	decreased bone mass	2	1.234807e-2	1.000000e+0	1.000000e+0	8.098432e+1	1.234807e-2	1	1.234807e-2	1.000000e+0	2	1.039385e-2	1.000000e+0	1.000000e+0	9.596277e+1	1.042071e-2	1	94	5.000000e-1	1.063830e-2	unnamed	FHL2
Mouse Phenotype	MP:0003141	cardiac fibrosis	3	1.893141e-2	1.000000e+0	1.000000e+0	5.282226e+1	1.893141e-2	1	1.893141e-2	1.000000e+0	3	1.754933e-2	1.000000e+0	1.000000e+0	5.673270e+1	1.762652e-2	1	159	5.000000e-1	6.289308e-3	unnamed	FHL2
Mouse Phenotype	MP:0001625	cardiac hypertrophy	4	2.027860e-2	1.000000e+0	1.000000e+0	4.931306e+1	2.027860e-2	1	2.027860e-2	1.000000e+0	4	1.886750e-2	1.000000e+0	1.000000e+0	5.275146e+1	1.895682e-2	1	171	5.000000e-1	5.847953e-3	unnamed	FHL2
Mouse Phenotype	MP:0000063	decreased bone mineral density	5	2.503843e-2	1.000000e+0	1.000000e+0	3.993860e+1	2.503843e-2	1	2.503843e-2	1.000000e+0	5	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	FHL2
Mouse Phenotype	MP:0010119	abnormal bone mineral density	6	3.282881e-2	1.000000e+0	1.000000e+0	3.046105e+1	3.282881e-2	1	3.282881e-2	1.000000e+0	6	2.850706e-2	1.000000e+0	1.000000e+0	3.482819e+1	2.871238e-2	1	259	5.000000e-1	3.861004e-3	unnamed	FHL2
Mouse Phenotype	MP:0000274	enlarged heart	7	4.315159e-2	1.000000e+0	1.000000e+0	2.317412e+1	4.315159e-2	1	4.315159e-2	1.000000e+0	7	3.983792e-2	1.000000e+0	1.000000e+0	2.484986e+1	4.024167e-2	1	363	5.000000e-1	2.754821e-3	unnamed	FHL2
Mouse Phenotype	MP:0005406	abnormal heart size	8	6.101337e-2	1.000000e+0	1.000000e+0	1.638985e+1	6.101337e-2	1	6.101337e-2	1.000000e+0	8	5.358449e-2	1.000000e+0	1.000000e+0	1.840918e+1	5.432071e-2	1	490	5.000000e-1	2.040816e-3	unnamed	FHL2
Mouse Phenotype	MP:0003795	abnormal bone structure	9	7.209275e-2	1.000000e+0	1.000000e+0	1.387102e+1	7.209275e-2	1	7.209275e-2	1.000000e+0	9	6.165600e-2	1.000000e+0	1.000000e+0	1.596549e+1	6.263511e-2	1	565	5.000000e-1	1.769912e-3	unnamed	FHL2
Mouse Phenotype	MP:0000266	abnormal heart morphology	10	1.360125e-1	1.000000e+0	1.000000e+0	7.352265e+0	1.360125e-1	1	1.360125e-1	1.000000e+0	10	1.151042e-1	1.000000e+0	1.000000e+0	8.430374e+0	1.186187e-1	1	1070	5.000000e-1	9.345794e-4	unnamed	FHL2
Mouse Phenotype	MP:0005508	abnormal skeleton morphology	11	1.720465e-1	1.000000e+0	1.000000e+0	5.812383e+0	1.720465e-1	1	1.720465e-1	1.000000e+0	11	1.447813e-1	1.000000e+0	1.000000e+0	6.647384e+0	1.504351e-1	1	1357	5.000000e-1	7.369197e-4	unnamed	FHL2
Mouse Phenotype	MP:0005390	skeleton phenotype	12	1.793833e-1	1.000000e+0	1.000000e+0	5.574655e+0	1.793833e-1	1	1.793833e-1	1.000000e+0	12	1.554104e-1	1.000000e+0	1.000000e+0	6.174196e+0	1.619644e-1	1	1461	5.000000e-1	6.844627e-4	unnamed	FHL2
Mouse Phenotype	MP:0002127	abnormal cardiovascular system morphology	13	1.879460e-1	1.000000e+0	1.000000e+0	5.320677e+0	1.879460e-1	1	1.879460e-1	1.000000e+0	13	1.683001e-1	1.000000e+0	1.000000e+0	5.680416e+0	1.760435e-1	1	1588	5.000000e-1	6.297229e-4	unnamed	FHL2
Mouse Phenotype	MP:0002169	no abnormal phenotype detected	14	1.886467e-1	1.000000e+0	1.000000e+0	5.300913e+0	1.886467e-1	1	1.886467e-1	1.000000e+0	14	1.797859e-1	1.000000e+0	1.000000e+0	5.299941e+0	1.886813e-1	1	1702	5.000000e-1	5.875441e-4	unnamed	FHL2
Mouse Phenotype	MP:0002873	normal phenotype	15	1.888473e-1	1.000000e+0	1.000000e+0	5.295284e+0	1.888473e-1	1	1.888473e-1	1.000000e+0	15	1.802878e-1	1.000000e+0	1.000000e+0	5.284417e+0	1.892356e-1	1	1707	5.000000e-1	5.858231e-4	unnamed	FHL2
Mouse Phenotype	MP:0005385	cardiovascular system phenotype	16	2.326762e-1	1.000000e+0	1.000000e+0	4.297818e+0	2.326762e-1	1	2.326762e-1	1.000000e+0	16	2.103199e-1	1.000000e+0	1.000000e+0	4.490045e+0	2.227149e-1	1	2009	5.000000e-1	4.977601e-4	unnamed	FHL2
Mouse Phenotype	MP:0000001	mammalian phenotype	17	6.422596e-1	1.000000e+0	1.000000e+0	1.557003e+0	6.422596e-1	1	6.422596e-1	1.000000e+0	17	6.601828e-1	1.000000e+0	1.000000e+0	1.198897e+0	8.341001e-1	1	7524	5.000000e-1	1.329080e-4	unnamed	FHL2
Human Phenotype	HP:0100578	Lipoatrophy	1	5.037417e-3	1.000000e+0	1.000000e+0	1.985144e+2	5.037417e-3	1	5.037417e-3	1.000000e+0	1	5.756499e-3	1.000000e+0	1.000000e+0	1.734712e+2	5.764647e-3	1	52	5.000000e-1	1.923077e-2	unnamed	FHL2
Human Phenotype	HP:0009125	Lipodystrophy	2	5.556385e-3	1.000000e+0	1.000000e+0	1.799731e+2	5.556385e-3	1	5.556385e-3	1.000000e+0	2	6.309133e-3	1.000000e+0	1.000000e+0	1.582544e+2	6.318940e-3	1	57	5.000000e-1	1.754386e-2	unnamed	FHL2
Human Phenotype	HP:0009124	Abnormality of adipose tissue	3	8.242189e-3	1.000000e+0	1.000000e+0	1.213270e+2	8.242189e-3	1	8.242189e-3	1.000000e+0	3	9.732033e-3	1.000000e+0	1.000000e+0	1.025057e+2	9.755557e-3	1	88	5.000000e-1	1.136364e-2	unnamed	FHL2
Human Phenotype	HP:0000982	Palmoplantar keratoderma	4	9.265830e-3	1.000000e+0	1.000000e+0	1.079234e+2	9.265830e-3	1	9.265830e-3	1.000000e+0	4	1.248814e-2	1.000000e+0	1.000000e+0	7.982743e+1	1.252702e-2	1	113	5.000000e-1	8.849558e-3	unnamed	FHL2
Human Phenotype	HP:0003198	Myopathy	5	1.118676e-2	1.000000e+0	1.000000e+0	8.939137e+1	1.118676e-2	1	1.118676e-2	1.000000e+0	7	1.458020e-2	1.000000e+0	1.000000e+0	6.833712e+1	1.463334e-2	1	132	5.000000e-1	7.575758e-3	unnamed	FHL2
Human Phenotype	HP:0001874	Abnormality of neutrophils	6	1.122807e-2	1.000000e+0	1.000000e+0	8.906248e+1	1.122807e-2	1	1.122807e-2	1.000000e+0	6	1.358950e-2	1.000000e+0	1.000000e+0	7.333740e+1	1.363561e-2	1	123	5.000000e-1	8.130081e-3	unnamed	FHL2
Human Phenotype	HP:0001911	Abnormality of granulocytes	7	1.244658e-2	1.000000e+0	1.000000e+0	8.034339e+1	1.244658e-2	1	1.244658e-2	1.000000e+0	8	1.502036e-2	1.000000e+0	1.000000e+0	6.632721e+1	1.507677e-2	1	136	5.000000e-1	7.352941e-3	unnamed	FHL2
Human Phenotype	HP:0010974	Abnormality of myeloid leukocytes	8	1.282913e-2	1.000000e+0	1.000000e+0	7.794763e+1	1.282913e-2	1	1.282913e-2	1.000000e+0	9	1.634023e-2	1.000000e+0	1.000000e+0	6.094932e+1	1.640707e-2	1	148	5.000000e-1	6.756757e-3	unnamed	FHL2
Human Phenotype	HP:0003457	EMG abnormality	9	1.301937e-2	1.000000e+0	1.000000e+0	7.680861e+1	1.301937e-2	1	1.301937e-2	1.000000e+0	5	1.325916e-2	1.000000e+0	1.000000e+0	7.517083e+1	1.330303e-2	1	120	5.000000e-1	8.333333e-3	unnamed	FHL2
Human Phenotype	HP:0000962	Hyperkeratosis	10	1.427604e-2	1.000000e+0	1.000000e+0	7.004741e+1	1.427604e-2	1	1.427604e-2	1.000000e+0	10	1.974579e-2	1.000000e+0	1.000000e+0	5.039385e+1	1.984369e-2	1	179	5.000000e-1	5.586592e-3	unnamed	FHL2
Human Phenotype	HP:0001639	Hypertrophic cardiomyopathy	11	1.549127e-2	1.000000e+0	1.000000e+0	6.455250e+1	1.549127e-2	1	1.549127e-2	1.000000e+0	11	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	FHL2
Human Phenotype	HP:0001638	Cardiomyopathy	12	2.024024e-2	1.000000e+0	1.000000e+0	4.940652e+1	2.024024e-2	1	2.024024e-2	1.000000e+0	12	2.686732e-2	1.000000e+0	1.000000e+0	3.696926e+1	2.704950e-2	1	244	5.000000e-1	4.098361e-3	unnamed	FHL2
Human Phenotype	HP:0001637	Abnormality of the myocardium	13	2.048425e-2	1.000000e+0	1.000000e+0	4.881799e+1	2.048425e-2	1	2.048425e-2	1.000000e+0	13	2.741405e-2	1.000000e+0	1.000000e+0	3.622691e+1	2.760379e-2	1	249	5.000000e-1	4.016064e-3	unnamed	FHL2
Human Phenotype	HP:0011368	Epidermal thickening	14	2.108661e-2	1.000000e+0	1.000000e+0	4.742345e+1	2.108661e-2	1	2.108661e-2	1.000000e+0	14	2.796063e-2	1.000000e+0	1.000000e+0	3.551378e+1	2.815808e-2	1	254	5.000000e-1	3.937008e-3	unnamed	FHL2
Human Phenotype	HP:0001072	Thickened skin	15	2.357460e-2	1.000000e+0	1.000000e+0	4.241854e+1	2.357460e-2	1	2.357460e-2	1.000000e+0	15	3.036376e-2	1.000000e+0	1.000000e+0	3.268297e+1	3.059697e-2	1	276	5.000000e-1	3.623188e-3	unnamed	FHL2
Human Phenotype	HP:0001881	Abnormality of leukocytes	16	2.780174e-2	1.000000e+0	1.000000e+0	3.596897e+1	2.780174e-2	1	2.780174e-2	1.000000e+0	16	3.516110e-2	1.000000e+0	1.000000e+0	2.818906e+1	3.547475e-2	1	320	5.000000e-1	3.125000e-3	unnamed	FHL2
Human Phenotype	HP:0000407	Sensorineural hearing impairment	17	4.795301e-2	1.000000e+0	1.000000e+0	2.085375e+1	4.795301e-2	1	4.795301e-2	1.000000e+0	17	4.753523e-2	1.000000e+0	1.000000e+0	2.078456e+1	4.811263e-2	1	434	5.000000e-1	2.304147e-3	unnamed	FHL2
Human Phenotype	HP:0011389	Functional abnormality of the inner ear	18	5.010074e-2	1.000000e+0	1.000000e+0	1.995978e+1	5.010074e-2	1	5.010074e-2	1.000000e+0	18	4.937365e-2	1.000000e+0	1.000000e+0	2.000111e+1	4.999723e-2	1	451	5.000000e-1	2.217295e-3	unnamed	FHL2
Human Phenotype	HP:0000359	Abnormality of the inner ear	19	5.043815e-2	1.000000e+0	1.000000e+0	1.982626e+1	5.043815e-2	1	5.043815e-2	1.000000e+0	19	4.980596e-2	1.000000e+0	1.000000e+0	1.982527e+1	5.044066e-2	1	455	5.000000e-1	2.197802e-3	unnamed	FHL2
Human Phenotype	HP:0011121	Abnormality of skin morphology	20	5.311577e-2	1.000000e+0	1.000000e+0	1.882680e+1	5.311577e-2	1	5.311577e-2	1.000000e+0	20	6.187077e-2	1.000000e+0	1.000000e+0	1.590917e+1	6.285683e-2	1	567	5.000000e-1	1.763668e-3	unnamed	FHL2
Human Phenotype	HP:0001871	Abnormality of  blood and blood-forming tissues	21	5.831227e-2	1.000000e+0	1.000000e+0	1.714905e+1	5.831227e-2	1	5.831227e-2	1.000000e+0	27	7.577790e-2	1.000000e+0	1.000000e+0	1.294189e+1	7.726844e-2	1	697	5.000000e-1	1.434720e-3	unnamed	FHL2
Human Phenotype	HP:0011805	Abnormality of muscle morphology	22	6.379056e-2	1.000000e+0	1.000000e+0	1.567630e+1	6.379056e-2	1	6.379056e-2	1.000000e+0	22	6.937213e-2	1.000000e+0	1.000000e+0	1.416091e+1	7.061693e-2	1	637	5.000000e-1	1.569859e-3	unnamed	FHL2
Human Phenotype	HP:0003549	Abnormality of connective tissue	23	6.968666e-2	1.000000e+0	1.000000e+0	1.434995e+1	6.968666e-2	1	6.968666e-2	1.000000e+0	21	6.798130e-2	1.000000e+0	1.000000e+0	1.445593e+1	6.917577e-2	1	624	5.000000e-1	1.602564e-3	unnamed	FHL2
Human Phenotype	HP:0002715	Abnormality of the immune system	24	7.036261e-2	1.000000e+0	1.000000e+0	1.421209e+1	7.036261e-2	1	7.036261e-2	1.000000e+0	28	8.555712e-2	1.000000e+0	1.000000e+0	1.143283e+1	8.746744e-2	1	789	5.000000e-1	1.267427e-3	unnamed	FHL2
Human Phenotype	HP:0002564	Malformation of the heart and great vessels	25	7.308175e-2	1.000000e+0	1.000000e+0	1.368331e+1	7.308175e-2	1	7.308175e-2	1.000000e+0	23	6.979987e-2	1.000000e+0	1.000000e+0	1.407254e+1	7.106036e-2	1	641	5.000000e-1	1.560062e-3	unnamed	FHL2
Human Phenotype	HP:0000365	Hearing impairment	26	7.358601e-2	1.000000e+0	1.000000e+0	1.358954e+1	7.358601e-2	1	7.358601e-2	1.000000e+0	25	7.300478e-2	1.000000e+0	1.000000e+0	1.344337e+1	7.438612e-2	1	671	5.000000e-1	1.490313e-3	unnamed	FHL2
Human Phenotype	HP:0001627	Abnormality of the heart	27	7.369587e-2	1.000000e+0	1.000000e+0	1.356928e+1	7.369587e-2	1	7.369587e-2	1.000000e+0	24	7.129618e-2	1.000000e+0	1.000000e+0	1.377176e+1	7.261238e-2	1	655	5.000000e-1	1.526718e-3	unnamed	FHL2
Human Phenotype	HP:0000364	Hearing abnormality	28	7.499185e-2	1.000000e+0	1.000000e+0	1.333478e+1	7.499185e-2	1	7.499185e-2	1.000000e+0	26	7.449852e-2	1.000000e+0	1.000000e+0	1.316861e+1	7.593814e-2	1	685	5.000000e-1	1.459854e-3	unnamed	FHL2
Human Phenotype	HP:0011354	Generalized abnormality of skin	29	7.852036e-2	1.000000e+0	1.000000e+0	1.273555e+1	7.852036e-2	1	7.852036e-2	1.000000e+0	29	9.349082e-2	1.000000e+0	1.000000e+0	1.044039e+1	9.578183e-2	1	864	5.000000e-1	1.157407e-3	unnamed	FHL2
Human Phenotype	HP:0011804	Abnormality of muscle physiology	30	9.636400e-2	1.000000e+0	1.000000e+0	1.037732e+1	9.636400e-2	1	9.636400e-2	1.000000e+0	30	1.050644e-1	1.000000e+0	1.000000e+0	9.261294e+0	1.079763e-1	1	974	5.000000e-1	1.026694e-3	unnamed	FHL2
Human Phenotype	HP:0000951	Abnormality of the skin	31	9.900756e-2	1.000000e+0	1.000000e+0	1.010024e+1	9.900756e-2	1	9.900756e-2	1.000000e+0	32	1.100914e-1	1.000000e+0	1.000000e+0	8.826321e+0	1.132975e-1	1	1022	5.000000e-1	9.784736e-4	unnamed	FHL2
Human Phenotype	HP:0000598	Abnormality of the ear	32	1.055161e-1	1.000000e+0	1.000000e+0	9.477228e+0	1.055161e-1	1	1.055161e-1	1.000000e+0	31	1.062177e-1	1.000000e+0	1.000000e+0	9.157868e+0	1.091957e-1	1	985	5.000000e-1	1.015228e-3	unnamed	FHL2
Human Phenotype	HP:0001626	Abnormality of the cardiovascular system	33	1.079230e-1	1.000000e+0	1.000000e+0	9.265867e+0	1.079230e-1	1	1.079230e-1	1.000000e+0	33	1.132260e-1	1.000000e+0	1.000000e+0	8.574620e+0	1.166232e-1	1	1052	5.000000e-1	9.505703e-4	unnamed	FHL2
Human Phenotype	HP:0003011	Abnormality of the musculature	34	1.167900e-1	1.000000e+0	1.000000e+0	8.562375e+0	1.167900e-1	1	1.167900e-1	1.000000e+0	34	1.247763e-1	1.000000e+0	1.000000e+0	7.756234e+0	1.289286e-1	1	1163	5.000000e-1	8.598452e-4	unnamed	FHL2
Human Phenotype	HP:0001574	Abnormality of the integument	35	1.221743e-1	1.000000e+0	1.000000e+0	8.185030e+0	1.221743e-1	1	1.221743e-1	1.000000e+0	35	1.310914e-1	1.000000e+0	1.000000e+0	7.369690e+0	1.356909e-1	1	1224	5.000000e-1	8.169935e-4	unnamed	FHL2
Human Phenotype	HP:0000118	Phenotypic abnormality	36	2.682332e-1	1.000000e+0	1.000000e+0	3.728099e+0	2.682332e-1	1	2.682332e-1	1.000000e+0	36	2.856679e-1	1.000000e+0	1.000000e+0	3.229681e+0	3.096281e-1	1	2793	5.000000e-1	3.580380e-4	unnamed	FHL2
Human Phenotype	HP:0000001	All	37	2.696410e-1	1.000000e+0	1.000000e+0	3.708635e+0	2.696410e-1	1	2.696410e-1	1.000000e+0	37	2.883826e-1	1.000000e+0	1.000000e+0	3.196492e+0	3.128430e-1	1	2822	5.000000e-1	3.543586e-4	unnamed	FHL2
Disease Ontology	DOID:8398	osteoarthritis	1	2.244189e-2	1.000000e+0	1.000000e+0	4.455953e+1	2.244189e-2	1	2.244189e-2	1.000000e+0	1	2.051397e-2	1.000000e+0	1.000000e+0	4.849731e+1	2.061970e-2	1	186	5.000000e-1	5.376344e-3	unnamed	FHL2
Disease Ontology	DOID:4001	epithelial ovarian cancer	2	2.825499e-2	1.000000e+0	1.000000e+0	3.539198e+1	2.825499e-2	1	2.825499e-2	1.000000e+0	3	3.047293e-2	1.000000e+0	1.000000e+0	3.256498e+1	3.070783e-2	1	277	5.000000e-1	3.610108e-3	unnamed	FHL2
Disease Ontology	DOID:9973	substance dependence	3	3.222615e-2	1.000000e+0	1.000000e+0	3.103070e+1	3.222615e-2	1	3.222615e-2	1.000000e+0	2	2.883484e-2	1.000000e+0	1.000000e+0	3.442939e+1	2.904495e-2	1	262	5.000000e-1	3.816794e-3	unnamed	FHL2
Disease Ontology	DOID:303	substance-related disease	4	3.398230e-2	1.000000e+0	1.000000e+0	2.942708e+1	3.398230e-2	1	3.398230e-2	1.000000e+0	4	3.123689e-2	1.000000e+0	1.000000e+0	3.176232e+1	3.148384e-2	1	284	5.000000e-1	3.521127e-3	unnamed	FHL2
Disease Ontology	DOID:3068	glioblastoma	5	3.687427e-2	1.000000e+0	1.000000e+0	2.711918e+1	3.687427e-2	1	3.687427e-2	1.000000e+0	5	3.265489e-2	1.000000e+0	1.000000e+0	3.037205e+1	3.292500e-2	1	297	5.000000e-1	3.367003e-3	unnamed	FHL2
Disease Ontology	DOID:3069	astrocytoma	6	4.313016e-2	1.000000e+0	1.000000e+0	2.318563e+1	4.313016e-2	1	4.313016e-2	1.000000e+0	6	4.157523e-2	1.000000e+0	1.000000e+0	2.380079e+1	4.201541e-2	1	379	5.000000e-1	2.638522e-3	unnamed	FHL2
Disease Ontology	DOID:2126	primary brain tumor	7	4.334785e-2	1.000000e+0	1.000000e+0	2.306920e+1	4.334785e-2	1	4.334785e-2	1.000000e+0	7	4.168376e-2	1.000000e+0	1.000000e+0	2.373816e+1	4.212627e-2	1	380	5.000000e-1	2.631579e-3	unnamed	FHL2
Disease Ontology	DOID:911	malignant neoplasm of brain	8	4.364353e-2	1.000000e+0	1.000000e+0	2.291290e+1	4.364353e-2	1	4.364353e-2	1.000000e+0	8	4.222631e-2	1.000000e+0	1.000000e+0	2.342987e+1	4.268056e-2	1	385	5.000000e-1	2.597403e-3	unnamed	FHL2
Disease Ontology	DOID:368	neoplasm of cerebrum	9	4.511970e-2	1.000000e+0	1.000000e+0	2.216327e+1	4.511970e-2	1	4.511970e-2	1.000000e+0	9	4.298563e-2	1.000000e+0	1.000000e+0	2.301148e+1	4.345657e-2	1	392	5.000000e-1	2.551020e-3	unnamed	FHL2
Disease Ontology	DOID:1659	supratentorial neoplasm	10	4.529725e-2	1.000000e+0	1.000000e+0	2.207640e+1	4.529725e-2	1	4.529725e-2	1.000000e+0	10	4.320252e-2	1.000000e+0	1.000000e+0	2.289467e+1	4.367829e-2	1	394	5.000000e-1	2.538071e-3	unnamed	FHL2
Disease Ontology	DOID:449	head neoplasm	11	5.090150e-2	1.000000e+0	1.000000e+0	1.964579e+1	5.090150e-2	1	5.090150e-2	1.000000e+0	14	5.045424e-2	1.000000e+0	1.000000e+0	1.956725e+1	5.110581e-2	1	461	5.000000e-1	2.169197e-3	unnamed	FHL2
Disease Ontology	DOID:769	neuroblastoma	12	5.857072e-2	1.000000e+0	1.000000e+0	1.707338e+1	5.857072e-2	1	5.857072e-2	1.000000e+0	11	4.861687e-2	1.000000e+0	1.000000e+0	2.031644e+1	4.922122e-2	1	444	5.000000e-1	2.252252e-3	unnamed	FHL2
Disease Ontology	DOID:3369	Ewings sarcoma	13	5.884188e-2	1.000000e+0	1.000000e+0	1.699470e+1	5.884188e-2	1	5.884188e-2	1.000000e+0	12	4.883312e-2	1.000000e+0	1.000000e+0	2.022534e+1	4.944294e-2	1	446	5.000000e-1	2.242152e-3	unnamed	FHL2
Disease Ontology	DOID:2438	tumor of dermis	14	6.071436e-2	1.000000e+0	1.000000e+0	1.647057e+1	6.071436e-2	1	6.071436e-2	1.000000e+0	13	5.002208e-2	1.000000e+0	1.000000e+0	1.973851e+1	5.066238e-2	1	457	5.000000e-1	2.188184e-3	unnamed	FHL2
Disease Ontology	DOID:4159	skin cancer	15	6.228896e-2	1.000000e+0	1.000000e+0	1.605421e+1	6.228896e-2	1	6.228896e-2	1.000000e+0	16	5.261359e-2	1.000000e+0	1.000000e+0	1.875364e+1	5.332299e-2	1	481	5.000000e-1	2.079002e-3	unnamed	FHL2
Disease Ontology	DOID:1192	peripheral nervous system neoplasm	16	6.432174e-2	1.000000e+0	1.000000e+0	1.554684e+1	6.432174e-2	1	6.432174e-2	1.000000e+0	15	5.228984e-2	1.000000e+0	1.000000e+0	1.887134e+1	5.299041e-2	1	478	5.000000e-1	2.092050e-3	unnamed	FHL2
Disease Ontology	DOID:848	arthritis	17	6.457103e-2	1.000000e+0	1.000000e+0	1.548682e+1	6.457103e-2	1	6.457103e-2	1.000000e+0	21	6.905126e-2	1.000000e+0	1.000000e+0	1.422792e+1	7.028435e-2	1	634	5.000000e-1	1.577287e-3	unnamed	FHL2
Disease Ontology	DOID:3342	bone inflammation disease	18	6.811308e-2	1.000000e+0	1.000000e+0	1.468147e+1	6.811308e-2	1	6.811308e-2	1.000000e+0	22	7.268454e-2	1.000000e+0	1.000000e+0	1.350374e+1	7.405354e-2	1	668	5.000000e-1	1.497006e-3	unnamed	FHL2
Disease Ontology	DOID:168	primitive neuroectodermal tumor	19	6.935969e-2	1.000000e+0	1.000000e+0	1.441760e+1	6.935969e-2	1	6.935969e-2	1.000000e+0	17	5.789360e-2	1.000000e+0	1.000000e+0	1.701981e+1	5.875506e-2	1	530	5.000000e-1	1.886792e-3	unnamed	FHL2
Disease Ontology	DOID:688	embryonal cancer	20	7.040036e-2	1.000000e+0	1.000000e+0	1.420447e+1	7.040036e-2	1	7.040036e-2	1.000000e+0	18	5.961449e-2	1.000000e+0	1.000000e+0	1.652106e+1	6.052880e-2	1	546	5.000000e-1	1.831502e-3	unnamed	FHL2
Disease Ontology	DOID:2144	malignant neoplasm of ovary	21	7.395274e-2	1.000000e+0	1.000000e+0	1.352215e+1	7.395274e-2	1	7.395274e-2	1.000000e+0	24	7.737589e-2	1.000000e+0	1.000000e+0	1.266924e+1	7.893132e-2	1	712	5.000000e-1	1.404494e-3	unnamed	FHL2
Disease Ontology	DOID:1244	malignant neoplasm of female genital organ	22	7.450734e-2	1.000000e+0	1.000000e+0	1.342150e+1	7.450734e-2	1	7.450734e-2	1.000000e+0	25	7.812114e-2	1.000000e+0	1.000000e+0	1.254590e+1	7.970733e-2	1	719	5.000000e-1	1.390821e-3	unnamed	FHL2
Disease Ontology	DOID:1281	female reproductive cancer	23	7.531950e-2	1.000000e+0	1.000000e+0	1.327677e+1	7.531950e-2	1	7.531950e-2	1.000000e+0	27	7.886609e-2	1.000000e+0	1.000000e+0	1.242493e+1	8.048334e-2	1	726	5.000000e-1	1.377410e-3	unnamed	FHL2
Disease Ontology	DOID:3347	osteosarcoma	24	7.547113e-2	1.000000e+0	1.000000e+0	1.325010e+1	7.547113e-2	1	7.547113e-2	1.000000e+0	19	6.498213e-2	1.000000e+0	1.000000e+0	1.513507e+1	6.607173e-2	1	596	5.000000e-1	1.677852e-3	unnamed	FHL2
Disease Ontology	DOID:2394	ovarian neoplasm	25	7.564403e-2	1.000000e+0	1.000000e+0	1.321981e+1	7.564403e-2	1	7.564403e-2	1.000000e+0	26	7.875969e-2	1.000000e+0	1.000000e+0	1.244207e+1	8.037248e-2	1	725	5.000000e-1	1.379310e-3	unnamed	FHL2
Disease Ontology	DOID:183	bone tissue neoplasm	26	7.606199e-2	1.000000e+0	1.000000e+0	1.314717e+1	7.606199e-2	1	7.606199e-2	1.000000e+0	20	6.551805e-2	1.000000e+0	1.000000e+0	1.500915e+1	6.662602e-2	1	601	5.000000e-1	1.663894e-3	unnamed	FHL2
Disease Ontology	DOID:120	female genital cancer	27	8.268050e-2	1.000000e+0	1.000000e+0	1.209475e+1	8.268050e-2	1	8.268050e-2	1.000000e+0	30	8.545110e-2	1.000000e+0	1.000000e+0	1.144734e+1	8.735658e-2	1	788	5.000000e-1	1.269036e-3	unnamed	FHL2
Disease Ontology	DOID:0080001	bone disease	28	8.760496e-2	1.000000e+0	1.000000e+0	1.141488e+1	8.760496e-2	1	8.760496e-2	1.000000e+0	32	8.831138e-2	1.000000e+0	1.000000e+0	1.106810e+1	9.034976e-2	1	815	5.000000e-1	1.226994e-3	unnamed	FHL2
Disease Ontology	DOID:201	connective tissue neoplasm	29	8.800066e-2	1.000000e+0	1.000000e+0	1.136355e+1	8.800066e-2	1	8.800066e-2	1.000000e+0	23	7.716290e-2	1.000000e+0	1.000000e+0	1.270493e+1	7.870961e-2	1	710	5.000000e-1	1.408451e-3	unnamed	FHL2
Disease Ontology	DOID:284	malignant neoplasm of abdomen	30	9.133327e-2	1.000000e+0	1.000000e+0	1.094891e+1	9.133327e-2	1	9.133327e-2	1.000000e+0	33	9.063867e-2	1.000000e+0	1.000000e+0	1.077718e+1	9.278865e-2	1	837	5.000000e-1	1.194743e-3	unnamed	FHL2
Disease Ontology	DOID:1318	malignant neoplasm of central nervous system	31	9.457325e-2	1.000000e+0	1.000000e+0	1.057381e+1	9.457325e-2	1	9.457325e-2	1.000000e+0	28	8.396623e-2	1.000000e+0	1.000000e+0	1.165439e+1	8.580456e-2	1	774	5.000000e-1	1.291990e-3	unnamed	FHL2
Disease Ontology	DOID:4695	malignant neoplasm of nervous system	32	9.564362e-2	1.000000e+0	1.000000e+0	1.045548e+1	9.564362e-2	1	9.564362e-2	1.000000e+0	29	8.439060e-2	1.000000e+0	1.000000e+0	1.159447e+1	8.624799e-2	1	778	5.000000e-1	1.285347e-3	unnamed	FHL2
Disease Ontology	DOID:3070	malignant glioma	33	9.870456e-2	1.000000e+0	1.000000e+0	1.013124e+1	9.870456e-2	1	9.870456e-2	1.000000e+0	31	8.714662e-2	1.000000e+0	1.000000e+0	1.121953e+1	8.913031e-2	1	804	5.000000e-1	1.243781e-3	unnamed	FHL2
Disease Ontology	DOID:1265	genitourinary cancer	34	1.098597e-1	1.000000e+0	1.000000e+0	9.102521e+0	1.098597e-1	1	1.098597e-1	1.000000e+0	37	1.099868e-1	1.000000e+0	1.000000e+0	8.834966e+0	1.131866e-1	1	1021	5.000000e-1	9.794319e-4	unnamed	FHL2
Disease Ontology	DOID:1240	leukemia	35	1.114394e-1	1.000000e+0	1.000000e+0	8.973483e+0	1.114394e-1	1	1.114394e-1	1.000000e+0	39	1.125996e-1	1.000000e+0	1.000000e+0	8.623805e+0	1.159581e-1	1	1046	5.000000e-1	9.560229e-4	unnamed	FHL2
Disease Ontology	DOID:122	abdominal cancer	36	1.132547e-1	1.000000e+0	1.000000e+0	8.829653e+0	1.132547e-1	1	1.132547e-1	1.000000e+0	40	1.128084e-1	1.000000e+0	1.000000e+0	8.607347e+0	1.161798e-1	1	1048	5.000000e-1	9.541985e-4	unnamed	FHL2
Disease Ontology	DOID:3165	skin neoplasm	37	1.200813e-1	1.000000e+0	1.000000e+0	8.327690e+0	1.200813e-1	1	1.200813e-1	1.000000e+0	35	1.090453e-1	1.000000e+0	1.000000e+0	8.913538e+0	1.121889e-1	1	1012	5.000000e-1	9.881423e-4	unnamed	FHL2
Disease Ontology	DOID:65	connective tissue disease	38	1.230503e-1	1.000000e+0	1.000000e+0	8.126760e+0	1.230503e-1	1	1.230503e-1	1.000000e+0	43	1.217659e-1	1.000000e+0	1.000000e+0	7.954586e+0	1.257137e-1	1	1134	5.000000e-1	8.818342e-4	unnamed	FHL2
Disease Ontology	DOID:2627	glioma	39	1.253026e-1	1.000000e+0	1.000000e+0	7.980682e+0	1.253026e-1	1	1.253026e-1	1.000000e+0	34	1.084173e-1	1.000000e+0	1.000000e+0	8.966700e+0	1.115238e-1	1	1006	5.000000e-1	9.940358e-4	unnamed	FHL2
Disease Ontology	DOID:1319	brain neoplasm	40	1.265868e-1	1.000000e+0	1.000000e+0	7.899721e+0	1.265868e-1	1	1.265868e-1	1.000000e+0	36	1.094638e-1	1.000000e+0	1.000000e+0	8.878445e+0	1.126323e-1	1	1016	5.000000e-1	9.842520e-4	unnamed	FHL2
Disease Ontology	DOID:3620	central nervous system neoplasm	41	1.271973e-1	1.000000e+0	1.000000e+0	7.861801e+0	1.271973e-1	1	1.271973e-1	1.000000e+0	38	1.101959e-1	1.000000e+0	1.000000e+0	8.817693e+0	1.134083e-1	1	1023	5.000000e-1	9.775171e-4	unnamed	FHL2
Disease Ontology	DOID:2227	malignant neoplasm of lymphatic and hemopoietic tissue	42	1.308045e-1	1.000000e+0	1.000000e+0	7.644994e+0	1.308045e-1	1	1.308045e-1	1.000000e+0	45	1.334666e-1	1.000000e+0	1.000000e+0	7.233761e+0	1.382407e-1	1	1247	5.000000e-1	8.019246e-4	unnamed	FHL2
Disease Ontology	DOID:171	neuroectodermal tumor	43	1.311969e-1	1.000000e+0	1.000000e+0	7.622132e+0	1.311969e-1	1	1.311969e-1	1.000000e+0	41	1.187505e-1	1.000000e+0	1.000000e+0	8.163348e+0	1.224988e-1	1	1105	5.000000e-1	9.049774e-4	unnamed	FHL2
Disease Ontology	DOID:3095	germ cell and embryonal cancer	44	1.321992e-1	1.000000e+0	1.000000e+0	7.564342e+0	1.321992e-1	1	1.321992e-1	1.000000e+0	42	1.204148e-1	1.000000e+0	1.000000e+0	8.046833e+0	1.242725e-1	1	1121	5.000000e-1	8.920607e-4	unnamed	FHL2
Disease Ontology	DOID:2994	germ cell cancer	45	1.346344e-1	1.000000e+0	1.000000e+0	7.427520e+0	1.346344e-1	1	1.346344e-1	1.000000e+0	44	1.229084e-1	1.000000e+0	1.000000e+0	7.878166e+0	1.269331e-1	1	1145	5.000000e-1	8.733624e-4	unnamed	FHL2
Disease Ontology	DOID:177	soft tissue neoplasm	46	1.450676e-1	1.000000e+0	1.000000e+0	6.893336e+0	1.450676e-1	1	1.450676e-1	1.000000e+0	46	1.364568e-1	1.000000e+0	1.000000e+0	7.069357e+0	1.414556e-1	1	1276	5.000000e-1	7.836991e-4	unnamed	FHL2
Disease Ontology	DOID:3350	mesenchymal cell neoplasm	47	1.453323e-1	1.000000e+0	1.000000e+0	6.880783e+0	1.453323e-1	1	1.453323e-1	1.000000e+0	47	1.369718e-1	1.000000e+0	1.000000e+0	7.041764e+0	1.420099e-1	1	1281	5.000000e-1	7.806401e-4	unnamed	FHL2
Disease Ontology	DOID:2531	hematologic cancer	48	1.484252e-1	1.000000e+0	1.000000e+0	6.737401e+0	1.484252e-1	1	1.484252e-1	1.000000e+0	49	1.514323e-1	1.000000e+0	1.000000e+0	6.343530e+0	1.576409e-1	1	1422	5.000000e-1	7.032349e-4	unnamed	FHL2
Disease Ontology	DOID:1115	sarcoma	49	1.495909e-1	1.000000e+0	1.000000e+0	6.684897e+0	1.495909e-1	1	1.495909e-1	1.000000e+0	48	1.416001e-1	1.000000e+0	1.000000e+0	6.802790e+0	1.469985e-1	1	1326	5.000000e-1	7.541478e-4	unnamed	FHL2
Disease Ontology	DOID:74	hematopoietic system disease	50	1.634383e-1	1.000000e+0	1.000000e+0	6.118517e+0	1.634383e-1	1	1.634383e-1	1.000000e+0	58	1.726418e-1	1.000000e+0	1.000000e+0	5.530656e+0	1.808104e-1	1	1631	5.000000e-1	6.131208e-4	unnamed	FHL2
Disease Ontology	DOID:3094	neuroepithelial neoplasm	51	1.687017e-1	1.000000e+0	1.000000e+0	5.927623e+0	1.687017e-1	1	1.687017e-1	1.000000e+0	51	1.534735e-1	1.000000e+0	1.000000e+0	6.255548e+0	1.598581e-1	1	1442	5.000000e-1	6.934813e-4	unnamed	FHL2
Disease Ontology	DOID:4241	malignant neoplasm of breast	52	1.689834e-1	1.000000e+0	1.000000e+0	5.917740e+0	1.689834e-1	1	1.689834e-1	1.000000e+0	54	1.624258e-1	1.000000e+0	1.000000e+0	5.895752e+0	1.696137e-1	1	1530	5.000000e-1	6.535948e-4	unnamed	FHL2
Disease Ontology	DOID:3937	malignant neoplasm of thorax	53	1.691008e-1	1.000000e+0	1.000000e+0	5.913634e+0	1.691008e-1	1	1.691008e-1	1.000000e+0	55	1.626287e-1	1.000000e+0	1.000000e+0	5.888055e+0	1.698354e-1	1	1532	5.000000e-1	6.527415e-4	unnamed	FHL2
Disease Ontology	DOID:3195	neural neoplasm	54	1.692055e-1	1.000000e+0	1.000000e+0	5.909975e+0	1.692055e-1	1	1.692055e-1	1.000000e+0	52	1.541874e-1	1.000000e+0	1.000000e+0	6.225328e+0	1.606341e-1	1	1449	5.000000e-1	6.901311e-4	unnamed	FHL2
Disease Ontology	DOID:5093	thoracic cancer	55	1.702657e-1	1.000000e+0	1.000000e+0	5.873173e+0	1.702657e-1	1	1.702657e-1	1.000000e+0	56	1.639470e-1	1.000000e+0	1.000000e+0	5.838511e+0	1.712765e-1	1	1545	5.000000e-1	6.472492e-4	unnamed	FHL2
Disease Ontology	DOID:3093	nervous system cancer	56	1.722624e-1	1.000000e+0	1.000000e+0	5.805099e+0	1.722624e-1	1	1.722624e-1	1.000000e+0	53	1.573451e-1	1.000000e+0	1.000000e+0	6.094932e+0	1.640707e-1	1	1480	5.000000e-1	6.756757e-4	unnamed	FHL2
Disease Ontology	DOID:150	disease of mental health	57	1.737444e-1	1.000000e+0	1.000000e+0	5.755580e+0	1.737444e-1	1	1.737444e-1	1.000000e+0	50	1.522491e-1	1.000000e+0	1.000000e+0	6.308042e+0	1.585278e-1	1	1430	5.000000e-1	6.993007e-4	unnamed	FHL2
Disease Ontology	DOID:1612	mammary cancer	58	1.772500e-1	1.000000e+0	1.000000e+0	5.641748e+0	1.772500e-1	1	1.772500e-1	1.000000e+0	57	1.677945e-1	1.000000e+0	1.000000e+0	5.698358e+0	1.754892e-1	1	1583	5.000000e-1	6.317119e-4	unnamed	FHL2
Disease Ontology	DOID:936	brain disease	59	1.872681e-1	1.000000e+0	1.000000e+0	5.339937e+0	1.872681e-1	1	1.872681e-1	1.000000e+0	59	1.748588e-1	1.000000e+0	1.000000e+0	5.457048e+0	1.832493e-1	1	1653	5.000000e-1	6.049607e-4	unnamed	FHL2
Disease Ontology	DOID:193	reproductive system cancer	60	2.095200e-1	1.000000e+0	1.000000e+0	4.772814e+0	2.095200e-1	1	2.095200e-1	1.000000e+0	60	2.033098e-1	1.000000e+0	1.000000e+0	4.654541e+0	2.148440e-1	1	1938	5.000000e-1	5.159959e-4	unnamed	FHL2
Disease Ontology	DOID:17	musculoskeletal system disease	61	2.136568e-1	1.000000e+0	1.000000e+0	4.680403e+0	2.136568e-1	1	2.136568e-1	1.000000e+0	62	2.140591e-1	1.000000e+0	1.000000e+0	4.406693e+0	2.269276e-1	1	2047	5.000000e-1	4.885198e-4	unnamed	FHL2
Disease Ontology	DOID:157	epithelial carcinoma	62	2.158701e-1	1.000000e+0	1.000000e+0	4.632416e+0	2.158701e-1	1	2.158701e-1	1.000000e+0	63	2.169067e-1	1.000000e+0	1.000000e+0	4.345135e+0	2.301425e-1	1	2076	5.000000e-1	4.816956e-4	unnamed	FHL2
Disease Ontology	DOID:155	glandular and epithelial neoplasm	63	2.196335e-1	1.000000e+0	1.000000e+0	4.553039e+0	2.196335e-1	1	2.196335e-1	1.000000e+0	61	2.107139e-1	1.000000e+0	1.000000e+0	4.481123e+0	2.231584e-1	1	2013	5.000000e-1	4.967710e-4	unnamed	FHL2
Disease Ontology	DOID:331	central nervous system disease	64	2.247960e-1	1.000000e+0	1.000000e+0	4.448477e+0	2.247960e-1	1	2.247960e-1	1.000000e+0	64	2.201408e-1	1.000000e+0	1.000000e+0	4.277146e+0	2.338008e-1	1	2109	5.000000e-1	4.741584e-4	unnamed	FHL2
Disease Ontology	DOID:1287	cardiovascular system disease	65	2.464292e-1	1.000000e+0	1.000000e+0	4.057961e+0	2.464292e-1	1	2.464292e-1	1.000000e+0	65	2.586189e-1	1.000000e+0	1.000000e+0	3.598125e+0	2.779225e-1	1	2507	5.000000e-1	3.988831e-4	unnamed	FHL2
Disease Ontology	DOID:863	nervous system disease	66	2.662634e-1	1.000000e+0	1.000000e+0	3.755680e+0	2.662634e-1	1	2.662634e-1	1.000000e+0	66	2.652858e-1	1.000000e+0	1.000000e+0	3.500388e+0	2.856826e-1	1	2577	5.000000e-1	3.880481e-4	unnamed	FHL2
Disease Ontology	DOID:2985	chronic rejection of renal transplant	67	2.674662e-1	1.000000e+0	1.000000e+0	3.738791e+0	2.674662e-1	1	2.674662e-1	1.000000e+0	67	2.866046e-1	1.000000e+0	1.000000e+0	3.218159e+0	3.107367e-1	1	2803	5.000000e-1	3.567606e-4	unnamed	FHL2
Disease Ontology	DOID:2108	transplant-related disease	68	2.674780e-1	1.000000e+0	1.000000e+0	3.738626e+0	2.674780e-1	1	2.674780e-1	1.000000e+0	68	2.866982e-1	1.000000e+0	1.000000e+0	3.217011e+0	3.108475e-1	1	2804	5.000000e-1	3.566334e-4	unnamed	FHL2
Disease Ontology	DOID:557	kidney disease	69	2.854845e-1	1.000000e+0	1.000000e+0	3.502817e+0	2.854845e-1	1	2.854845e-1	1.000000e+0	69	3.062252e-1	1.000000e+0	1.000000e+0	2.992867e+0	3.341278e-1	1	3014	5.000000e-1	3.317850e-4	unnamed	FHL2
Disease Ontology	DOID:18	urinary system disease	70	2.923209e-1	1.000000e+0	1.000000e+0	3.420898e+0	2.923209e-1	1	2.923209e-1	1.000000e+0	70	3.122143e-1	1.000000e+0	1.000000e+0	2.929685e+0	3.413336e-1	1	3079	5.000000e-1	3.247808e-4	unnamed	FHL2
Disease Ontology	DOID:2914	immune system disease	71	3.205063e-1	1.000000e+0	1.000000e+0	3.120063e+0	3.205063e-1	1	3.205063e-1	1.000000e+0	72	3.434783e-1	1.000000e+0	1.000000e+0	2.635261e+0	3.794690e-1	1	3423	5.000000e-1	2.921414e-4	unnamed	FHL2
Disease Ontology	DOID:305	carcinoma	72	3.218892e-1	1.000000e+0	1.000000e+0	3.106659e+0	3.218892e-1	1	3.218892e-1	1.000000e+0	71	3.253901e-1	1.000000e+0	1.000000e+0	2.798790e+0	3.572973e-1	1	3223	5.000000e-1	3.102699e-4	unnamed	FHL2
Disease Ontology	DOID:462	cancer by anatomical entity	73	3.485076e-1	1.000000e+0	1.000000e+0	2.869378e+0	3.485076e-1	1	3.485076e-1	1.000000e+0	73	3.467081e-1	1.000000e+0	1.000000e+0	2.607835e+0	3.834599e-1	1	3459	5.000000e-1	2.891009e-4	unnamed	FHL2
Disease Ontology	DOID:162	cancer	74	4.681931e-1	1.000000e+0	1.000000e+0	2.135871e+0	4.681931e-1	1	4.681931e-1	1.000000e+0	74	4.854768e-1	1.000000e+0	1.000000e+0	1.768725e+0	5.653789e-1	1	5100	5.000000e-1	1.960784e-4	unnamed	FHL2
Disease Ontology	DOID:7	disease of anatomical entity	75	5.144599e-1	1.000000e+0	1.000000e+0	1.943786e+0	5.144599e-1	1	5.144599e-1	1.000000e+0	75	5.469036e-1	1.000000e+0	1.000000e+0	1.529676e+0	6.537332e-1	1	5897	5.000000e-1	1.695778e-4	unnamed	FHL2
Disease Ontology	DOID:4	disease	76	6.581397e-1	1.000000e+0	1.000000e+0	1.519434e+0	6.581397e-1	1	6.581397e-1	1.000000e+0	76	6.831746e-1	1.000000e+0	1.000000e+0	1.143863e+0	8.742309e-1	1	7886	5.000000e-1	1.268070e-4	unnamed	FHL2
MSigDB Cancer Neighborhood	GNF2_MYL3	Neighborhood of MYL3	1	1.816120e-3	7.754832e-1	7.754832e-1	5.506245e+2	1.816120e-3	1	1.816120e-3	1.000000e+0	1	3.433759e-3	1.000000e+0	1.000000e+0	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	FHL2
MSigDB Pathway	BIOCARTA_P53HYPOXIA_PATHWAY	Hypoxia and p53 in the Cardiovascular system	1	1.908006e-3	1.000000e+0	1.000000e+0	5.241075e+2	1.908006e-3	1	1.908006e-3	1.000000e+0	1	2.548193e-3	1.000000e+0	1.000000e+0	3.921957e+2	2.549748e-3	1	23	5.000000e-1	4.347826e-2	unnamed	FHL2
MSigDB Pathway	PID_HDAC_CLASSIII_PATHWAY	Signaling events mediated by HDAC Class III	2	2.569709e-3	1.000000e+0	1.000000e+0	3.891491e+2	2.569709e-3	1	2.569709e-3	1.000000e+0	2	2.769621e-3	1.000000e+0	1.000000e+0	3.608200e+2	2.771465e-3	1	25	5.000000e-1	4.000000e-2	unnamed	FHL2
MSigDB Pathway	PID_AR_PATHWAY	Coregulation of Androgen receptor activity	3	8.204837e-3	1.000000e+0	1.000000e+0	1.218793e+2	8.204837e-3	1	8.204837e-3	1.000000e+0	3	6.972090e-3	1.000000e+0	1.000000e+0	1.431825e+2	6.984092e-3	1	63	5.000000e-1	1.587302e-2	unnamed	FHL2
MSigDB Pathway	REACTOME_PPARA_ACTIVATES_GENE_EXPRESSION	Genes involved in PPARA Activates Gene Expression	4	9.939616e-3	1.000000e+0	1.000000e+0	1.006075e+2	9.939616e-3	1	9.939616e-3	1.000000e+0	4	1.149638e-2	1.000000e+0	1.000000e+0	8.673558e+1	1.152929e-2	1	104	5.000000e-1	9.615385e-3	unnamed	FHL2
MSigDB Pathway	REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM	Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism	5	1.673734e-2	1.000000e+0	1.000000e+0	5.974667e+1	1.673734e-2	1	1.673734e-2	1.000000e+0	5	1.853804e-2	1.000000e+0	1.000000e+0	5.369345e+1	1.862424e-2	1	168	5.000000e-1	5.952381e-3	unnamed	FHL2
MSigDB Pathway	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS	Genes involved in Metabolism of lipids and lipoproteins	6	4.109831e-2	1.000000e+0	1.000000e+0	2.433190e+1	4.109831e-2	1	4.109831e-2	1.000000e+0	6	5.153422e-2	1.000000e+0	1.000000e+0	1.915180e+1	5.221440e-2	1	471	5.000000e-1	2.123142e-3	unnamed	FHL2
MGI Expression: Detected	5882	TS22_umbilical vein	1	2.506594e-4	1.000000e+0	1.000000e+0	3.989478e+3	2.506594e-4	1	2.506594e-4	1.000000e+0	1	5.542315e-4	1.000000e+0	1.000000e+0	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	FHL2
MGI Expression: Detected	17175	TS23_presumptive mesangium of capillary loop renal corpuscle	2	1.882253e-3	1.000000e+0	1.000000e+0	5.312783e+2	1.882253e-3	1	1.882253e-3	1.000000e+0	3	1.883760e-3	1.000000e+0	1.000000e+0	5.306176e+2	1.884596e-3	1	17	5.000000e-1	5.882353e-2	unnamed	FHL2
MGI Expression: Detected	5881	TS22_venous system	3	2.031782e-3	1.000000e+0	1.000000e+0	4.921787e+2	2.031782e-3	1	2.031782e-3	1.000000e+0	2	1.551461e-3	1.000000e+0	1.000000e+0	6.443214e+2	1.552020e-3	1	14	5.000000e-1	7.142857e-2	unnamed	FHL2
MGI Expression: Detected	17177	TS23_glomerular mesangium of maturing glomerular tuft	4	2.285007e-3	1.000000e+0	1.000000e+0	4.376354e+2	2.285007e-3	1	2.285007e-3	1.000000e+0	4	2.105263e-3	1.000000e+0	1.000000e+0	4.747632e+2	2.106313e-3	1	19	5.000000e-1	5.263158e-2	unnamed	FHL2
MGI Expression: Detected	6076	TS22_tongue skeletal muscle	5	4.492550e-3	1.000000e+0	1.000000e+0	2.225907e+2	4.492550e-3	1	4.492550e-3	1.000000e+0	5	2.548193e-3	1.000000e+0	1.000000e+0	3.921957e+2	2.549748e-3	1	23	5.000000e-1	4.347826e-2	unnamed	FHL2
MGI Expression: Detected	14467	TS22_cardiac muscle	6	4.627036e-3	1.000000e+0	1.000000e+0	2.161211e+2	4.627036e-3	1	4.627036e-3	1.000000e+0	6	3.212404e-3	1.000000e+0	1.000000e+0	3.110517e+2	3.214899e-3	1	29	5.000000e-1	3.448276e-2	unnamed	FHL2
MGI Expression: Detected	16810	TS23_capillary loop renal corpuscle	7	8.160189e-3	1.000000e+0	1.000000e+0	1.225462e+2	8.160189e-3	1	8.160189e-3	1.000000e+0	8	6.530143e-3	1.000000e+0	1.000000e+0	1.528898e+2	6.540657e-3	1	59	5.000000e-1	1.694915e-2	unnamed	FHL2
MGI Expression: Detected	16759	TS23_ureter smooth muscle layer	8	1.046430e-2	1.000000e+0	1.000000e+0	9.556299e+1	1.046430e-2	1	1.046430e-2	1.000000e+0	7	6.198618e-3	1.000000e+0	1.000000e+0	1.610804e+2	6.208082e-3	1	56	5.000000e-1	1.785714e-2	unnamed	FHL2
MGI Expression: Detected	17248	TS23_mesenchymal layer of pelvic urethra of male	9	1.078237e-2	1.000000e+0	1.000000e+0	9.274397e+1	1.078237e-2	1	1.078237e-2	1.000000e+0	14	1.061440e-2	1.000000e+0	1.000000e+0	9.396354e+1	1.064243e-2	1	96	5.000000e-1	1.041667e-2	unnamed	FHL2
MGI Expression: Detected	15522	TS23_maturing glomerular tuft	10	1.087721e-2	1.000000e+0	1.000000e+0	9.193537e+1	1.087721e-2	1	1.087721e-2	1.000000e+0	9	8.628517e-3	1.000000e+0	1.000000e+0	1.156474e+2	8.646971e-3	1	78	5.000000e-1	1.282051e-2	unnamed	FHL2
MGI Expression: Detected	15521	TS23_maturing renal corpuscle	11	1.226656e-2	1.000000e+0	1.000000e+0	8.152243e+1	1.226656e-2	1	1.226656e-2	1.000000e+0	13	9.952663e-3	1.000000e+0	1.000000e+0	1.002278e+2	9.977274e-3	1	90	5.000000e-1	1.111111e-2	unnamed	FHL2
MGI Expression: Detected	16809	TS23_developing capillary loop stage nephron	12	1.288244e-2	1.000000e+0	1.000000e+0	7.762504e+1	1.288244e-2	1	1.288244e-2	1.000000e+0	12	9.511379e-3	1.000000e+0	1.000000e+0	1.048895e+2	9.533840e-3	1	86	5.000000e-1	1.162791e-2	unnamed	FHL2
MGI Expression: Detected	16821	TS23_ureter mesenchyme	13	1.519424e-2	1.000000e+0	1.000000e+0	6.581443e+1	1.519424e-2	1	1.519424e-2	1.000000e+0	10	8.959636e-3	1.000000e+0	1.000000e+0	1.113642e+2	8.979547e-3	1	81	5.000000e-1	1.234568e-2	unnamed	FHL2
MGI Expression: Detected	17246	TS23_pelvic urethra of male	14	1.532731e-2	1.000000e+0	1.000000e+0	6.524303e+1	1.532731e-2	1	1.532731e-2	1.000000e+0	16	1.535041e-2	1.000000e+0	1.000000e+0	6.489568e+1	1.540935e-2	1	139	5.000000e-1	7.194245e-3	unnamed	FHL2
MGI Expression: Detected	16799	TS23_nephrogenic interstitium	15	1.566910e-2	1.000000e+0	1.000000e+0	6.381988e+1	1.566910e-2	1	1.566910e-2	1.000000e+0	11	9.290700e-3	1.000000e+0	1.000000e+0	1.073869e+2	9.312122e-3	1	84	5.000000e-1	1.190476e-2	unnamed	FHL2
MGI Expression: Detected	15520	TS23_maturing nephron	16	1.892436e-2	1.000000e+0	1.000000e+0	5.284195e+1	1.892436e-2	1	1.892436e-2	1.000000e+0	17	1.612031e-2	1.000000e+0	1.000000e+0	6.178425e+1	1.618536e-2	1	146	5.000000e-1	6.849315e-3	unnamed	FHL2
MGI Expression: Detected	16779	TS23_renal cortex interstitium	17	2.068219e-2	1.000000e+0	1.000000e+0	4.835079e+1	2.068219e-2	1	2.068219e-2	1.000000e+0	15	1.325916e-2	1.000000e+0	1.000000e+0	7.517083e+1	1.330303e-2	1	120	5.000000e-1	8.333333e-3	unnamed	FHL2
MGI Expression: Detected	7573	TS24_heart	18	2.832578e-2	1.000000e+0	1.000000e+0	3.530353e+1	2.832578e-2	1	2.832578e-2	1.000000e+0	18	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	FHL2
MGI Expression: Detected	7478	TS24_cardiovascular system	19	3.432954e-2	1.000000e+0	1.000000e+0	2.912943e+1	3.432954e-2	1	3.432954e-2	1.000000e+0	19	2.653920e-2	1.000000e+0	1.000000e+0	3.742946e+1	2.671692e-2	1	241	5.000000e-1	4.149378e-3	unnamed	FHL2
MGI Expression: Detected	3401	TS19_heart	20	3.700342e-2	1.000000e+0	1.000000e+0	2.702453e+1	3.700342e-2	1	3.700342e-2	1.000000e+0	20	2.785133e-2	1.000000e+0	1.000000e+0	3.565415e+1	2.804723e-2	1	253	5.000000e-1	3.952569e-3	unnamed	FHL2
MGI Expression: Detected	4801	TS21_heart	21	3.739422e-2	1.000000e+0	1.000000e+0	2.674210e+1	3.739422e-2	1	3.739422e-2	1.000000e+0	21	2.872559e-2	1.000000e+0	1.000000e+0	3.456130e+1	2.893409e-2	1	261	5.000000e-1	3.831418e-3	unnamed	FHL2
MGI Expression: Detected	4800	TS21_cardiovascular system	22	4.474454e-2	1.000000e+0	1.000000e+0	2.234909e+1	4.474454e-2	1	4.474454e-2	1.000000e+0	22	3.624975e-2	1.000000e+0	1.000000e+0	2.733485e+1	3.658334e-2	1	330	5.000000e-1	3.030303e-3	unnamed	FHL2
MGI Expression: Detected	3400	TS19_cardiovascular system	23	5.020065e-2	1.000000e+0	1.000000e+0	1.992006e+1	5.020065e-2	1	5.020065e-2	1.000000e+0	23	3.962064e-2	1.000000e+0	1.000000e+0	2.498753e+1	4.001995e-2	1	361	5.000000e-1	2.770083e-3	unnamed	FHL2
MGI Expression: Detected	1156	TS15_heart	24	5.631118e-2	1.000000e+0	1.000000e+0	1.775846e+1	5.631118e-2	1	5.631118e-2	1.000000e+0	24	4.135815e-2	1.000000e+0	1.000000e+0	2.392706e+1	4.179369e-2	1	377	5.000000e-1	2.652520e-3	unnamed	FHL2
MGI Expression: Detected	1155	TS15_cardiovascular system	25	6.403033e-2	1.000000e+0	1.000000e+0	1.561760e+1	6.403033e-2	1	6.403033e-2	1.000000e+0	25	4.818428e-2	1.000000e+0	1.000000e+0	2.050114e+1	4.877778e-2	1	440	5.000000e-1	2.272727e-3	unnamed	FHL2
MGI Expression: Detected	2167	TS17_heart	26	7.832814e-2	1.000000e+0	1.000000e+0	1.276680e+1	7.832814e-2	1	7.832814e-2	1.000000e+0	27	6.455328e-2	1.000000e+0	1.000000e+0	1.523733e+1	6.562829e-2	1	592	5.000000e-1	1.689189e-3	unnamed	FHL2
MGI Expression: Detected	14321	TS22_blood vessel	27	8.078372e-2	1.000000e+0	1.000000e+0	1.237873e+1	8.078372e-2	1	8.078372e-2	1.000000e+0	26	6.219287e-2	1.000000e+0	1.000000e+0	1.582544e+1	6.318940e-2	1	570	5.000000e-1	1.754386e-3	unnamed	FHL2
MGI Expression: Detected	2166	TS17_cardiovascular system	28	8.586664e-2	1.000000e+0	1.000000e+0	1.164597e+1	8.586664e-2	1	8.586664e-2	1.000000e+0	28	7.193709e-2	1.000000e+0	1.000000e+0	1.364675e+1	7.327753e-2	1	661	5.000000e-1	1.512859e-3	unnamed	FHL2
MGI Expression: Detected	16777	TS23_late tubule	29	8.864057e-2	1.000000e+0	1.000000e+0	1.128152e+1	8.864057e-2	1	8.864057e-2	1.000000e+0	33	1.020204e-1	1.000000e+0	1.000000e+0	9.545503e+0	1.047614e-1	1	945	5.000000e-1	1.058201e-3	unnamed	FHL2
MGI Expression: Detected	15997	TS23_nephrogenic zone	30	9.983179e-2	1.000000e+0	1.000000e+0	1.001685e+1	9.983179e-2	1	9.983179e-2	1.000000e+0	34	1.065321e-1	1.000000e+0	1.000000e+0	9.130061e+0	1.095283e-1	1	988	5.000000e-1	1.012146e-3	unnamed	FHL2
MGI Expression: Detected	5821	TS22_heart ventricle	31	1.076795e-1	1.000000e+0	1.000000e+0	9.286823e+0	1.076795e-1	1	1.076795e-1	1.000000e+0	29	9.042722e-2	1.000000e+0	1.000000e+0	1.080299e+1	9.256693e-2	1	835	5.000000e-1	1.197605e-3	unnamed	FHL2
MGI Expression: Detected	16778	TS23_renal interstitium	32	1.097768e-1	1.000000e+0	1.000000e+0	9.109396e+0	1.097768e-1	1	1.097768e-1	1.000000e+0	36	1.132260e-1	1.000000e+0	1.000000e+0	8.574620e+0	1.166232e-1	1	1052	5.000000e-1	9.505703e-4	unnamed	FHL2
MGI Expression: Detected	5796	TS22_heart atrium	33	1.107744e-1	1.000000e+0	1.000000e+0	9.027353e+0	1.107744e-1	1	1.107744e-1	1.000000e+0	30	9.327970e-2	1.000000e+0	1.000000e+0	1.046462e+1	9.556011e-2	1	862	5.000000e-1	1.160093e-3	unnamed	FHL2
MGI Expression: Detected	7163	TS21_head	34	1.120297e-1	1.000000e+0	1.000000e+0	8.926202e+0	1.120297e-1	1	1.120297e-1	1.000000e+0	31	9.433504e-2	1.000000e+0	1.000000e+0	1.034461e+1	9.666870e-2	1	872	5.000000e-1	1.146789e-3	unnamed	FHL2
MGI Expression: Detected	10313	TS23_ureter	35	1.164252e-1	1.000000e+0	1.000000e+0	8.589207e+0	1.164252e-1	1	1.164252e-1	1.000000e+0	35	1.106142e-1	1.000000e+0	1.000000e+0	8.783350e+0	1.138518e-1	1	1027	5.000000e-1	9.737098e-4	unnamed	FHL2
MGI Expression: Detected	6369	TS22_pituitary gland	36	1.180244e-1	1.000000e+0	1.000000e+0	8.472823e+0	1.180244e-1	1	1.180244e-1	1.000000e+0	32	9.549520e-2	1.000000e+0	1.000000e+0	1.021574e+1	9.788814e-2	1	883	5.000000e-1	1.132503e-3	unnamed	FHL2
MGI Expression: Detected	15433	TS23_renal cortex	37	1.301941e-1	1.000000e+0	1.000000e+0	7.680839e+0	1.301941e-1	1	1.301941e-1	1.000000e+0	42	1.364568e-1	1.000000e+0	1.000000e+0	7.069357e+0	1.414556e-1	1	1276	5.000000e-1	7.836991e-4	unnamed	FHL2
MGI Expression: Detected	17245	TS23_urethra of male	38	1.342634e-1	1.000000e+0	1.000000e+0	7.448047e+0	1.342634e-1	1	1.342634e-1	1.000000e+0	37	1.246725e-1	1.000000e+0	1.000000e+0	7.762909e+0	1.288177e-1	1	1162	5.000000e-1	8.605852e-4	unnamed	FHL2
MGI Expression: Detected	9169	TS23_drainage component	39	1.457842e-1	1.000000e+0	1.000000e+0	6.859453e+0	1.457842e-1	1	1.457842e-1	1.000000e+0	43	1.384131e-1	1.000000e+0	1.000000e+0	6.965637e+0	1.435619e-1	1	1295	5.000000e-1	7.722008e-4	unnamed	FHL2
MGI Expression: Detected	7125	TS28_skeletal muscle	40	1.519191e-1	1.000000e+0	1.000000e+0	6.582450e+0	1.519191e-1	1	1.519191e-1	1.000000e+0	45	1.554104e-1	1.000000e+0	1.000000e+0	6.174196e+0	1.619644e-1	1	1461	5.000000e-1	6.844627e-4	unnamed	FHL2
MGI Expression: Detected	6073	TS22_tongue	41	1.571634e-1	1.000000e+0	1.000000e+0	6.362804e+0	1.571634e-1	1	1.571634e-1	1.000000e+0	38	1.260204e-1	1.000000e+0	1.000000e+0	7.677021e+0	1.302589e-1	1	1175	5.000000e-1	8.510638e-4	unnamed	FHL2
MGI Expression: Detected	5786	TS22_heart	42	1.580825e-1	1.000000e+0	1.000000e+0	6.325810e+0	1.580825e-1	1	1.580825e-1	1.000000e+0	39	1.308847e-1	1.000000e+0	1.000000e+0	7.381751e+0	1.354692e-1	1	1222	5.000000e-1	8.183306e-4	unnamed	FHL2
MGI Expression: Detected	6069	TS22_pharynx	43	1.630132e-1	1.000000e+0	1.000000e+0	6.134472e+0	1.630132e-1	1	1.630132e-1	1.000000e+0	40	1.333634e-1	1.000000e+0	1.000000e+0	7.239567e+0	1.381298e-1	1	1246	5.000000e-1	8.025682e-4	unnamed	FHL2
MGI Expression: Detected	9198	TS23_testis	44	1.636246e-1	1.000000e+0	1.000000e+0	6.111550e+0	1.636246e-1	1	1.636246e-1	1.000000e+0	49	1.707248e-1	1.000000e+0	1.000000e+0	5.595844e+0	1.787041e-1	1	1612	5.000000e-1	6.203474e-4	unnamed	FHL2
MGI Expression: Detected	5785	TS22_cardiovascular system	45	1.703620e-1	1.000000e+0	1.000000e+0	5.869853e+0	1.703620e-1	1	1.703620e-1	1.000000e+0	44	1.424216e-1	1.000000e+0	1.000000e+0	6.761994e+0	1.478854e-1	1	1334	5.000000e-1	7.496252e-4	unnamed	FHL2
MGI Expression: Detected	17231	TS23_urethra	46	1.733427e-1	1.000000e+0	1.000000e+0	5.768919e+0	1.733427e-1	1	1.733427e-1	1.000000e+0	46	1.661756e-1	1.000000e+0	1.000000e+0	5.756541e+0	1.737154e-1	1	1567	5.000000e-1	6.381621e-4	unnamed	FHL2
MGI Expression: Detected	8416	TS23_urinary bladder	47	1.763697e-1	1.000000e+0	1.000000e+0	5.669908e+0	1.763697e-1	1	1.763697e-1	1.000000e+0	47	1.676934e-1	1.000000e+0	1.000000e+0	5.701960e+0	1.753783e-1	1	1582	5.000000e-1	6.321113e-4	unnamed	FHL2
MGI Expression: Detected	1154	TS15_organ system	48	1.790828e-1	1.000000e+0	1.000000e+0	5.584008e+0	1.790828e-1	1	1.790828e-1	1.000000e+0	41	1.356324e-1	1.000000e+0	1.000000e+0	7.113959e+0	1.405687e-1	1	1268	5.000000e-1	7.886435e-4	unnamed	FHL2
MGI Expression: Detected	7123	TS28_muscle	49	1.884267e-1	1.000000e+0	1.000000e+0	5.307102e+0	1.884267e-1	1	1.884267e-1	1.000000e+0	50	1.924875e-1	1.000000e+0	1.000000e+0	4.931930e+0	2.027604e-1	1	1829	5.000000e-1	5.467469e-4	unnamed	FHL2
MGI Expression: Detected	6367	TS22_diencephalon	50	2.176277e-1	1.000000e+0	1.000000e+0	4.595004e+0	2.176277e-1	1	2.176277e-1	1.000000e+0	48	1.696139e-1	1.000000e+0	1.000000e+0	5.634291e+0	1.774846e-1	1	1601	5.000000e-1	6.246096e-4	unnamed	FHL2
MGI Expression: Detected	6059	TS22_foregut	51	2.181768e-1	1.000000e+0	1.000000e+0	4.583440e+0	2.181768e-1	1	2.181768e-1	1.000000e+0	51	1.966662e-1	1.000000e+0	1.000000e+0	4.821219e+0	2.074164e-1	1	1871	5.000000e-1	5.344735e-4	unnamed	FHL2
MGI Expression: Detected	2413	TS17_central nervous system	52	2.230048e-1	1.000000e+0	1.000000e+0	4.484208e+0	2.230048e-1	1	2.230048e-1	1.000000e+0	52	1.997435e-1	1.000000e+0	1.000000e+0	4.742639e+0	2.108531e-1	1	1902	5.000000e-1	5.257624e-4	unnamed	FHL2
MGI Expression: Detected	8259	TS23_male reproductive system	53	2.246603e-1	1.000000e+0	1.000000e+0	4.451166e+0	2.246603e-1	1	2.246603e-1	1.000000e+0	54	2.139608e-1	1.000000e+0	1.000000e+0	4.408847e+0	2.268167e-1	1	2046	5.000000e-1	4.887586e-4	unnamed	FHL2
MGI Expression: Detected	2412	TS17_nervous system	54	2.273547e-1	1.000000e+0	1.000000e+0	4.398414e+0	2.273547e-1	1	2.273547e-1	1.000000e+0	53	2.029139e-1	1.000000e+0	1.000000e+0	4.664168e+0	2.144005e-1	1	1934	5.000000e-1	5.170631e-4	unnamed	FHL2
MGI Expression: Detected	7103	TS28_heart	55	2.471289e-1	1.000000e+0	1.000000e+0	4.046471e+0	2.471289e-1	1	2.471289e-1	1.000000e+0	58	2.465427e-1	1.000000e+0	1.000000e+0	3.788534e+0	2.639543e-1	1	2381	5.000000e-1	4.199916e-4	unnamed	FHL2
MGI Expression: Detected	1016	TS15_embryo	56	2.533670e-1	1.000000e+0	1.000000e+0	3.946844e+0	2.533670e-1	1	2.533670e-1	1.000000e+0	55	2.237590e-1	1.000000e+0	1.000000e+0	4.203402e+0	2.379026e-1	1	2146	5.000000e-1	4.659832e-4	unnamed	FHL2
MGI Expression: Detected	7098	TS28_cardiovascular system	57	2.541249e-1	1.000000e+0	1.000000e+0	3.935073e+0	2.541249e-1	1	2.541249e-1	1.000000e+0	60	2.524013e-1	1.000000e+0	1.000000e+0	3.693898e+0	2.707167e-1	1	2442	5.000000e-1	4.095004e-4	unnamed	FHL2
MGI Expression: Detected	1015	Theiler_stage_15	58	2.573675e-1	1.000000e+0	1.000000e+0	3.885495e+0	2.573675e-1	1	2.573675e-1	1.000000e+0	56	2.277584e-1	1.000000e+0	1.000000e+0	4.124600e+0	2.424478e-1	1	2187	5.000000e-1	4.572474e-4	unnamed	FHL2
MGI Expression: Detected	6020	TS22_gut	59	2.671263e-1	1.000000e+0	1.000000e+0	3.743547e+0	2.671263e-1	1	2.671263e-1	1.000000e+0	59	2.480816e-1	1.000000e+0	1.000000e+0	3.763246e+0	2.657281e-1	1	2397	5.000000e-1	4.171882e-4	unnamed	FHL2
MGI Expression: Detected	7648	TS23_reproductive system	60	2.726454e-1	1.000000e+0	1.000000e+0	3.667768e+0	2.726454e-1	1	2.726454e-1	1.000000e+0	62	2.658558e-1	1.000000e+0	1.000000e+0	3.492257e+0	2.863478e-1	1	2583	5.000000e-1	3.871467e-4	unnamed	FHL2
MGI Expression: Detected	6366	TS22_forebrain	61	2.941681e-1	1.000000e+0	1.000000e+0	3.399417e+0	2.941681e-1	1	2.941681e-1	1.000000e+0	57	2.455801e-1	1.000000e+0	1.000000e+0	3.804513e+0	2.628457e-1	1	2371	5.000000e-1	4.217630e-4	unnamed	FHL2
MGI Expression: Detected	6019	TS22_alimentary system	62	2.958102e-1	1.000000e+0	1.000000e+0	3.380547e+0	2.958102e-1	1	2.958102e-1	1.000000e+0	66	2.795646e-1	1.000000e+0	1.000000e+0	3.306635e+0	3.024223e-1	1	2728	5.000000e-1	3.665689e-4	unnamed	FHL2
MGI Expression: Detected	7446	TS24_organ system	63	2.979509e-1	1.000000e+0	1.000000e+0	3.356258e+0	2.979509e-1	1	2.979509e-1	1.000000e+0	61	2.626226e-1	1.000000e+0	1.000000e+0	3.538839e+0	2.825786e-1	1	2549	5.000000e-1	3.923107e-4	unnamed	FHL2
MGI Expression: Detected	8013	TS23_metanephros	64	2.993178e-1	1.000000e+0	1.000000e+0	3.340931e+0	2.993178e-1	1	2.993178e-1	1.000000e+0	67	2.899716e-1	1.000000e+0	1.000000e+0	3.177351e+0	3.147276e-1	1	2839	5.000000e-1	3.522367e-4	unnamed	FHL2
MGI Expression: Detected	2165	TS17_organ system	65	3.004442e-1	1.000000e+0	1.000000e+0	3.328405e+0	3.004442e-1	1	3.004442e-1	1.000000e+0	63	2.687975e-1	1.000000e+0	1.000000e+0	3.450842e+0	2.897844e-1	1	2614	5.000000e-1	3.825555e-4	unnamed	FHL2
MGI Expression: Detected	4799	TS21_organ system	66	3.222661e-1	1.000000e+0	1.000000e+0	3.103025e+0	3.222661e-1	1	3.222661e-1	1.000000e+0	65	2.733407e-1	1.000000e+0	1.000000e+0	3.388618e+0	2.951056e-1	1	2662	5.000000e-1	3.756574e-4	unnamed	FHL2
MGI Expression: Detected	3399	TS19_organ system	67	3.233706e-1	1.000000e+0	1.000000e+0	3.092427e+0	3.233706e-1	1	3.233706e-1	1.000000e+0	64	2.724900e-1	1.000000e+0	1.000000e+0	3.400113e+0	2.941079e-1	1	2653	5.000000e-1	3.769318e-4	unnamed	FHL2
MGI Expression: Detected	6928	TS24_embryo	68	3.290828e-1	1.000000e+0	1.000000e+0	3.038749e+0	3.290828e-1	1	3.290828e-1	1.000000e+0	68	2.959376e-1	1.000000e+0	1.000000e+0	3.107303e+0	3.218225e-1	1	2903	5.000000e-1	3.444712e-4	unnamed	FHL2
MGI Expression: Detected	6927	Theiler_stage_24	69	3.296590e-1	1.000000e+0	1.000000e+0	3.033437e+0	3.296590e-1	1	3.296590e-1	1.000000e+0	69	2.964026e-1	1.000000e+0	1.000000e+0	3.101960e+0	3.223768e-1	1	2908	5.000000e-1	3.438790e-4	unnamed	FHL2
MGI Expression: Detected	6018	TS22_visceral organ	70	3.446359e-1	1.000000e+0	1.000000e+0	2.901613e+0	3.446359e-1	1	3.446359e-1	1.000000e+0	79	3.321114e-1	1.000000e+0	1.000000e+0	2.735972e+0	3.655008e-1	1	3297	5.000000e-1	3.033060e-4	unnamed	FHL2
MGI Expression: Detected	6365	TS22_brain	71	3.486991e-1	1.000000e+0	1.000000e+0	2.867802e+0	3.486991e-1	1	3.486991e-1	1.000000e+0	70	2.970534e-1	1.000000e+0	1.000000e+0	3.094511e+0	3.231528e-1	1	2915	5.000000e-1	3.430532e-4	unnamed	FHL2
MGI Expression: Detected	7644	TS23_renal-urinary system	72	3.497890e-1	1.000000e+0	1.000000e+0	2.858867e+0	3.497890e-1	1	3.497890e-1	1.000000e+0	80	3.379875e-1	1.000000e+0	1.000000e+0	2.683076e+0	3.727066e-1	1	3362	5.000000e-1	2.974420e-4	unnamed	FHL2
MGI Expression: Detected	2023	TS17_embryo	73	3.504112e-1	1.000000e+0	1.000000e+0	2.853790e+0	3.504112e-1	1	3.504112e-1	1.000000e+0	77	3.281190e-1	1.000000e+0	1.000000e+0	2.772979e+0	3.606230e-1	1	3253	5.000000e-1	3.074085e-4	unnamed	FHL2
MGI Expression: Detected	2022	Theiler_stage_17	74	3.517739e-1	1.000000e+0	1.000000e+0	2.842735e+0	3.517739e-1	1	3.517739e-1	1.000000e+0	78	3.303888e-1	1.000000e+0	1.000000e+0	2.751830e+0	3.633945e-1	1	3278	5.000000e-1	3.050641e-4	unnamed	FHL2
MGI Expression: Detected	6351	TS22_central nervous system	75	3.611614e-1	1.000000e+0	1.000000e+0	2.768845e+0	3.611614e-1	1	3.611614e-1	1.000000e+0	71	3.110186e-1	1.000000e+0	1.000000e+0	2.942107e+0	3.398925e-1	1	3066	5.000000e-1	3.261579e-4	unnamed	FHL2
MGI Expression: Detected	4761	TS21_embryo	76	3.653552e-1	1.000000e+0	1.000000e+0	2.737062e+0	3.653552e-1	1	3.653552e-1	1.000000e+0	72	3.195499e-1	1.000000e+0	1.000000e+0	2.855492e+0	3.502023e-1	1	3159	5.000000e-1	3.165559e-4	unnamed	FHL2
MGI Expression: Detected	4760	Theiler_stage_21	77	3.661005e-1	1.000000e+0	1.000000e+0	2.731490e+0	3.661005e-1	1	3.661005e-1	1.000000e+0	73	3.205555e-1	1.000000e+0	1.000000e+0	2.845584e+0	3.514218e-1	1	3170	5.000000e-1	3.154574e-4	unnamed	FHL2
MGI Expression: Detected	6350	TS22_nervous system	78	3.685477e-1	1.000000e+0	1.000000e+0	2.713353e+0	3.685477e-1	1	3.685477e-1	1.000000e+0	74	3.206469e-1	1.000000e+0	1.000000e+0	2.844686e+0	3.515326e-1	1	3171	5.000000e-1	3.153579e-4	unnamed	FHL2
MGI Expression: Detected	3341	TS19_embryo	79	3.699199e-1	1.000000e+0	1.000000e+0	2.703288e+0	3.699199e-1	1	3.699199e-1	1.000000e+0	75	3.257542e-1	1.000000e+0	1.000000e+0	2.795321e+0	3.577407e-1	1	3227	5.000000e-1	3.098853e-4	unnamed	FHL2
MGI Expression: Detected	3340	Theiler_stage_19	80	3.711587e-1	1.000000e+0	1.000000e+0	2.694265e+0	3.711587e-1	1	3.711587e-1	1.000000e+0	76	3.271190e-1	1.000000e+0	1.000000e+0	2.782387e+0	3.594036e-1	1	3242	5.000000e-1	3.084516e-4	unnamed	FHL2
MGI Expression: Detected	5784	TS22_organ system	81	4.769468e-1	1.000000e+0	1.000000e+0	2.096670e+0	4.769468e-1	1	4.769468e-1	1.000000e+0	81	4.454434e-1	1.000000e+0	1.000000e+0	1.958424e+0	5.106147e-1	1	4606	5.000000e-1	2.171081e-4	unnamed	FHL2
MGI Expression: Detected	7005	TS28_brain	82	4.776274e-1	1.000000e+0	1.000000e+0	2.093682e+0	4.776274e-1	1	4.776274e-1	1.000000e+0	82	4.562057e-1	1.000000e+0	1.000000e+0	1.904264e+0	5.251372e-1	1	4737	5.000000e-1	2.111041e-4	unnamed	FHL2
MGI Expression: Detected	7003	TS28_central nervous system	83	4.961740e-1	1.000000e+0	1.000000e+0	2.015422e+0	4.961740e-1	1	4.961740e-1	1.000000e+0	85	4.783750e-1	1.000000e+0	1.000000e+0	1.800140e+0	5.555124e-1	1	5011	5.000000e-1	1.995610e-4	unnamed	FHL2
MGI Expression: Detected	7001	TS28_nervous system	84	4.974351e-1	1.000000e+0	1.000000e+0	2.010313e+0	4.974351e-1	1	4.974351e-1	1.000000e+0	86	4.798952e-1	1.000000e+0	1.000000e+0	1.793340e+0	5.576188e-1	1	5030	5.000000e-1	1.988072e-4	unnamed	FHL2
MGI Expression: Detected	5741	TS22_embryo	85	5.012384e-1	1.000000e+0	1.000000e+0	1.995059e+0	5.012384e-1	1	5.012384e-1	1.000000e+0	83	4.751674e-1	1.000000e+0	1.000000e+0	1.814625e+0	5.510781e-1	1	4971	5.000000e-1	2.011668e-4	unnamed	FHL2
MGI Expression: Detected	5740	Theiler_stage_22	86	5.025708e-1	1.000000e+0	1.000000e+0	1.989769e+0	5.025708e-1	1	5.025708e-1	1.000000e+0	84	4.770932e-1	1.000000e+0	1.000000e+0	1.805906e+0	5.537387e-1	1	4995	5.000000e-1	2.002002e-4	unnamed	FHL2
MGI Expression: Detected	7489	TS23_visceral organ	87	5.150818e-1	1.000000e+0	1.000000e+0	1.941439e+0	5.150818e-1	1	5.150818e-1	1.000000e+0	87	5.216365e-1	1.000000e+0	1.000000e+0	1.621517e+0	6.167064e-1	1	5563	5.000000e-1	1.797591e-4	unnamed	FHL2
MGI Expression: Detected	6944	TS28_organ system	88	6.191523e-1	1.000000e+0	1.000000e+0	1.615112e+0	6.191523e-1	1	6.191523e-1	1.000000e+0	88	6.326325e-1	1.000000e+0	1.000000e+0	1.269420e+0	7.877612e-1	1	7106	5.000000e-1	1.407261e-4	unnamed	FHL2
MGI Expression: Detected	6937	TS28_postnatal mouse	89	6.225233e-1	1.000000e+0	1.000000e+0	1.606366e+0	6.225233e-1	1	6.225233e-1	1.000000e+0	89	6.373878e-1	1.000000e+0	1.000000e+0	1.256862e+0	7.956322e-1	1	7177	5.000000e-1	1.393340e-4	unnamed	FHL2
MGI Expression: Detected	7445	TS23_organ system	90	6.921258e-1	1.000000e+0	1.000000e+0	1.444824e+0	6.921258e-1	1	6.921258e-1	1.000000e+0	90	6.938167e-1	1.000000e+0	1.000000e+0	1.119447e+0	8.932986e-1	1	8058	5.000000e-1	1.241003e-4	unnamed	FHL2
MGI Expression: Detected	6925	TS23_embryo	91	7.220129e-1	1.000000e+0	1.000000e+0	1.385017e+0	7.220129e-1	1	7.220129e-1	1.000000e+0	91	7.337668e-1	1.000000e+0	1.000000e+0	1.033039e+0	9.680173e-1	1	8732	5.000000e-1	1.145213e-4	unnamed	FHL2
MGI Expression: Detected	6924	Theiler_stage_23	92	7.220179e-1	1.000000e+0	1.000000e+0	1.385007e+0	7.220179e-1	1	7.220179e-1	1.000000e+0	92	7.339383e-1	1.000000e+0	1.000000e+0	1.032685e+0	9.683499e-1	1	8735	5.000000e-1	1.144820e-4	unnamed	FHL2
MSigDB Perturbation	EHRLICH_ICF_SYNDROM_UP	Up-regulated in B lymphocytes from patients with ICF syndrom caused by mutations in DNMT3B [GeneID=1789] compared to normals.	1	1.067912e-3	1.000000e+0	1.000000e+0	9.364071e+2	1.067912e-3	1	1.067912e-3	1.000000e+0	1	1.219107e-3	1.000000e+0	1.000000e+0	8.200455e+2	1.219445e-3	1	11	5.000000e-1	9.090909e-2	unnamed	FHL2
MSigDB Perturbation	KOHOUTEK_CCNT1_TARGETS	Genes down-regulated in E14 ES (embryonic stem) cells upon knockdown of CYCT1 [GeneID=904] by RNAi.	2	2.617811e-3	1.000000e+0	1.000000e+0	3.819986e+2	2.617811e-3	1	2.617811e-3	1.000000e+0	12	5.203711e-3	1.000000e+0	1.000000e+0	1.919255e+2	5.210354e-3	1	47	5.000000e-1	2.127660e-2	unnamed	FHL2
MSigDB Perturbation	CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP	Genes up-regulated in type 1 (soleus) vs type 2B (EDL) myofibers.	3	2.785318e-3	1.000000e+0	1.000000e+0	3.590254e+2	2.785318e-3	1	2.785318e-3	1.000000e+0	5	3.987038e-3	1.000000e+0	1.000000e+0	2.505694e+2	3.990910e-3	1	36	5.000000e-1	2.777778e-2	unnamed	FHL2
MSigDB Perturbation	STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA	Genes up-regulated by estradiol [PubChem=5757] and not modulated by ESRRA [GeneID=2101] in MCF-7 cells (breast cancer).	4	2.840393e-3	1.000000e+0	1.000000e+0	3.520640e+2	2.840393e-3	1	2.840393e-3	1.000000e+0	3	1.994515e-3	1.000000e+0	1.000000e+0	5.011389e+2	1.995455e-3	1	18	5.000000e-1	5.555556e-2	unnamed	FHL2
MSigDB Perturbation	LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP	Genes up-regulated in LSK cells (bone marrow) as a function of a QTL for the size of hematopoietic stem cell (HSC) population: comparison of congenic D.B. Chr 3 (DB, small HSC population) vs parental D2 strain (huge HSC population).	5	3.000806e-3	1.000000e+0	1.000000e+0	3.332438e+2	3.000806e-3	1	3.000806e-3	1.000000e+0	6	4.097676e-3	1.000000e+0	1.000000e+0	2.437973e+2	4.101768e-3	1	37	5.000000e-1	2.702703e-2	unnamed	FHL2
MSigDB Perturbation	MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN	Genes down-regulated in derivatives of MCF-7aro cells (breast cancer) that developed resistance to tamoxifen [PubChem=5376] or  inhibitors of aromatase (CYP19A1) [GeneID=1588].	6	3.329777e-3	1.000000e+0	1.000000e+0	3.003204e+2	3.329777e-3	1	3.329777e-3	1.000000e+0	4	2.326740e-3	1.000000e+0	1.000000e+0	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	FHL2
MSigDB Perturbation	DORN_ADENOVIRUS_INFECTION_12HR_DN	Genes down-regulated in HeLa cells (cervical carcinoma) 12 h after infection with adenovirus Ad12.	7	3.355285e-3	1.000000e+0	1.000000e+0	2.980372e+2	3.355285e-3	1	3.355285e-3	1.000000e+0	12	5.203711e-3	1.000000e+0	1.000000e+0	1.919255e+2	5.210354e-3	1	47	5.000000e-1	2.127660e-2	unnamed	FHL2
MSigDB Perturbation	KANNAN_TP53_TARGETS_UP	Primary up-regulated targets of TP53 [GeneID=7157] in the H1299 (lung cancer) cell line.	8	3.719382e-3	1.000000e+0	1.000000e+0	2.688619e+2	3.719382e-3	1	3.719382e-3	1.000000e+0	17	6.419641e-3	1.000000e+0	1.000000e+0	1.555259e+2	6.429799e-3	1	58	5.000000e-1	1.724138e-2	unnamed	FHL2
MSigDB Perturbation	AIYAR_COBRA1_TARGETS_UP	Genes up-regulated in T47D cells (breast cancer) after COBRA1 [GeneID=25920] knockdown by RNAi.	9	3.740238e-3	1.000000e+0	1.000000e+0	2.673627e+2	3.740238e-3	1	3.740238e-3	1.000000e+0	8	4.429551e-3	1.000000e+0	1.000000e+0	2.255125e+2	4.434344e-3	1	40	5.000000e-1	2.500000e-2	unnamed	FHL2
MSigDB Perturbation	DORN_ADENOVIRUS_INFECTION_32HR_DN	Genes down-regulated in HeLa cells (cervical carcinoma) 32 h after infection with adenovirus Ad12.	10	4.021237e-3	1.000000e+0	1.000000e+0	2.486797e+2	4.021237e-3	1	4.021237e-3	1.000000e+0	7	4.318932e-3	1.000000e+0	1.000000e+0	2.312949e+2	4.323485e-3	1	39	5.000000e-1	2.564103e-2	unnamed	FHL2
MSigDB Perturbation	DORN_ADENOVIRUS_INFECTION_24HR_DN	Genes down-regulated in HeLa cells (cervical carcinoma) 24 h after infection with adenovirus Ad12.	11	4.035887e-3	1.000000e+0	1.000000e+0	2.477770e+2	4.035887e-3	1	4.035887e-3	1.000000e+0	10	4.761371e-3	1.000000e+0	1.000000e+0	2.097791e+2	4.766920e-3	1	43	5.000000e-1	2.325581e-2	unnamed	FHL2
MSigDB Perturbation	DORN_ADENOVIRUS_INFECTION_48HR_DN	Genes down-regulated in HeLa cells (cervical carcinoma) 48 h after infection with adenovirus Ad12.	12	4.156899e-3	1.000000e+0	1.000000e+0	2.405639e+2	4.156899e-3	1	4.156899e-3	1.000000e+0	8	4.429551e-3	1.000000e+0	1.000000e+0	2.255125e+2	4.434344e-3	1	40	5.000000e-1	2.500000e-2	unnamed	FHL2
MSigDB Perturbation	HENDRICKS_SMARCA4_TARGETS_UP	Genes up-regulated in ALAB cells (breast cancer) upon reintroduction of SMARCA4 [GeneID=6597] expressed off adenoviral vector.	13	5.018882e-3	1.000000e+0	1.000000e+0	1.992476e+2	5.018882e-3	1	5.018882e-3	1.000000e+0	16	5.977571e-3	1.000000e+0	1.000000e+0	1.670463e+2	5.986364e-3	1	54	5.000000e-1	1.851852e-2	unnamed	FHL2
MSigDB Perturbation	ENGELMANN_CANCER_PROGENITORS_UP	Up-regulated genes in the cancer progenitor (stem) cells corresponding to side population (SP) MCF7 cells (breast cancer) positive for MUC1 [GeneID=4582].	14	6.232289e-3	1.000000e+0	1.000000e+0	1.604547e+2	6.232289e-3	1	6.232289e-3	1.000000e+0	11	4.982553e-3	1.000000e+0	1.000000e+0	2.004556e+2	4.988637e-3	1	45	5.000000e-1	2.222222e-2	unnamed	FHL2
MSigDB Perturbation	HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN	Genes down-regulated in MCF7 cells (breast cancer, normal TP53 [GeneID=7157]) undergoing mitotic arrest and apoptosis after treatment with 100 nM docetaxel [PubChem=148124].	15	6.236280e-3	1.000000e+0	1.000000e+0	1.603520e+2	6.236280e-3	1	6.236280e-3	1.000000e+0	15	5.645954e-3	1.000000e+0	1.000000e+0	1.768725e+2	5.653789e-3	1	51	5.000000e-1	1.960784e-2	unnamed	FHL2
MSigDB Perturbation	NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	Top 100 probe sets contrubuting to the positive side of the 1st principal component; predominantly associated with spindle cell and pleomorphic sarcoma samples.	16	6.723459e-3	1.000000e+0	1.000000e+0	1.487330e+2	6.723459e-3	1	6.723459e-3	1.000000e+0	21	7.855690e-3	1.000000e+0	1.000000e+0	1.270493e+2	7.870961e-3	1	71	5.000000e-1	1.408451e-2	unnamed	FHL2
MSigDB Perturbation	ROSS_AML_OF_FAB_M7_TYPE	Top 100 probe sets for pediatric acute myeloid leukemia (AML) subtype FAB M7 (also known as acute megakaryoblastic leukemia, AMKL).	17	7.666017e-3	1.000000e+0	1.000000e+0	1.304458e+2	7.666017e-3	1	7.666017e-3	1.000000e+0	20	7.413939e-3	1.000000e+0	1.000000e+0	1.346343e+2	7.427526e-3	1	67	5.000000e-1	1.492537e-2	unnamed	FHL2
MSigDB Perturbation	LIN_NPAS4_TARGETS_DN	Genes down-regulated in neurons after NPAS4 [GeneID=266743] knockdown by RNAi.	18	7.854855e-3	1.000000e+0	1.000000e+0	1.273098e+2	7.854855e-3	1	7.854855e-3	1.000000e+0	19	7.303486e-3	1.000000e+0	1.000000e+0	1.366742e+2	7.316668e-3	1	66	5.000000e-1	1.515152e-2	unnamed	FHL2
MSigDB Perturbation	PUJANA_BREAST_CANCER_LIT_INT_NETWORK	Genes constituting the LIT-Int network of proteins interacting with breast cancer reference proteins BRCA1, BRCA2, ATM, and CHEK2 [GeneID=672;675;472;11200]; the interactions were manually curated from the literature.	19	8.136893e-3	1.000000e+0	1.000000e+0	1.228970e+2	8.136893e-3	1	8.136893e-3	1.000000e+0	29	1.116569e-2	1.000000e+0	1.000000e+0	8.931188e+1	1.119672e-2	1	101	5.000000e-1	9.900990e-3	unnamed	FHL2
MSigDB Perturbation	MCCLUNG_DELTA_FOSB_TARGETS_2WK	Genes up-regulated in the nucleus accumbens (a major reward center in brain) 2 weeks after induction of deltaFosB, a FOSB [GeneID=2354] splice variant.	20	8.993599e-3	1.000000e+0	1.000000e+0	1.111902e+2	8.993599e-3	1	8.993599e-3	1.000000e+0	14	5.424845e-3	1.000000e+0	1.000000e+0	1.840918e+2	5.432071e-3	1	49	5.000000e-1	2.040816e-2	unnamed	FHL2
MSigDB Perturbation	SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN	Genes down-regulated in 293 cells (embryonic kidney) upon expression of KHSV (Kaposi sarcoma-associated herpesvirus) microRNAs.	21	9.590248e-3	1.000000e+0	1.000000e+0	1.042726e+2	9.590248e-3	1	9.590248e-3	1.000000e+0	18	6.530143e-3	1.000000e+0	1.000000e+0	1.528898e+2	6.540657e-3	1	59	5.000000e-1	1.694915e-2	unnamed	FHL2
MSigDB Perturbation	HOEBEKE_LYMPHOID_STEM_CELL_DN	Genes down-regulated in the common lymphoid progenitor (CLP, defined as CD34+CD38-CD7+ [GeneID=947;952;924]) compared to a multipotent cord blood cell (defined as CD34+CD38+CD7-).	22	9.890082e-3	1.000000e+0	1.000000e+0	1.011114e+2	9.890082e-3	1	9.890082e-3	1.000000e+0	25	9.621709e-3	1.000000e+0	1.000000e+0	1.036839e+2	9.644698e-3	1	87	5.000000e-1	1.149425e-2	unnamed	FHL2
MSigDB Perturbation	STEIN_ESR1_TARGETS	Genes regulated by ESR1 [GeneID=2099] in MCF-7 cells (breast cancer).	23	1.009961e-2	1.000000e+0	1.000000e+0	9.901374e+1	1.009961e-2	1	1.009961e-2	1.000000e+0	24	9.401043e-3	1.000000e+0	1.000000e+0	1.061235e+2	9.422981e-3	1	85	5.000000e-1	1.176471e-2	unnamed	FHL2
MSigDB Perturbation	RADMACHER_AML_PROGNOSIS	The 'Bullinger validation signature' [PMID=15084693] used to validate prediction of prognostic outcome of acute myeloid leukemia (AML) patients with a normal karyotype.	24	1.011658e-2	1.000000e+0	1.000000e+0	9.884765e+1	1.011658e-2	1	1.011658e-2	1.000000e+0	22	8.518131e-3	1.000000e+0	1.000000e+0	1.171494e+2	8.536112e-3	1	77	5.000000e-1	1.298701e-2	unnamed	FHL2
MSigDB Perturbation	CERVERA_SDHB_TARGETS_1_UP	Genes turned on in Hep3B cells (hepatocellular carcinoma, HCC) upon knockdown of SDHB [GeneID=6390] by RNAi.	25	1.170449e-2	1.000000e+0	1.000000e+0	8.543733e+1	1.170449e-2	1	1.170449e-2	1.000000e+0	30	1.204742e-2	1.000000e+0	1.000000e+0	8.275688e+1	1.208359e-2	1	109	5.000000e-1	9.174312e-3	unnamed	FHL2
MSigDB Perturbation	SANA_TNF_SIGNALING_DN	Genes down-regulated in five primary endothelial cell types (lung, aortic, iliac, dermal, and colon) by TNF [GeneID=7124].	26	1.228872e-2	1.000000e+0	1.000000e+0	8.137543e+1	1.228872e-2	1	1.228872e-2	1.000000e+0	26	9.732033e-3	1.000000e+0	1.000000e+0	1.025057e+2	9.755557e-3	1	88	5.000000e-1	1.136364e-2	unnamed	FHL2
MSigDB Perturbation	STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP	Genes induced in SKBR3 cells (breast cancer) by 25-hydroxyvitamin D3 [PubChem=1593].	27	1.242875e-2	1.000000e+0	1.000000e+0	8.045860e+1	1.242875e-2	1	1.242875e-2	1.000000e+0	23	9.069997e-3	1.000000e+0	1.000000e+0	1.100061e+2	9.090405e-3	1	82	5.000000e-1	1.219512e-2	unnamed	FHL2
MSigDB Perturbation	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN	Genes down-regulated in reverted NIH3T3 cells (fibroblasts transformed by activated KRAS [GeneID=3845] which then reverted to normal cells upon stable over-expression of a dominant negative form of CDC25 [GeneID=5923]) vs normal fibroblasts.	28	1.266477e-2	1.000000e+0	1.000000e+0	7.895922e+1	1.266477e-2	1	1.266477e-2	1.000000e+0	36	1.732955e-2	1.000000e+0	1.000000e+0	5.745541e+1	1.740480e-2	1	157	5.000000e-1	6.369427e-3	unnamed	FHL2
MSigDB Perturbation	PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4	Genes regulated in MCF7 cells (breast cancer) by expression of the full-length and truncated (611-CTF) forms of ERBB2 [GeneID=2064] at 60 h time point.	29	1.430951e-2	1.000000e+0	1.000000e+0	6.988361e+1	1.430951e-2	1	1.430951e-2	1.000000e+0	27	1.105544e-2	1.000000e+0	1.000000e+0	9.020500e+1	1.108586e-2	1	100	5.000000e-1	1.000000e-2	unnamed	FHL2
MSigDB Perturbation	SMIRNOV_RESPONSE_TO_IR_6HR_UP	Genes up-regulated in B lymphocytes at 6 h after exprosure to 10 Gy dose of ionizing radiation.	30	1.433802e-2	1.000000e+0	1.000000e+0	6.974465e+1	1.433802e-2	1	1.433802e-2	1.000000e+0	38	1.787895e-2	1.000000e+0	1.000000e+0	5.568210e+1	1.795909e-2	1	162	5.000000e-1	6.172840e-3	unnamed	FHL2
MSigDB Perturbation	GERY_CEBP_TARGETS	Genes changed in NIH 3T3 cells (embryonic fibroblast) by expression of one or more of C/EBP proteins: CEBPA, CEBPB, CEBPG,  and CEBPD [GeneID=1050;1051;1054;1052].	31	1.444823e-2	1.000000e+0	1.000000e+0	6.921263e+1	1.444823e-2	1	1.444823e-2	1.000000e+0	33	1.546041e-2	1.000000e+0	1.000000e+0	6.443214e+1	1.552020e-2	1	140	5.000000e-1	7.142857e-3	unnamed	FHL2
MSigDB Perturbation	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN	Genes down-regulated in normal hematopoietic progenitors by RUNX1-RUNX1T1 [GeneID=861;862] fusion.	32	1.675923e-2	1.000000e+0	1.000000e+0	5.966862e+1	1.675923e-2	1	1.675923e-2	1.000000e+0	43	1.974579e-2	1.000000e+0	1.000000e+0	5.039385e+1	1.984369e-2	1	179	5.000000e-1	5.586592e-3	unnamed	FHL2
MSigDB Perturbation	RUIZ_TNC_TARGETS_DN	Genes down-regulated in T98G cells (glioblastoma) by TNC [GeneID=3371].	33	1.700761e-2	1.000000e+0	1.000000e+0	5.879722e+1	1.700761e-2	1	1.700761e-2	1.000000e+0	34	1.579039e-2	1.000000e+0	1.000000e+0	6.308042e+1	1.585278e-2	1	143	5.000000e-1	6.993007e-3	unnamed	FHL2
MSigDB Perturbation	GOZGIT_ESR1_TARGETS_UP	Genes up-regulated in TMX2-28 cells (breast cancer) which do not express ESR1 [GeneID=2099]) compared to the parental MCF7 cells which do.	34	1.766136e-2	1.000000e+0	1.000000e+0	5.662077e+1	1.766136e-2	1	1.766136e-2	1.000000e+0	32	1.535041e-2	1.000000e+0	1.000000e+0	6.489568e+1	1.540935e-2	1	139	5.000000e-1	7.194245e-3	unnamed	FHL2
MSigDB Perturbation	SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	Genes up-regulated in MCF10A cells (breast cancer) grown at low (mesenchymal phenotype) compared to those grown at high (epithelial, basal-like phenotype) confluency.	35	1.771869e-2	1.000000e+0	1.000000e+0	5.643757e+1	1.771869e-2	1	1.771869e-2	1.000000e+0	45	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	FHL2
MSigDB Perturbation	LIU_CMYB_TARGETS_UP	Genes up-regulated in MCF-7 cells (breast cancer) by overexpression of CMYB [GeneID=4602] off adenovirus vector.	36	1.804377e-2	1.000000e+0	1.000000e+0	5.542078e+1	1.804377e-2	1	1.804377e-2	1.000000e+0	41	1.798882e-2	1.000000e+0	1.000000e+0	5.534049e+1	1.806995e-2	1	163	5.000000e-1	6.134969e-3	unnamed	FHL2
MSigDB Perturbation	BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP	Genes bound by ESR1 [GeneID=2099] and up-regulated by estradiol [PubChemID=5757] in MCF-7 cells (breast cancer).	37	1.846262e-2	1.000000e+0	1.000000e+0	5.416350e+1	1.846262e-2	1	1.846262e-2	1.000000e+0	46	2.226868e-2	1.000000e+0	1.000000e+0	4.465594e+1	2.239344e-2	1	202	5.000000e-1	4.950495e-3	unnamed	FHL2
MSigDB Perturbation	NAGASHIMA_NRG1_SIGNALING_UP	Genes up-regulated in MCF7 cells (breast cancer) after stimulation with NRG1 [GeneID=3084].	38	1.873764e-2	1.000000e+0	1.000000e+0	5.336852e+1	1.873764e-2	1	1.873764e-2	1.000000e+0	42	1.853804e-2	1.000000e+0	1.000000e+0	5.369345e+1	1.862424e-2	1	168	5.000000e-1	5.952381e-3	unnamed	FHL2
MSigDB Perturbation	BROWNE_HCMV_INFECTION_12HR_DN	Genes down-regulated in primary fibroblast cell culture after infection with HCMV (AD169 strain) at 12 h time point that were not down-regulated at the previous time point, 10 h.	39	1.874045e-2	1.000000e+0	1.000000e+0	5.336050e+1	1.874045e-2	1	1.874045e-2	1.000000e+0	27	1.105544e-2	1.000000e+0	1.000000e+0	9.020500e+1	1.108586e-2	1	100	5.000000e-1	1.000000e-2	unnamed	FHL2
MSigDB Perturbation	AMUNDSON_RESPONSE_TO_ARSENITE	Genes discriminating responses to sodium arsenite [PubChem=26435] from other stresses.	40	1.881258e-2	1.000000e+0	1.000000e+0	5.315592e+1	1.881258e-2	1	1.881258e-2	1.000000e+0	49	2.358369e-2	1.000000e+0	1.000000e+0	4.215187e+1	2.372374e-2	1	214	5.000000e-1	4.672897e-3	unnamed	FHL2
MSigDB Perturbation	PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN	Genes up-regulated in BEC (blood endothelial cells) compared to LEC (lymphatic endothelial cells).	41	1.889531e-2	1.000000e+0	1.000000e+0	5.292319e+1	1.889531e-2	1	1.889531e-2	1.000000e+0	38	1.787895e-2	1.000000e+0	1.000000e+0	5.568210e+1	1.795909e-2	1	162	5.000000e-1	6.172840e-3	unnamed	FHL2
MSigDB Perturbation	TIEN_INTESTINE_PROBIOTICS_6HR_DN	Genes down-regulated in Caco-2 cells (intestinal epithelium) after coculture with the probiotic bacteria L. casei for 6h.	42	2.009742e-2	1.000000e+0	1.000000e+0	4.975762e+1	2.009742e-2	1	2.009742e-2	1.000000e+0	38	1.787895e-2	1.000000e+0	1.000000e+0	5.568210e+1	1.795909e-2	1	162	5.000000e-1	6.172840e-3	unnamed	FHL2
MSigDB Perturbation	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	Genes up-regulated in CD34+ [GeneID=947] hematopoetic cells by expression of NUP98-HOXA9 fusion [GeneID=4928;3205] off a retroviral vector at 8 days after transduction.	43	2.091328e-2	1.000000e+0	1.000000e+0	4.781650e+1	2.091328e-2	1	2.091328e-2	1.000000e+0	35	1.645017e-2	1.000000e+0	1.000000e+0	6.054027e+1	1.651793e-2	1	149	5.000000e-1	6.711409e-3	unnamed	FHL2
MSigDB Perturbation	SASAKI_ADULT_T_CELL_LEUKEMIA	Genes up-regulated in adult T-cell leukemia (ATL) cells compared to T lymphocytes from healthy controls.	44	2.133045e-2	1.000000e+0	1.000000e+0	4.688133e+1	2.133045e-2	1	2.133045e-2	1.000000e+0	44	2.051397e-2	1.000000e+0	1.000000e+0	4.849731e+1	2.061970e-2	1	186	5.000000e-1	5.376344e-3	unnamed	FHL2
MSigDB Perturbation	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP	Genes up-regulated in CD34+ [GeneID=947] hematopoetic cells by expression of NUP98-HOXA9 fusion [GeneID=4928;3205] off a retroviral vector at 16 days after transduction.	45	2.140041e-2	1.000000e+0	1.000000e+0	4.672808e+1	2.140041e-2	1	2.140041e-2	1.000000e+0	37	1.765921e-2	1.000000e+0	1.000000e+0	5.637812e+1	1.773738e-2	1	160	5.000000e-1	6.250000e-3	unnamed	FHL2
MSigDB Perturbation	MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	Genes with high-CpG-density promoters (HCP) bearing histone H3 trimethylation marks at k4 (H3K4me3) and K27 ((H3K27me3) in neural precursor cells (NPC).	46	2.269992e-2	1.000000e+0	1.000000e+0	4.405301e+1	2.269992e-2	1	2.269992e-2	1.000000e+0	31	1.524040e-2	1.000000e+0	1.000000e+0	6.536594e+1	1.529849e-2	1	138	5.000000e-1	7.246377e-3	unnamed	FHL2
MSigDB Perturbation	LI_INDUCED_T_TO_NATURAL_KILLER_UP	Genes up-regulated in ITNK cells (T-lymphocyte progenitors (DN3 cells) reprogrammed to natural killer (NK) cells by ablation of BCL11B [GeneID=64919] gene), compared to the parental DN3 cells.	47	2.276746e-2	1.000000e+0	1.000000e+0	4.392234e+1	2.276746e-2	1	2.276746e-2	1.000000e+0	55	3.232775e-2	1.000000e+0	1.000000e+0	3.068197e+1	3.259243e-2	1	294	5.000000e-1	3.401361e-3	unnamed	FHL2
MSigDB Perturbation	BHAT_ESR1_TARGETS_VIA_AKT1_UP	Genes bound by ESR1 [GeneID=2099] and up-regulated by estradiol [PubChemID=5757] in MCF-7 cells (breast cancer) expressing constitutevly active form of AKT1 [GeneID=207].	48	2.344270e-2	1.000000e+0	1.000000e+0	4.265720e+1	2.344270e-2	1	2.344270e-2	1.000000e+0	53	3.003624e-2	1.000000e+0	1.000000e+0	3.304212e+1	3.026440e-2	1	273	5.000000e-1	3.663004e-3	unnamed	FHL2
MSigDB Perturbation	HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP	Up-regulated genes in the cancer gene signature, representing a gene signature of cellular transformation.	49	2.364951e-2	1.000000e+0	1.000000e+0	4.228418e+1	2.364951e-2	1	2.364951e-2	1.000000e+0	50	2.642982e-2	1.000000e+0	1.000000e+0	3.758542e+1	2.660606e-2	1	240	5.000000e-1	4.166667e-3	unnamed	FHL2
MSigDB Perturbation	VERHAAK_GLIOBLASTOMA_NEURAL	Genes correlated with neural type of glioblastoma multiforme tumors.	50	2.387691e-2	1.000000e+0	1.000000e+0	4.188147e+1	2.387691e-2	1	2.387691e-2	1.000000e+0	47	2.325502e-2	1.000000e+0	1.000000e+0	4.275118e+1	2.339116e-2	1	211	5.000000e-1	4.739336e-3	unnamed	FHL2
MSigDB Perturbation	LEI_MYB_TARGETS	Myb-regulated genes in MCF7 (breast cancer) and lung epithelial cell lines overexpressing MYBL2, MYBL1 or MYB [GeneID=4605;4603;4602].	51	2.437585e-2	1.000000e+0	1.000000e+0	4.102422e+1	2.437585e-2	1	2.437585e-2	1.000000e+0	57	3.439869e-2	1.000000e+0	1.000000e+0	2.881949e+1	3.469874e-2	1	313	5.000000e-1	3.194888e-3	unnamed	FHL2
MSigDB Perturbation	GOLDRATH_ANTIGEN_RESPONSE	Genes up-regulated at the peak of an antigen response of naive CD8+ [GeneID=925;926] T-cells.	52	2.675801e-2	1.000000e+0	1.000000e+0	3.737199e+1	2.675801e-2	1	2.675801e-2	1.000000e+0	59	3.755531e-2	1.000000e+0	1.000000e+0	2.637573e+1	3.791364e-2	1	342	5.000000e-1	2.923977e-3	unnamed	FHL2
MSigDB Perturbation	JIANG_HYPOXIA_NORMAL	Genes up-regulated in RPTEC cells (normal kidney) by hypoxia.	53	2.802354e-2	1.000000e+0	1.000000e+0	3.568428e+1	2.802354e-2	1	2.802354e-2	1.000000e+0	56	3.352698e-2	1.000000e+0	1.000000e+0	2.957541e+1	3.381187e-2	1	305	5.000000e-1	3.278689e-3	unnamed	C2orf49
MSigDB Perturbation	KIM_WT1_TARGETS_UP	Genes up-regulated in UB27 cells (osteosarcoma) at any time point after inducing the expression of a mutant form of WT1 [GeneID=7490].	54	3.039094e-2	1.000000e+0	1.000000e+0	3.290455e+1	3.039094e-2	1	3.039094e-2	1.000000e+0	47	2.325502e-2	1.000000e+0	1.000000e+0	4.275118e+1	2.339116e-2	1	211	5.000000e-1	4.739336e-3	unnamed	FHL2
MSigDB Perturbation	WANG_LMO4_TARGETS_DN	Genes down-regulated in MCF7 cells (breast cancer) engineered to conditionally express LMO4 [GeneID=8543] by a Tet Off system.	55	3.100095e-2	1.000000e+0	1.000000e+0	3.225708e+1	3.100095e-2	1	3.100095e-2	1.000000e+0	60	3.766407e-2	1.000000e+0	1.000000e+0	2.629883e+1	3.802450e-2	1	343	5.000000e-1	2.915452e-3	unnamed	FHL2
MSigDB Perturbation	ENK_UV_RESPONSE_KERATINOCYTE_UP	Genes up-regulated in NHEK cells (normal epidermal keratinocytes) after UVB irradiation.	56	3.205700e-2	1.000000e+0	1.000000e+0	3.119443e+1	3.205700e-2	1	3.205700e-2	1.000000e+0	71	5.961449e-2	1.000000e+0	1.000000e+0	1.652106e+1	6.052880e-2	1	546	5.000000e-1	1.831502e-3	unnamed	FHL2
MSigDB Perturbation	KAAB_HEART_ATRIUM_VS_VENTRICLE_DN	Genes up-regulated in the ventricles of healthy hearts, compared to atria.	57	3.219427e-2	1.000000e+0	1.000000e+0	3.106143e+1	3.219427e-2	1	3.219427e-2	1.000000e+0	51	2.872559e-2	1.000000e+0	1.000000e+0	3.456130e+1	2.893409e-2	1	261	5.000000e-1	3.831418e-3	unnamed	FHL2
MSigDB Perturbation	DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP	Genes up-regulated in HEK293 cells (embryonic kidney) at 6 h, 12 h or 24 h after infection with reovirus strain T3A (known as a strong inducer of apoptosis).	58	3.489959e-2	1.000000e+0	1.000000e+0	2.865363e+1	3.489959e-2	1	3.489959e-2	1.000000e+0	58	3.472547e-2	1.000000e+0	1.000000e+0	2.854589e+1	3.503132e-2	1	316	5.000000e-1	3.164557e-3	unnamed	FHL2
MSigDB Perturbation	CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4	The 'group 4 set' of genes associated with acquired endocrine therapy resistance in breast tumors expressing ESR1 but not ERBB2 [GeneID=2099;2064].	59	3.519695e-2	1.000000e+0	1.000000e+0	2.841155e+1	3.519695e-2	1	3.519695e-2	1.000000e+0	54	3.178240e-2	1.000000e+0	1.000000e+0	3.121280e+1	3.203814e-2	1	289	5.000000e-1	3.460208e-3	unnamed	C2orf49
MSigDB Perturbation	ODONNELL_TFRC_TARGETS_UP	Genes up-regulated in P493-6 cells (B lymphocyte, Burkitt's lymphoma model) upon knockdown of TFRC [GeneID=7037] by RNAi.	60	4.149779e-2	1.000000e+0	1.000000e+0	2.409767e+1	4.149779e-2	1	4.149779e-2	1.000000e+0	61	4.190080e-2	1.000000e+0	1.000000e+0	2.361387e+1	4.234799e-2	1	382	5.000000e-1	2.617801e-3	unnamed	FHL2
MSigDB Perturbation	WANG_SMARCE1_TARGETS_UP	Genes up-regulated in BT549 cells (breast cancer) by expression of SMARCE1 [GeneID=6605] off a retroviral vector.	61	4.574006e-2	1.000000e+0	1.000000e+0	2.186267e+1	4.574006e-2	1	4.574006e-2	1.000000e+0	52	2.981786e-2	1.000000e+0	1.000000e+0	3.328598e+1	3.004268e-2	1	271	5.000000e-1	3.690037e-3	unnamed	FHL2
MSigDB Perturbation	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN	Genes commonly down-regulated in human alveolar rhabdomyosarcoma (ARMS) and its mouse model overexpressing PAX3-FOXO1 [GeneID=5077;2308] fusion.	62	4.599214e-2	1.000000e+0	1.000000e+0	2.174284e+1	4.599214e-2	1	4.599214e-2	1.000000e+0	62	4.461173e-2	1.000000e+0	1.000000e+0	2.216339e+1	4.511945e-2	1	407	5.000000e-1	2.457002e-3	unnamed	FHL2
MSigDB Perturbation	PILON_KLF1_TARGETS_UP	Genes up-regulated in erythroid progenitor cells from fetal livers of E13.5 embryos with KLF1 [GeneID=10661] knockout compared to those from the wild type embryos.	63	5.387062e-2	1.000000e+0	1.000000e+0	1.856299e+1	5.387062e-2	1	5.387062e-2	1.000000e+0	65	5.347664e-2	1.000000e+0	1.000000e+0	1.844683e+1	5.420986e-2	1	489	5.000000e-1	2.044990e-3	unnamed	C2orf49
MSigDB Perturbation	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	Genes down-regulated in APL (acute promyeolocytic leukemia) blasts expressing PML-RARA fusion [GeneID=5371;5914] compared to normal promyeloblasts.	64	5.446063e-2	1.000000e+0	1.000000e+0	1.836189e+1	5.446063e-2	1	5.446063e-2	1.000000e+0	74	7.086879e-2	1.000000e+0	1.000000e+0	1.385637e+1	7.216895e-2	1	651	5.000000e-1	1.536098e-3	unnamed	FHL2
MSigDB Perturbation	MARTINEZ_RB1_AND_TP53_TARGETS_UP	Genes up-regulated in mice with skin specific double knockout of both RB1 and TP53 [GeneID=5925;7157] by Cre-lox.	65	5.663788e-2	1.000000e+0	1.000000e+0	1.765603e+1	5.663788e-2	1	5.663788e-2	1.000000e+0	73	6.390983e-2	1.000000e+0	1.000000e+0	1.539334e+1	6.496314e-2	1	586	5.000000e-1	1.706485e-3	unnamed	FHL2
MSigDB Perturbation	MARTINEZ_TP53_TARGETS_DN	Genes down-regulated in mice with skin specific knockout of TP53 [GeneID=7157].	66	5.892566e-2	1.000000e+0	1.000000e+0	1.697053e+1	5.892566e-2	1	5.892566e-2	1.000000e+0	72	6.262226e-2	1.000000e+0	1.000000e+0	1.571516e+1	6.363284e-2	1	574	5.000000e-1	1.742160e-3	unnamed	FHL2
MSigDB Perturbation	KIM_ALL_DISORDERS_CALB1_CORR_UP	Genes whose expression significantly and positively correlated with the density of CALB1-positive [GeneID=793]  GABAergic interneurons in the BA9 brain region across all subjects with psychiatric disorders.	67	6.127712e-2	1.000000e+0	1.000000e+0	1.631931e+1	6.127712e-2	1	6.127712e-2	1.000000e+0	69	5.939946e-2	1.000000e+0	1.000000e+0	1.658180e+1	6.030708e-2	1	544	5.000000e-1	1.838235e-3	unnamed	FHL2
MSigDB Perturbation	ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF	Class I of genes transiently induced by EGF [GeneID =1950] in 184A1 cells (mammary epithelium).	68	6.194948e-2	1.000000e+0	1.000000e+0	1.614218e+1	6.194948e-2	1	6.194948e-2	1.000000e+0	64	5.272149e-2	1.000000e+0	1.000000e+0	1.871473e+1	5.343385e-2	1	482	5.000000e-1	2.074689e-3	unnamed	FHL2
MSigDB Perturbation	ONKEN_UVEAL_MELANOMA_DN	Genes down-regulated in uveal melanoma: class 2 vs class 1 tumors.	69	6.267829e-2	1.000000e+0	1.000000e+0	1.595449e+1	6.267829e-2	1	6.267829e-2	1.000000e+0	68	5.574028e-2	1.000000e+0	1.000000e+0	1.768725e+1	5.653789e-2	1	510	5.000000e-1	1.960784e-3	unnamed	FHL2
MSigDB Perturbation	ENK_UV_RESPONSE_EPIDERMIS_DN	Genes down-regulated in epidermis after to UVB irradiation.	70	6.268049e-2	1.000000e+0	1.000000e+0	1.595393e+1	6.268049e-2	1	6.268049e-2	1.000000e+0	67	5.530932e-2	1.000000e+0	1.000000e+0	1.782708e+1	5.609445e-2	1	506	5.000000e-1	1.976285e-3	unnamed	FHL2
MSigDB Perturbation	BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP	Genes up-regulated in cultured stromal stem cells from adipose tissue, compared to the freshly isolated cells.	71	6.459289e-2	1.000000e+0	1.000000e+0	1.548158e+1	6.459289e-2	1	6.459289e-2	1.000000e+0	63	4.591162e-2	1.000000e+0	1.000000e+0	2.152864e+1	4.644975e-2	1	419	5.000000e-1	2.386635e-3	unnamed	FHL2
MSigDB Perturbation	MARTINEZ_RB1_TARGETS_UP	Genes up-regulated in mice with skin specific knockout of RB1 [GeneID=5925] by Cre-lox.	72	6.518802e-2	1.000000e+0	1.000000e+0	1.534024e+1	6.518802e-2	1	6.518802e-2	1.000000e+0	75	7.150984e-2	1.000000e+0	1.000000e+0	1.372983e+1	7.283410e-2	1	657	5.000000e-1	1.522070e-3	unnamed	FHL2
MSigDB Perturbation	CHICAS_RB1_TARGETS_CONFLUENT	Genes up-regulated in confluent IMR90 cells (fibroblast) after knockdown of RB1 [GeneID=5925] by RNAi.	73	7.290419e-2	1.000000e+0	1.000000e+0	1.371663e+1	7.290419e-2	1	7.290419e-2	1.000000e+0	69	5.939946e-2	1.000000e+0	1.000000e+0	1.658180e+1	6.030708e-2	1	544	5.000000e-1	1.838235e-3	unnamed	FHL2
MSigDB Perturbation	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP	Genes up-regulated in ME-A cells (breast cancer) undergoing apoptosis in response to doxorubicin [PubChem=31703].	74	7.551862e-2	1.000000e+0	1.000000e+0	1.324177e+1	7.551862e-2	1	7.551862e-2	1.000000e+0	79	1.189586e-1	1.000000e+0	1.000000e+0	8.148600e+0	1.227205e-1	1	1107	5.000000e-1	9.033424e-4	unnamed	FHL2
MSigDB Perturbation	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN	Genes down-regulated in MCF7 cells (breast cancer) at 24 h of estradiol [PubChemID=5757] treatment.	75	7.665633e-2	1.000000e+0	1.000000e+0	1.304524e+1	7.665633e-2	1	7.665633e-2	1.000000e+0	66	5.444710e-2	1.000000e+0	1.000000e+0	1.811345e+1	5.520758e-2	1	498	5.000000e-1	2.008032e-3	unnamed	FHL2
MSigDB Perturbation	MARSON_BOUND_BY_FOXP3_STIMULATED	Genes with promoters bound by FOXP3 [GeneID=50943] in hybridoma cells stimulated by PMA [PubChem=4792] and ionomycin [PubChem=3733].	76	7.982095e-2	1.000000e+0	1.000000e+0	1.252804e+1	7.982095e-2	1	7.982095e-2	1.000000e+0	78	1.065321e-1	1.000000e+0	1.000000e+0	9.130061e+0	1.095283e-1	1	988	5.000000e-1	1.012146e-3	unnamed	FHL2
MSigDB Perturbation	NUYTTEN_NIPP1_TARGETS_UP	Genes up-regulated in PC3 cells (prostate cancer) after knockdown of NIPP1 [GeneID=5511] by RNAi.	77	8.459132e-2	1.000000e+0	1.000000e+0	1.182154e+1	8.459132e-2	1	8.459132e-2	1.000000e+0	2	1.671193e-3	1.000000e+0	1.000000e+0	2.444580e+1	8.181365e-2	2	738	1.000000e+0	2.710027e-3	unnamed	C2orf49,FHL2
MSigDB Perturbation	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3	Genes with promoters occupied by SMAD2 or SMAD3 [GeneID=4087, 4088] in HaCaT cells (keratinocyte) according to a ChIP-chip analysis.	78	8.589428e-2	1.000000e+0	1.000000e+0	1.164222e+1	8.589428e-2	1	8.589428e-2	1.000000e+0	76	8.767615e-2	1.000000e+0	1.000000e+0	1.115019e+1	8.968461e-2	1	809	5.000000e-1	1.236094e-3	unnamed	FHL2
MSigDB Perturbation	GEORGES_TARGETS_OF_MIR192_AND_MIR215	Genes down-regulated in HCT116 cells (colon cancer) by expression of MIR192 or MIR215 [GeneID=406967;406997] at 24 h.	79	9.671084e-2	1.000000e+0	1.000000e+0	1.034010e+1	9.671084e-2	1	9.671084e-2	1.000000e+0	77	9.137854e-2	1.000000e+0	1.000000e+0	1.068780e+1	9.356466e-2	1	844	5.000000e-1	1.184834e-3	unnamed	C2orf49
MSigDB Perturbation	CHEN_METABOLIC_SYNDROM_NETWORK	Genes forming the macrophage-enriched metabolic network (MEMN) claimed to have a causal relationship with the metabolic syndrom traits.	80	1.026637e-1	1.000000e+0	1.000000e+0	9.740537e+0	1.026637e-1	1	1.026637e-1	1.000000e+0	80	1.250874e-1	1.000000e+0	1.000000e+0	7.736278e+0	1.292611e-1	1	1166	5.000000e-1	8.576329e-4	unnamed	FHL2
MSigDB Perturbation	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP	Genes up-regulated in CD34+ [GeneID=947] cells isolated from bone marrow of CML (chronic myelogenous leukemia) patients, compared to those from normal donors.	81	1.224048e-1	1.000000e+0	1.000000e+0	8.169613e+0	1.224048e-1	1	1.224048e-1	1.000000e+0	81	1.472401e-1	1.000000e+0	1.000000e+0	6.531861e+0	1.530957e-1	1	1381	5.000000e-1	7.241130e-4	unnamed	FHL2
MSigDB Perturbation	DODD_NASOPHARYNGEAL_CARCINOMA_UP	Genes up-regulated in nasopharyngeal carcinoma (NPC) compared to the normal tissue.	82	1.332338e-1	1.000000e+0	1.000000e+0	7.505605e+0	1.332338e-1	1	1.332338e-1	1.000000e+0	82	1.575486e-1	1.000000e+0	1.000000e+0	6.086707e+0	1.642924e-1	1	1482	5.000000e-1	6.747638e-4	unnamed	FHL2
MSigDB Predicted Promoter Motifs	YGTCCTTGR_UNKNOWN	Motif YGTCCTTGR (no known TF)	1	1.138869e-2	1.000000e+0	1.000000e+0	8.780640e+1	1.138869e-2	1	1.138869e-2	1.000000e+0	1	1.039385e-2	1.000000e+0	1.000000e+0	9.596277e+1	1.042071e-2	1	94	5.000000e-1	1.063830e-2	unnamed	FHL2
MSigDB Predicted Promoter Motifs	V$SRF_C	Motif DCCWTATATGGNCWN matches SRF: serum response factor (c-fos serum response element-binding transcription factor)	2	2.419482e-2	1.000000e+0	1.000000e+0	4.133116e+1	2.419482e-2	1	2.419482e-2	1.000000e+0	4	2.259752e-2	1.000000e+0	1.000000e+0	4.400244e+1	2.272601e-2	1	205	5.000000e-1	4.878049e-3	unnamed	FHL2
MSigDB Predicted Promoter Motifs	V$TFIIA_Q6	Motif TMTRWRAGGRSS matches GTF2A1: general transcription factor IIA, 1, 19/37kDa&lt;br&gt; GTF2A2: general transcription factor IIA, 2, 12kDa	3	2.690865e-2	1.000000e+0	1.000000e+0	3.716277e+1	2.690865e-2	1	2.690865e-2	1.000000e+0	7	2.653920e-2	1.000000e+0	1.000000e+0	3.742946e+1	2.671692e-2	1	241	5.000000e-1	4.149378e-3	unnamed	FHL2
MSigDB Predicted Promoter Motifs	V$GATA_Q6	Motif WGATARN matches GATA1: GATA binding protein 1 (globin transcription factor 1)	4	2.737398e-2	1.000000e+0	1.000000e+0	3.653104e+1	2.737398e-2	1	2.737398e-2	1.000000e+0	2	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	FHL2
MSigDB Predicted Promoter Motifs	V$TBP_01	Motif TATAAATW matches TBP: TATA box binding protein	5	3.119938e-2	1.000000e+0	1.000000e+0	3.205192e+1	3.119938e-2	1	3.119938e-2	1.000000e+0	5	2.544509e-2	1.000000e+0	1.000000e+0	3.904978e+1	2.560834e-2	1	231	5.000000e-1	4.329004e-3	unnamed	FHL2
MSigDB Predicted Promoter Motifs	V$HFH8_01	Motif NNNTGTTTATNTR matches FOXJ1: forkhead box J1	6	3.658712e-2	1.000000e+0	1.000000e+0	2.733202e+1	3.658712e-2	1	3.658712e-2	1.000000e+0	3	2.172051e-2	1.000000e+0	1.000000e+0	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	FHL2
MSigDB Predicted Promoter Motifs	V$TCF11_01	Motif GTCATNNWNNNNN matches NFE2L1: nuclear factor (erythroid-derived 2)-like 1	7	3.906347e-2	1.000000e+0	1.000000e+0	2.559936e+1	3.906347e-2	1	3.906347e-2	1.000000e+0	6	2.642982e-2	1.000000e+0	1.000000e+0	3.758542e+1	2.660606e-2	1	240	5.000000e-1	4.166667e-3	unnamed	FHL2
MSigDB Predicted Promoter Motifs	GATAAGR_V$GATA_C	Motif GATAAGR (no known TF)	8	4.396273e-2	1.000000e+0	1.000000e+0	2.274654e+1	4.396273e-2	1	4.396273e-2	1.000000e+0	8	3.178240e-2	1.000000e+0	1.000000e+0	3.121280e+1	3.203814e-2	1	289	5.000000e-1	3.460208e-3	unnamed	FHL2
MSigDB Predicted Promoter Motifs	MGGAAGTG_V$GABP_B	Motif MGGAAGTG matches GABPA: GA binding protein transcription factor, alpha subunit 60kDa&lt;br&gt; GABPB2: GA binding protein transcription factor, beta subunit 2	9	6.066059e-2	1.000000e+0	1.000000e+0	1.648517e+1	6.066059e-2	1	6.066059e-2	1.000000e+0	10	8.014245e-2	1.000000e+0	1.000000e+0	1.222290e+1	8.181365e-2	1	738	5.000000e-1	1.355014e-3	unnamed	C2orf49
MSigDB Predicted Promoter Motifs	GTGACGY_V$E4F1_Q6	Motif GTGACGY matches E4F1: E4F transcription factor 1	10	6.080213e-2	1.000000e+0	1.000000e+0	1.644679e+1	6.080213e-2	1	6.080213e-2	1.000000e+0	9	7.118934e-2	1.000000e+0	1.000000e+0	1.379281e+1	7.250152e-2	1	654	5.000000e-1	1.529052e-3	unnamed	C2orf49
MSigDB Predicted Promoter Motifs	SCGGAAGY_V$ELK1_02	Motif SCGGAAGY matches ELK1: ELK1, member of ETS oncogene family	11	7.801699e-2	1.000000e+0	1.000000e+0	1.281772e+1	7.801699e-2	1	7.801699e-2	1.000000e+0	12	1.233236e-1	1.000000e+0	1.000000e+0	7.850740e+0	1.273765e-1	1	1149	5.000000e-1	8.703220e-4	unnamed	C2orf49
MSigDB Predicted Promoter Motifs	RTAAACA_V$FREAC2_01	Motif RTAAACA matches FOXF2: forkhead box F2	12	1.342136e-1	1.000000e+0	1.000000e+0	7.450812e+0	1.342136e-1	1	1.342136e-1	1.000000e+0	11	9.528432e-2	1.000000e+0	1.000000e+0	1.023893e+1	9.766643e-2	1	881	5.000000e-1	1.135074e-3	unnamed	FHL2
MSigDB Predicted Promoter Motifs	TATAAA_V$TATA_01	Motif TATAAA matches TAF&lt;br&gt; TATA	13	1.585244e-1	1.000000e+0	1.000000e+0	6.308178e+0	1.585244e-1	1	1.585244e-1	1.000000e+0	13	1.364568e-1	1.000000e+0	1.000000e+0	7.069357e+0	1.414556e-1	1	1276	5.000000e-1	7.836991e-4	unnamed	FHL2
MSigDB miRNA Motifs	ACTGCCT,MIR-34B	Targets of MicroRNA ACTGCCT,MIR-34B	1	3.346860e-2	1.000000e+0	1.000000e+0	2.987876e+1	3.346860e-2	1	3.346860e-2	1.000000e+0	1	2.358369e-2	1.000000e+0	1.000000e+0	4.215187e+1	2.372374e-2	1	214	5.000000e-1	4.672897e-3	unnamed	FHL2
MSigDB miRNA Motifs	GTGCAAT,MIR-25,MIR-32,MIR-92,MIR-363,MIR-367	Targets of MicroRNA GTGCAAT,MIR-25,MIR-32,MIR-92,MIR-363,MIR-367	2	4.874316e-2	1.000000e+0	1.000000e+0	2.051570e+1	4.874316e-2	1	4.874316e-2	1.000000e+0	2	3.298197e-2	1.000000e+0	1.000000e+0	3.006833e+1	3.325758e-2	1	300	5.000000e-1	3.333333e-3	unnamed	FHL2
InterPro	IPR024887	Ashwin	1	2.301921e-5	2.168870e-1	2.168870e-1	4.344198e+4	2.301921e-5	1	2.301921e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	C2orf49
InterPro	IPR001781	Zinc finger, LIM-type	2	8.931215e-3	1.000000e+0	1.000000e+0	1.119668e+2	8.931215e-3	1	8.931215e-3	1.000000e+0	2	8.076528e-3	1.000000e+0	1.000000e+0	1.235685e+2	8.092678e-3	1	73	5.000000e-1	1.369863e-2	unnamed	FHL2
TreeFam	TF332084	C2orf49	1	2.301921e-5	1.870541e-1	1.870541e-1	4.344198e+4	2.301921e-5	1	2.301921e-5	1.000000e+0	1	1.108586e-4	9.008370e-1	9.008370e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	C2orf49
TreeFam	TF321684	FHL2	2	1.403317e-4	1.000000e+0	5.701677e-1	7.125974e+3	1.403317e-4	1	1.403317e-4	1.000000e+0	1	1.108586e-4	9.008370e-1	9.008370e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	FHL2
Ensembl Genes	11242	C2orf49	1	2.301921e-5	4.152896e-1	4.152896e-1	4.344198e+4	2.301921e-5	1	2.301921e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	C2orf49
Ensembl Genes	11243	FHL2	2	1.403317e-4	1.000000e+0	1.000000e+0	7.125974e+3	1.403317e-4	1	1.403317e-4	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	FHL2
MSigDB Oncogenic Signatures	CYCLIN_D1_UP.V1_UP	Genes up-regulated in MCF-7 cells (breast cancer) over-expressing CCND1 [Gene ID=595] gene.	1	1.228176e-2	1.000000e+0	1.000000e+0	8.142156e+1	1.228176e-2	1	1.228176e-2	1.000000e+0	6	2.183015e-2	1.000000e+0	6.803730e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	FHL2
MSigDB Oncogenic Signatures	CYCLIN_D1_KE_.V1_UP	Genes up-regulated in MCF-7 cells (breast cancer) over-expressing a mutant K112E form of CCND1 [Gene ID=595] gene.	2	1.571145e-2	1.000000e+0	1.000000e+0	6.364785e+1	1.571145e-2	1	1.571145e-2	1.000000e+0	3	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	FHL2
MSigDB Oncogenic Signatures	ESC_V6.5_UP_EARLY.V1_DN	Genes down-regulated during early stages of differentiation of embryoid bodies from V6.5 embryonic stem cells.	3	1.910320e-2	1.000000e+0	1.000000e+0	5.234725e+1	1.910320e-2	1	1.910320e-2	1.000000e+0	1	1.809867e-2	1.000000e+0	1.000000e+0	5.500305e+1	1.818081e-2	1	164	5.000000e-1	6.097561e-3	unnamed	FHL2
MSigDB Oncogenic Signatures	ERB2_UP.V1_DN	Genes down-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] and engineered to express ligand-activatable ERBB2 [Gene ID=2064].	4	2.349699e-2	1.000000e+0	1.000000e+0	4.255865e+1	2.349699e-2	1	2.349699e-2	1.000000e+0	5	2.117217e-2	1.000000e+0	7.918392e-1	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	FHL2
MSigDB Oncogenic Signatures	ESC_J1_UP_LATE.V1_UP	Genes up-regulated during late stages of differentiation of embryoid bodies from J1 embryonic stem cells.	5	2.355319e-2	1.000000e+0	8.808893e-1	4.245709e+1	2.355319e-2	1	2.355319e-2	1.000000e+0	2	2.073340e-2	1.000000e+0	1.000000e+0	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	FHL2
MSigDB Oncogenic Signatures	LTE2_UP.V1_DN	Genes down-regulated in MCF-7 cells (breast cancer) positive for ESR1 [Gene ID=2099] MCF-7 cells (breast cancer) and long-term adapted for estrogen-independent growth.	6	2.722443e-2	1.000000e+0	8.484947e-1	3.673171e+1	2.722443e-2	1	2.722443e-2	1.000000e+0	7	2.489780e-2	1.000000e+0	6.651269e-1	3.991372e+1	2.505404e-2	1	226	5.000000e-1	4.424779e-3	unnamed	FHL2
MSigDB Oncogenic Signatures	P53_DN.V1_UP	Genes up-regulated in NCI-60 panel of cell lines with mutated TP53 [Gene ID=7157].	7	2.848799e-2	1.000000e+0	7.610363e-1	3.510251e+1	2.848799e-2	1	2.848799e-2	1.000000e+0	4	2.106249e-2	1.000000e+0	9.846714e-1	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	FHL2
MSigDB Immunologic Signatures	GSE24634_NAIVE_CD4_TCELL_VS_DAY5_IL4_CONV_TREG_DN	Genes down-regulated in comparison of naive T cells at day 0 versus CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 5.	1	1.187574e-2	1.000000e+0	1.000000e+0	8.420530e+1	1.187574e-2	1	1.187574e-2	1.000000e+0	36	2.172051e-2	1.000000e+0	1.000000e+0	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	FHL2
MSigDB Immunologic Signatures	GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_DN	Genes down-regulated in comparison of naive T cells at day 0 versus CD25+ regulatory T cell (Treg) treated with IL4 [GeneID=3565] at day 7.	2	1.358914e-2	1.000000e+0	1.000000e+0	7.358818e+1	1.358914e-2	1	1.358914e-2	1.000000e+0	51	2.336458e-2	1.000000e+0	8.750264e-1	4.254953e+1	2.350202e-2	1	212	5.000000e-1	4.716981e-3	unnamed	FHL2
MSigDB Immunologic Signatures	GSE9650_EFFECTOR_VS_EXHAUSTED_CD8_TCELL_UP	Genes up-regulated in comparison of effector CD8 T cells versus exhausted CD8 T cells.	3	1.359352e-2	1.000000e+0	1.000000e+0	7.356448e+1	1.359352e-2	1	1.359352e-2	1.000000e+0	36	2.172051e-2	1.000000e+0	1.000000e+0	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	FHL2
MSigDB Immunologic Signatures	GSE11924_TH1_VS_TH2_CD4_TCELL_UP	Genes up-regulated in comparison of Th1 cells versus Th17 cells.	4	1.360185e-2	1.000000e+0	1.000000e+0	7.351944e+1	1.360185e-2	1	1.360185e-2	1.000000e+0	12	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	FHL2
MSigDB Immunologic Signatures	GSE17721_POLYIC_VS_GARDIQUIMOD_8H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 8 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 8 h.	5	1.367515e-2	1.000000e+0	1.000000e+0	7.312536e+1	1.367515e-2	1	1.367515e-2	1.000000e+0	12	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	C2orf49
MSigDB Immunologic Signatures	GSE2197_IMMUNOSUPPRESSIVE_DNA__VS_UNTREATEDIN_DC_DN	Genes down-regulated in comparison of dendritic cells (DC) treated with immunosuppressive DNA versus the untreated cells.	6	1.386549e-2	1.000000e+0	1.000000e+0	7.212152e+1	1.386549e-2	1	1.386549e-2	1.000000e+0	8	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	FHL2
MSigDB Immunologic Signatures	GSE15930_STIM_VS_STIM_AND_IL-12_48H_CD8_T_CELL_UP	Genes up-regulated in comparison of unstimulated CD8 T cells at 48 h versus CD8 T cells at 48 h after stimulation with IL12.	7	1.433121e-2	1.000000e+0	1.000000e+0	6.977778e+1	1.433121e-2	1	1.433121e-2	1.000000e+0	40	2.193980e-2	1.000000e+0	1.000000e+0	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	FHL2
MSigDB Immunologic Signatures	GSE17721_POLYIC_VS_GARDIQUIMOD_16H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 16 h versus DC cells stimulated with Gardiquimod (TLR7 agonist) at 16 h.	8	1.435079e-2	1.000000e+0	1.000000e+0	6.968259e+1	1.435079e-2	1	1.435079e-2	1.000000e+0	15	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	C2orf49
MSigDB Immunologic Signatures	GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) 3 days after stimulation with YF17D vaccine versus PBMC 7 days after the stimulation.	9	1.454909e-2	1.000000e+0	1.000000e+0	6.873281e+1	1.454909e-2	1	1.454909e-2	1.000000e+0	26	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	FHL2
MSigDB Immunologic Signatures	GSE13485_CTRL_VS_DAY21_YF17D_VACCINE_PBMC_UP	Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) versus PBMC 21 days after stimulation with YF17D vaccine.	10	1.492974e-2	1.000000e+0	1.000000e+0	6.698042e+1	1.492974e-2	1	1.492974e-2	1.000000e+0	3	1.985555e-2	1.000000e+0	1.000000e+0	5.011389e+1	1.995455e-2	1	180	5.000000e-1	5.555556e-3	unnamed	C2orf49
MSigDB Immunologic Signatures	GSE9650_EFFECTOR_VS_MEMORY_CD8_TCELL_UP	Genes up-regulated in comparison of effector CD8 T cells versus memory CD8 T cells.	11	1.500060e-2	1.000000e+0	1.000000e+0	6.666400e+1	1.500060e-2	1	1.500060e-2	1.000000e+0	43	2.215906e-2	1.000000e+0	9.842745e-1	4.487811e+1	2.228258e-2	1	201	5.000000e-1	4.975124e-3	unnamed	FHL2
MSigDB Immunologic Signatures	GSE29615_CTRL_VS_LAIV_FLU_VACCINE_PBMC_UP	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee pre-vaccination versus those post-vaccination.	12	1.572806e-2	1.000000e+0	1.000000e+0	6.358062e+1	1.572806e-2	1	1.572806e-2	1.000000e+0	3	1.985555e-2	1.000000e+0	1.000000e+0	5.011389e+1	1.995455e-2	1	180	5.000000e-1	5.555556e-3	unnamed	C2orf49
MSigDB Immunologic Signatures	GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_DN	Genes down-regulated in comparison of pre-germinal center B cells versus dark zone germinal center B cells.	13	1.576777e-2	1.000000e+0	1.000000e+0	6.342051e+1	1.576777e-2	1	1.576777e-2	1.000000e+0	26	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	C2orf49
MSigDB Immunologic Signatures	GSE20366_EX_VIVO_VS_DEC205_CONVERSION_NAIVE_CD4_TCELL_UP	Genes up-regulated in comparison of TconvLP versus DEC-Pept CD25- (see Table S1 in the paper for details).	14	1.583498e-2	1.000000e+0	1.000000e+0	6.315132e+1	1.583498e-2	1	1.583498e-2	1.000000e+0	22	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	C2orf49
MSigDB Immunologic Signatures	GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_DN	Genes down-regulated in comparison of B cells from influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.	15	1.588255e-2	1.000000e+0	1.000000e+0	6.296219e+1	1.588255e-2	1	1.588255e-2	1.000000e+0	8	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	FHL2
MSigDB Immunologic Signatures	GSE37416_12H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP	Genes up-regulated in comparison of control polymorphonuclear leukocytes (PMN) at 12 h versus PMN treated with F. tularensis vaccine at 48 h.	16	1.596829e-2	1.000000e+0	1.000000e+0	6.262410e+1	1.596829e-2	1	1.596829e-2	1.000000e+0	22	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	C2orf49
MSigDB Immunologic Signatures	GSE8678_IL7R_LOW_VS_HIGH_EFF_CD8_TCELL_UP	Genes up-regulated in IL7R [GeneID=3575] low effector CD8 T cells versus IL7R [GeneID=3575] high effector CD8 T cells.	17	1.623717e-2	1.000000e+0	1.000000e+0	6.158709e+1	1.623717e-2	1	1.623717e-2	1.000000e+0	22	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	FHL2
MSigDB Immunologic Signatures	GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_UP	Genes up-regulated in comparison of wild type CD8 effector T cells at day 6 versus those at day 10.	18	1.635850e-2	1.000000e+0	1.000000e+0	6.113031e+1	1.635850e-2	1	1.635850e-2	1.000000e+0	19	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	FHL2
MSigDB Immunologic Signatures	GSE3982_DC_VS_MAC_UP	Genes up-regulated in comparison of dendritic cells (DC) versus macrophages.	19	1.649751e-2	1.000000e+0	1.000000e+0	6.061520e+1	1.649751e-2	1	1.649751e-2	1.000000e+0	5	2.007505e-2	1.000000e+0	1.000000e+0	4.956319e+1	2.017627e-2	1	182	5.000000e-1	5.494505e-3	unnamed	FHL2
MSigDB Immunologic Signatures	GSE17721_LPS_VS_CPG_16H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 16 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 16 h.	20	1.678438e-2	1.000000e+0	1.000000e+0	5.957921e+1	1.678438e-2	1	1.678438e-2	1.000000e+0	32	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	FHL2
MSigDB Immunologic Signatures	GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_DN	Genes down-regulated in comparison of naÃ¯ve CD8 T cells versus effector CD8 T cells.	21	1.689214e-2	1.000000e+0	1.000000e+0	5.919913e+1	1.689214e-2	1	1.689214e-2	1.000000e+0	40	2.193980e-2	1.000000e+0	1.000000e+0	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	FHL2
MSigDB Immunologic Signatures	GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_UP	Genes up-regulated in comparison of untreated CD25+ T effector cells at day 5 versus untreated CD25- T cells at day 5.	22	1.714712e-2	1.000000e+0	1.000000e+0	5.831884e+1	1.714712e-2	1	1.714712e-2	1.000000e+0	26	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	FHL2
MSigDB Immunologic Signatures	GSE3982_NKCELL_VS_TH2_DN	Genes down-regulated in comparison of NK cells versus Th2 cells.	23	1.720574e-2	1.000000e+0	1.000000e+0	5.812015e+1	1.720574e-2	1	1.720574e-2	1.000000e+0	50	2.281671e-2	1.000000e+0	8.715983e-1	4.357729e+1	2.294773e-2	1	207	5.000000e-1	4.830918e-3	unnamed	C2orf49
MSigDB Immunologic Signatures	GSE14000_UNSTIM_VS_16H_LPS_DC_DN	Genes down-regulated in comparison of dendritic cells (DC) before and 16 h after LPS (TLR4 agonist) stimulation.	24	1.764712e-2	1.000000e+0	1.000000e+0	5.666647e+1	1.764712e-2	1	1.764712e-2	1.000000e+0	49	2.259752e-2	1.000000e+0	8.808421e-1	4.400244e+1	2.272601e-2	1	205	5.000000e-1	4.878049e-3	unnamed	C2orf49
MSigDB Immunologic Signatures	GSE17721_LPS_VS_POLYIC_6H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 6 h versus DC cells stimulated with poly(I:C) (TLR3 agonist) at 6 h.	25	1.816279e-2	1.000000e+0	1.000000e+0	5.505761e+1	1.816279e-2	1	1.816279e-2	1.000000e+0	26	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	C2orf49
MSigDB Immunologic Signatures	GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_MEMORY_CD8_TCELL_UP	Genes up-regulated in comparison of stimulated memory CD8 T cells from pmel-1 mice versus unstimulated memory CD8 T cells from pmel-1 mice.	26	1.860398e-2	1.000000e+0	1.000000e+0	5.375195e+1	1.860398e-2	1	1.860398e-2	1.000000e+0	15	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	FHL2
MSigDB Immunologic Signatures	GSE26928_EFF_MEM_VS_CENTR_MEM_CD4_TCELL_UP	Genes up-regulated in comparison of CD4 [GeneID=920] effector memory T cells versus CD4 [GeneID=920] central memory T cells.	27	1.872494e-2	1.000000e+0	1.000000e+0	5.340471e+1	1.872494e-2	1	1.872494e-2	1.000000e+0	2	1.930669e-2	1.000000e+0	1.000000e+0	5.154571e+1	1.940025e-2	1	175	5.000000e-1	5.714286e-3	unnamed	FHL2
MSigDB Immunologic Signatures	GSE17721_PAM3CSK4_VS_CPG_24H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with Pam3Csk4 (TLR1/2 agonist) at 24 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 24 h.	28	1.874120e-2	1.000000e+0	1.000000e+0	5.335839e+1	1.874120e-2	1	1.874120e-2	1.000000e+0	40	2.193980e-2	1.000000e+0	1.000000e+0	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	FHL2
MSigDB Immunologic Signatures	GSE7460_FOXP3_MUT_VS_WT_ACT_WITH_TGFB_TCONV_UP	Genes up-regulated in comparsion of sfActCD4TGF versus ActCD4TGF (see Fig. 1 in the paper for details).	29	1.875041e-2	1.000000e+0	1.000000e+0	5.333217e+1	1.875041e-2	1	1.875041e-2	1.000000e+0	26	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	FHL2
MSigDB Immunologic Signatures	GSE36392_TYPE_2_MYELOID_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP	Genes up-regulated in comparison of type 2 myeloid (T2M) cells treated with IL25 [GeneID=64806] versus neutrophils treated with IL25 [GeneID=64806].	30	1.896865e-2	1.000000e+0	1.000000e+0	5.271855e+1	1.896865e-2	1	1.896865e-2	1.000000e+0	26	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	FHL2
MSigDB Immunologic Signatures	GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_UP	Genes up-regulated in comparison of type 2 myeloid (T2M) cells treated with IL25 [GeneID=64806] versus eosinophils treated with IL25 [GeneID=64806].	31	1.915142e-2	1.000000e+0	1.000000e+0	5.221545e+1	1.915142e-2	1	1.915142e-2	1.000000e+0	7	2.073340e-2	1.000000e+0	1.000000e+0	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	FHL2
MSigDB Immunologic Signatures	GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_DN	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) cultured for 0 h versus PBMC cultured for 12 h with YF17D vaccine.	32	1.926059e-2	1.000000e+0	1.000000e+0	5.191950e+1	1.926059e-2	1	1.926059e-2	1.000000e+0	46	2.237830e-2	1.000000e+0	9.291859e-1	4.443596e+1	2.250430e-2	1	203	5.000000e-1	4.926108e-3	unnamed	C2orf49
MSigDB Immunologic Signatures	GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MONOCYTE_UP	Genes up-regulated in comparison of monocytes from TIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination	33	1.960928e-2	1.000000e+0	1.000000e+0	5.099626e+1	1.960928e-2	1	1.960928e-2	1.000000e+0	38	2.183015e-2	1.000000e+0	1.000000e+0	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	C2orf49
MSigDB Immunologic Signatures	GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_UP	Genes up-regulated in comparison of memory CD4 [GeneID=920] T cells from young donors treated with TSST at 16 h versus those from old donors treated with TSST at 16 h.	34	1.966926e-2	1.000000e+0	1.000000e+0	5.084075e+1	1.966926e-2	1	1.966926e-2	1.000000e+0	6	2.040425e-2	1.000000e+0	1.000000e+0	4.875946e+1	2.050884e-2	1	185	5.000000e-1	5.405405e-3	unnamed	C2orf49
MSigDB Immunologic Signatures	GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_UP	Genes up-regulated in comparsion of ActCD8 versus ActCD4 (see Fig. 1 in the paper for details).	35	2.014422e-2	1.000000e+0	1.000000e+0	4.964204e+1	2.014422e-2	1	2.014422e-2	1.000000e+0	12	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	FHL2
MSigDB Immunologic Signatures	GSE17721_LPS_VS_PAM3CSK4_0.5H_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 0.5 h versus DC cells stimulated with Pam3Csk4 (TLR1/2 agonist) at 0.5 h.	36	2.022880e-2	1.000000e+0	1.000000e+0	4.943446e+1	2.022880e-2	1	2.022880e-2	1.000000e+0	15	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	C2orf49
MSigDB Immunologic Signatures	GSE17721_4_VS_24H_CPG_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with CpG DNA (TLR9 agonist) at 4 h versus those stimulated with CpG DNA (TLR9 agonist) at 24 h.	37	2.039166e-2	1.000000e+0	1.000000e+0	4.903967e+1	2.039166e-2	1	2.039166e-2	1.000000e+0	19	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	FHL2
MSigDB Immunologic Signatures	GSE13229_IMM_VS_MATURE_NKCELL_UP	Genes up-regulated in comparison of immature NK cells versus mature NK cells.	38	2.084607e-2	1.000000e+0	1.000000e+0	4.797066e+1	2.084607e-2	1	2.084607e-2	1.000000e+0	8	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	C2orf49
MSigDB Immunologic Signatures	GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_DN	Genes down-regulated in comparison of memory CD4 [GeneID=920] T cells from young donors treated with TSST at 16 h versus those from old donors treated with TSST at 16 h.	39	2.097092e-2	1.000000e+0	1.000000e+0	4.768507e+1	2.097092e-2	1	2.097092e-2	1.000000e+0	15	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	FHL2
MSigDB Immunologic Signatures	GSE10325_CD4_TCELL_VS_LUPUS_CD4_TCELL_DN	Genes down-regulated in comparison of healthy CD4 [GeneID=920] T cells versus systemic lupus erythematosus CD4 [GeneID=920] T cells.	40	2.106344e-2	1.000000e+0	1.000000e+0	4.747562e+1	2.106344e-2	1	2.106344e-2	1.000000e+0	32	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	FHL2
MSigDB Immunologic Signatures	GSE3982_CTRL_VS_LPS_48H_DC_UP	Genes up-regulated in comparison of untreated dendritic cells (DC) versus DCs treated with LPS (TLR4 agonist) at 48 h.	41	2.113892e-2	1.000000e+0	9.847643e-1	4.730610e+1	2.113892e-2	1	2.113892e-2	1.000000e+0	46	2.237830e-2	1.000000e+0	9.291859e-1	4.443596e+1	2.250430e-2	1	203	5.000000e-1	4.926108e-3	unnamed	FHL2
MSigDB Immunologic Signatures	GSE3982_DC_VS_NKCELL_UP	Genes up-regulated in comparison of dendritic cells (DC) versus NK cells.	42	2.124184e-2	1.000000e+0	9.659980e-1	4.707691e+1	2.124184e-2	1	2.124184e-2	1.000000e+0	45	2.226868e-2	1.000000e+0	9.451818e-1	4.465594e+1	2.239344e-2	1	202	5.000000e-1	4.950495e-3	unnamed	FHL2
MSigDB Immunologic Signatures	GSE11924_TH1_VS_TH17_CD4_TCELL_UP	Genes up-regulated in comparison of Th1 cells versus Th17 cells.	43	2.175643e-2	1.000000e+0	9.663903e-1	4.596343e+1	2.175643e-2	1	2.175643e-2	1.000000e+0	1	1.068704e-4	2.041225e-1	2.041225e-1	9.647594e+1	2.073056e-2	2	187	1.000000e+0	1.069519e-2	unnamed	C2orf49,FHL2
MSigDB Immunologic Signatures	GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_UP	Genes up-regulated in comparison of untreated CD25+ T effector cells at day 10 versus untreated CD25- T cells at day 10.	44	2.178263e-2	1.000000e+0	9.455642e-1	4.590815e+1	2.178263e-2	1	2.178263e-2	1.000000e+0	32	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	FHL2
MSigDB Immunologic Signatures	GSE3982_MAC_VS_NKCELL_UP	Genes up-regulated in comparison of macrophages versus NK cells.	45	2.181443e-2	1.000000e+0	9.259014e-1	4.584121e+1	2.181443e-2	1	2.181443e-2	1.000000e+0	38	2.183015e-2	1.000000e+0	1.000000e+0	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	C2orf49
MSigDB Immunologic Signatures	GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP	Genes up-regulated in comparison of CD4 [GeneID=920] thymocytes versus naive CD4 [GeneID=920] T cells from cord blood.	46	2.191022e-2	1.000000e+0	9.097504e-1	4.564081e+1	2.191022e-2	1	2.191022e-2	1.000000e+0	43	2.215906e-2	1.000000e+0	9.842745e-1	4.487811e+1	2.228258e-2	1	201	5.000000e-1	4.975124e-3	unnamed	FHL2
MSigDB Immunologic Signatures	GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP	Genes up-regulated in comparison of CD4 [GeneID=920] thymocytes versus naive CD4 [GeneID=920] T cells from adult blood.	47	2.231274e-2	1.000000e+0	9.067518e-1	4.481744e+1	2.231274e-2	1	2.231274e-2	1.000000e+0	46	2.237830e-2	1.000000e+0	9.291859e-1	4.443596e+1	2.250430e-2	1	203	5.000000e-1	4.926108e-3	unnamed	FHL2
MSigDB Immunologic Signatures	GSE9037_WT_VS_IRAK4_KO_BMDM_UP	Genes up-regulated in comparison of untreated wild type macrophages at 4 h versus those from IRAK4 [GeneID=51135] deficient mice at 4 h.	48	2.460623e-2	1.000000e+0	9.791229e-1	4.064012e+1	2.460623e-2	1	2.460623e-2	1.000000e+0	22	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	FHL2
MSigDB Immunologic Signatures	GSE36392_TYPE_2_MYELOID_VS_MAC_IL25_TREATED_LUNG_UP	Genes up-regulated in comparison of type 2 myeloid (T2M) cells treated with IL25 [GeneID=64806] versus macrophages treated with IL25 [GeneID=64806].	49	2.505265e-2	1.000000e+0	9.765421e-1	3.991594e+1	2.505265e-2	1	2.505265e-2	1.000000e+0	8	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	FHL2
MSigDB Immunologic Signatures	GSE7460_TREG_VS_TCONV_ACT_UP	Genes up-regulated in comparsion of ActTreg versus ActCD4 (see Fig. 1 in the paper for details).	50	2.544316e-2	1.000000e+0	9.719287e-1	3.930329e+1	2.544316e-2	1	2.544316e-2	1.000000e+0	19	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	FHL2
MSigDB Immunologic Signatures	GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_DN	Genes down-regulated in comparison of intrathymic T progenitor cells (ITTP) versus thymic stromal cells.	51	2.716302e-2	1.000000e+0	1.000000e+0	3.681475e+1	2.716302e-2	1	2.716302e-2	1.000000e+0	32	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	FHL2
#
# Ontology	TermsTested	MinAnnotCount	MaxAnnotCount
#
# GO Molecular Function	3688	1	Inf
# GO Biological Process	10440	1	Inf
# GO Cellular Component	1265	1	Inf
# Mouse Phenotype	7918	1	Inf
# Human Phenotype	6146	1	Inf
# Disease Ontology	2235	1	Inf
# MSigDB Cancer Neighborhood	427	1	Inf
# Placenta Disorders	3	1	Inf
# PANTHER Pathway	152	1	Inf
# BioCyc Pathway	332	1	Inf
# MSigDB Pathway	1320	1	Inf
# MGI Expression: Detected	9337	1	Inf
# MSigDB Perturbation	3364	1	Inf
# MSigDB Predicted Promoter Motifs	615	1	Inf
# MSigDB miRNA Motifs	221	1	Inf
# InterPro	9422	1	Inf
# TreeFam	8126	1	Inf
# HGNC Gene Families	478	1	Inf
# Ensembl Genes	18041	1	Inf
# MSigDB Oncogenic Signatures	187	1	Inf
# MSigDB Immunologic Signatures	1910	1	Inf
